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Abstract
This thesis is concerned with the development and implementation of 11C carbon disulfide as
a method of radiolabelling molecules to form radiotracers for application in positron emission
tomography (PET).
The development of the synthetic route to [11C] carbon disulfide is described. The preferred
synthesis method for the main body of this work was to pass [11C] methyl iodide over sulfur
at high temperature. Other methods of [11C] carbon disulfide production were also explored
including synthesis from [11C] methane and also direct synthesis in the cyclotron target.
Following the improved and robust synthesis of [11C] carbon disulfide a series of radiolabelled
thiourea compounds were synthesised from the reaction of [11C] carbon disulfide and amines.
This thiourea production method was further developed into the synthesis of 2 potential
radiotracers. The progestin inhibitor tanaproget, and the CXCR4 inhibitors IT1a and IT1t
which are still undergoing synthetic development.
As well as [11C] carbon disulfide, [11C] ammonium thiocyanate was also explored as a potential
[11C] radiolabelling reagent, with interest paid to its nucleophilic properties. Ammonium
thiocyanate formed from the reaction of carbon disulfide with ammonia in solution. A series of
[11C] phenacyl thiocyanate compounds were synthesised from the reaction of [11C] ammonium
thiocyanate and acetophenone precursors. These [11C] radiolabelled phenacyl thiocyanates
were reacted on to form a series of analogous radiolabelled thiazole compounds.
Once a more comprehensive understanding of the chemistry surrounding [11C] carbon disul-
fide had been established, a series of experiments were carried out in order to trap [11C]
carbon disulfide on a cooled microfluidic device (MFD) before passing a droplet of precursor
along the reaction channel of the MFD to react with the trapped [11C] carbon disulfide, form-
ing the desired product, in this case monocyclohexyldithiocarbamate cyclohexylammonium
salt.
The final chapter, while not directly related to PET applications investigates the use of
microfluidic and flow systems for the homogeneous and heterogeneous hydrogenation of a
range of alkanes. The hydrogenation of styrene to ethylbenzene was used as a model reaction
of the testing of various experimental set-ups including stopped flow, and continuous flow
in a range of flow systems. During annular flow experiments in a microfluidic device the
deposition of a rhodium deposit was also collected and analysed for its catalytic properties.
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Chapter 1
Introduction
1 Positron Emission Tomography
Positron Emission Tomography (PET) is a powerful molecular imaging technique that is
used to study and visualise biological processes in living organisms; its uses include drug
development, preclinical and clinical imaging. The technique uses short lived positron emit-
ting radiopharmaceuticals which can provide information on metabolism, receptor/enzyme
function, tissue and organ function along with biochemical mechanisms within living tissue
in real time. This differs from other clinical imaging modalities such as magnetic resonance
imaging (MRI) or computer tomography (CT) which are predominantly used to give detailed
anatomical images.
The PET imaging technique relies on positron emitting radiopharmaceuticals (also known
as a tracer) that have been administered to the subject. As the radiopharmaceutical is
distributed around the body to the desired target, the radioactive isotope within the tracer
molecule decays by emission of a positron. The decay process involves the emission of a
positron (β+) from the nucleus, that results in the conversion of the radioisotope to a new
1
Fig. 1.1 Decay equation of 11C to 11B- with the emission of a positron and a neutrino
stable atom with a lower atomic number. The example of C-11 to B-11 is shown in Fig. 1.1.
The emitted positron has a high kinetic energy and can travel a mean distance of between 1
and 5 mm in tissue;1 depending on the specific radioisotope and its positron energy, before
interacting with an electron and undergoing an annihilation process. This process produces
two approximately antiparallel gamma (γ) rays with an energy of 511 keV. These gamma rays
have enough energy to penetrate through the tissue and out of the subject where they are
detected by a ring of photon detectors (Fig. 1.2). The PET techniques relies upon coincident
detection of the antiparallel gamma rays in order to build up a an image of the subject.
Millions of decays and annihilation events are necessary to build up an image showing the
location and also local density of the tracer in the subject.
1.1 Radioisotopes
A range of different radioisotopes are available for PET. They have different physical charac-
teristics such as half-lives, decay properties and production methods. The choice of which one
to use is dependant on the biological question and the time frame involved. It is also guided
by the chemistry available to label compounds of interest. Some of the common shorter lived
isotopes include 18F, 11C, 13N and 15O (Table 1.1). It is often desirable to use isotopes with
shorter half-lives in order to minimise radiation exposure to the patient. However longer lived
metal isotopes such as 64Cu and 89Zr are increasingly being used, particularly for imaging
longer biological processes such as antibody action and longer lived oncological processes.2,3
One of the main challenges that PET chemists face is the short time frame in which they have
to perform the necessary chemistry in order to incorporate the radionuclide into the tracer
2
Fig. 1.2 Schematic showing the release of a positron from a radionuclide followed by the
annihilation with an electron to give two gamma rays
Table 1.1 Commonly used β+ emitting radionuclide and their formation in the cyclotron.
Radionuclide Half-life, t1/2 (mins) Nuclear reaction
15O 2.04 15N(d,n)15O
13N 9.97 16O(p,α)13N
11C 20.4 14N(p,α)11C
18F 109.7 20Ne(d,α)18F
18H2O(p,n)
18F
64Cu 12.7 hours 64Ni(p,n)64Cu
89Zr 3.3 days 89Y(p,n)89Zr
3
molecule. The entire process from radionuclide production in the cyclotron to administering
the tracer to the patient; which includes, synthesis, purification and quality control should
take place within approximately three half-lives. Longer than this will result in poor specific
activity (SA); where SA is defined as the amount of radioactivity of a radiotracer per unit
mass of the labelled compound, i.e the number of gigabequerels per micromole of radiotracer,
and is represented by the units GBq/µmol. A low SA results in a poor quality image due
to competitive binding from ’cold’ unlabelled compounds, hence this can obscure the PET
signal due to a high signal to noise ratio from unbound radiotracer.4
Due to their favourable physical characteristics, half-lives and chemical properties, 18F and
11C are the most commonly used radioisotopes for PET imaging. Their half-lives allow
enough time to carry out necessary chemical steps between cyclotron bombardment and
administration to the subject, while being short enough to provide a high quality image
without excessive radiation exposure to the subject.
Both 18F and 11C have their advantages and disadvantages over one another. 18F has a
longer half-life (109.7 min) making synthesis more straightforward and allowing for multiple
synthetic steps and a low positron energy (0.64 MeV) which gives a theoretically high spatial
resolution. However the fluorine atom is not usually found in biologically relevant molecules,
therefore its incorporation into a PET radiotracer will involve some degree of substance
alteration which can subsequently affect how the molecule behaves in the body. 11C has a
larger positron energy (0.96 MeV) which in theory results in a poorer resolution, however
it has been shown that this effect is largely insignificant as the physical size of the detector
element usually plays the dominant role in determining resolution.5 The shorter half-life (20.4
min) means that in practice the range of available chemistry is limited. Importantly carbon
is present in all naturally occurring biological compounds and can therefore be introduced
into a molecule without affecting its biological properties. Our ability to synthesise complex
carbon containing molecules through our understanding of organic chemistry allows much
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better control and design of 11C PET tracers when compared to 18F. One of the key difficulties
for 18F radiotracers is for them to cross the blood brain barrier (BBB) and enter the brain to
image certain central nervous system (CNS) diseases and functions. This difficulty is largely
due to the effect the 18F atom has on a small molecules lipophilicity. In these instances 11C
is particularly suited to the development of these CNS radiotracers.
The short labelling time-frame is not the only challenge that PET chemists face when com-
pared to normal synthetic chemistry. The quantity of the radioisotope produced in the
cyclotron is typically on the order of nanomoles, this means that reactions must be pre-
formed on a very small scale. The non-radioactive precursor reagents will be in huge excess
to the radioactive species which has an effect on the kinetics of the reaction making them
pseudo-first-order. Secondly, due to the radioactive nature of the chemistry all reactions must
be performed behind lead shielded hot cells and manual manipulation should be minimised,
using automated systems where possible. This is a considerable technical challenge, hence
automated and miniaturised reaction systems are commonly used.
1.2 Common PET radiotracers
The most commonly used PET tracer in clinical studies is [18F]fluoro-2-deoxy-D-glucose
(18FDG)(Fig. 1.3, Fig1.4a), a labelled analogue of glucose. It is made on a large scale
commercially in PET centres worldwide. The 110 minute half-life of 18F allows for production
and scanning centres to be separate, eliminating the need for on-site cyclotrons. Being a
glucose analogue 18FDG behaves in a similar manner to glucose when inside the body. It is
transported around the blood stream and taken up by tissues as an energy source; tissues
with a higher energy requirement, such as cancerous cells, take up a higher proportion than
healthy cells. Once inside the cell the 18FDG is phosphorylated by hexokinase to 18FDG-
6-phosphate. The usual glycolysis pathway involves the phosphoglucose isomerase enzyme
isomerising the α-D-glucose 6-phosphate into β-D-fructose 6-phosphate, this step uses the
5
Fig. 1.3 18FDG scan of a human brain with red areas showing higher uptake of the radio-
tracer indicating more active areas of the brain.
2-hydroxy group. However in the case of 18FDG this 2-hydroxy group has been replaced
with 18F which prevents this process from occurring. This causes the accumulation of 18FDG
in the cells and prevents further metabolisation. 18FDG is used in a variety of PET studies
including oncology, neurology and cardiology accounting for over 90% of all PET scans carried
out with a sales total of over $ 416 million in 2012.6,7
Another widely used 18F tracer is [18F]-DOPA (Fig 1.4b), an analogue of L-DOPA which is
itself a precursor to the neurotransmitter dopamine. 18F-DOPA is used as a radiotracer to
image the concentration of dopamine receptors in the brain. Due to the high physiological
rate of metabolism by normal brain tissue, the difference between healthy brain tissue and
tumours is only small, therefore 18FDG is less suitable.8 18F-DOPA is primarily used for
imaging Parkinson’s disease. Also many brain tumours are known to accumulate L-dopa,
therefore making 18F-DOPA an excellent imaging agent.9
Pittsburgh compound B (PiB) is a 11C radiotracer (Fig 1.4c) analogous to the dye thioflavin
T. It is used to image β-amyloid plaques in the neuronal tissue. The build up of these plaques
6
(a) [18F]-FDG (b) [18F]-DOPA
(c) [11C]-PiB (d) [11C]-carfentanil
(e) [11C]-flumazenil (f) [11C]-raclopride
Fig. 1.4 Some commonly used PET tracers
is a consequence of Alzheimer’s disease, hence PiB is used to study patients who suffer from
this disease. It is synthesised by trapping 11CH3I in a DMSO solution of target precursor and
heating for 5 minutes at 95 oC.10 18F PET tracers have also been developed for the imaging of
β-amaloid plaques including 18F-FDDNP (2-(1-6-[(2-[fluorine-18]fluoroethyl)(methyl)amino]-
2-naphthyl-ethylidene)malononitrile) and 18F stilbene derivatives.11,12
[11C]Carfentanil (Fig 1.4d) is an opioid receptor ligand commonly used in the study of pain13
and [11C]flumazenil (Fig 1.4e) used for the imaging of benzodiazepine receptors associated
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with epilepsy and Alzheimer’s disease, have both been synthesised using 11CH3I in the cap-
tive solvent method. Whereby 11CH3I is trapped in a solution of the radiotracer precursor
and heated to give the desired radiolabelled product. 11C-Raclopride (Fig 1.4f) is an an-
tagonist of D2 dopamine receptors. It is used to assess the degree of dopamine binding to
the D2 dopamine receptor, as well a method to determine the efficacy and neurotoxicity of
dopaminergic drugs. Studies have shown that schizophrenic patients have lower binding of
11C-raclopride compared to healthy patients.14 The original synthetic procedure for the pro-
duction of 11C-Raclopride involved the methylation using 11CH3OTf.
15,16 However it has also
been synthesised via a different radiolabelling approach involving the palladium mediated
carbonylation using 11CO.17
1.3 Carbon-11
11C has a number of properties that make it particularly desirable for PET imaging, how-
ever its short half-life (20.4 min) makes its chemistry challenging, with approximately 1 hour
between end of bombardment (EOB) in the cyclotron to subject administration. The sub-
stitution of a 12C for a 11C atom within a molecule will not affect the molecules structure,
polarity, lipophilicity or charge. Therefore the molecules’ biodistribution, target affinity and
selectivity will also remain unchanged. There is a vast library of preclinical studies which
have been carried out on a wide range or organic lead molecules, these studies act as an
excellent source for the development of novel PET tracers. It is often desirable to ensure
minimal changes in the target compound structure. If the structure is changed then biologi-
cal parameters may vary leading to lower levels of confidence of results from the original lead
compound. Labelling with 11C cannot be achieved by a simple atom exchange. It is neces-
sary to incorporate the 11C atom into the molecule using specialised 11C chemical labelling
reagents and techniques.
11C is typically produced in a cyclotron from the bombardment of 14N by protons. Protons
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are generated by the ionisation of hydrogen gas in an arc ion source, these ions enter into the
centre of the cyclotron between the dee electrodes, these accelerate the ions in a circular path
towards the outer circumference of the cyclotron before the accelerating ion beam is deflected
from its path and into the target. This proton bombardment into the target gas causes the
ejection of an α particle from the nucleus of the 14N atom resulting in the formation of a
11C atom (14N(p,α)11C). This naked radioisotope immediately reacts with trace amounts of
oxygen in the nitrogen target gas (0.5 %) to form 11CO2. In some cases the target nitrogen
gas is instead doped with trace amounts of hydrogen which results on the formation of 11CH4
however the formation of 11CO2 is more widely used as not all cyclotron target systems have
the capability of forming 11CH4. Once formed
11CO2 is released from the target into a trap
located in either a minicell or hotcell, here it can undergo a wide range of reactions, either
to other radiolabelling reagents such as 11CH3I,
11CH3OTf, H
11CN,11COCl2 and
11CS2 or
incorporated directly into a molecule via carbonylation reactions.
2 11C labelling methods
The suitability of 11C for PET has led to a wide range of 11C labelled molecules which have
been extensively studied. Almost all 11C labelled compounds for PET are made from either
11CO2 or
11CH4. There has been significant amounts of research into converting
11CO2 and
11CH4 into secondary precursors which are more reactive for labelling purposes (Fig. 1.5).
Although 11CH4 can be produced in target it is most commonly synthesised by converting
11CO2 to
11CH4. First trapping the
11CO2 and passing it through an oven at 400
oC in the
presence of hydrogen gas and a nickel catalyst. 11CH4 is typically used to produce
11CH3I
for labelling.
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Fig. 1.5 The most commonly used 11C precursors derived from 11CH4 or
11CO2
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2.1 11C-methyl iodide
The most common method of incorporating 11C into a target molecule is via a methylation
reaction using 11CH3I.
19 This is typically synthesised directly from 11CH4 via high temper-
ature iodination reaction. 11CH3I is a versatile methylating reagent which has been used
to label a wide range of compounds. It has a range of chemical properties which make it
particularly attractive as a radiolabelling reagent, its reactivity enables the methylation of
N, O ans S groups to take place quickly and under mild conditions. Its low boiling point (42
oC) means that it is liquid at room temperature so is easily trapped, but can be transferred
between reaction vessels in a straightforward manner with mild heating or a gas flow.
There are two common methods to produce 11CH3I. The gas phase method that uses
11CO2
or 11CH4, or the so-called ’wet method’ that uses
11CO2. The gas phase method is most
common, and can be achieved using automated and commercially available units. Typically
the 11CO2 is first trapped at -170
0C before being released trough an oven at 450 oC with a
flow of hydrogen in the presence of a nickel catalyst forming 11CH4 and subsequently trapped
at -100 0C. This is released from the trap and circulated through the high temperature (750
10
oC) oven with iodine gas, via a free radical reaction to form 11CH3I.
18 This is then trapped
on a porapak support before being released into the hotcell in a stream of helium carrier gas.
This process is commonly carried out in automated synthesis units in the radiochemistry
lab one such commercial system is the Synthra unit (Fig. 1.6). The alternative method,
know as the wet method involves the reduction of 11CO2 with LiAlH4 followed by reaction
with hydroiodic acid.20 However yields and specific activities are typically lower than the gas
phase method.
Fig. 1.6 Image of a Synthra MeI production unit
The primary method of labelling with 11CH3I is nucleophilic substitution, most commonly
at a heteroatom such as N, O or S. Methylation reactions are the current standard route
to many of the common 11C tracers, such as Pittsburgh compound B (PiB),21–23 raclopride
(Scheme 1.1)15,16,24 and carfentanil.25–27
In addition to direct methylation reactions there are also a number of examples of indirect
labelling methods using 11CH3I. This is beneficial where there are multiple sites on the target
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Scheme 1.1 Methylation using 11CH3I to form
11C-Raclopride
precursor which are susceptible to being methylated, for example labelling a methylamine
to give 11C-dimethylamine before reacting this with the target precursor.28 Transition metal
catalysts have also been used to aid methylation reactions. The palladium mediated Suzuki
and Stille coupling reactions have been widely used in the formation of 11C-methylated targets
in a wide range of PET applications; the methods not only improves reaction time but
ensures labelling occurs in the correct position.28 This has been demonstrated in the synthesis
of [11C]MENET ([11C](2S,3S)-2-[α-(2-methylphenoxy)phenylmethyl] morpholine) via Suzuki
coupling with 11CH3I.
29 A popular alternative to 11CH3I is
11C-methyl triflate.30 Its increased
reactivity provides an alternative strategy when radiochemical yields (RCY) using 11CH3I are
poor. It is synthesised by passing 11CH3I though an oven at 200
oC in the presence of silver
triflate. 11CH3I generally takes precedence over
11CH3OTf unless
11CH3I is not sufficiently
reactive, this is to reduce the number of steps in the reaction where possible which could
lead to losses in SA and RCY. Aside from 11CH3OTf,
11CH3I is also used for the synthesis
of a range of other secondary radiolabelling reagents (Fig. 1.5) including 11C radiolabelled
formaldehyde, carbon disulfide and nitromethane. Many of these reactions are fast and high
yielding, a greater range of available 11C radiolabelling reagents enables a wider range of
positions which can be labelled and subsequently more 11C radiotracers can be developed.
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2.2 11C-carbon dioxide
Although 11CO2 is primarily converted to more reactive secondary precursors, it is a useful
labelling reagent in its own right. Using 11CO2 straight from the cyclotron has the advantage
of saving considerable time that would be spent performing multiple reactions to give a
secondary precursor. However the specific activity of 11CO2 labelled tracers may be poor if
care is not taken to exclude atmospheric CO2 from the reaction. Trapping of gasses such as
11CO2 can also present some complications with regards to efficient labelling reactions.
The most common reaction carried out using 11CO2 is the reaction with Grignard and organo-
lithium reagents.31,32 From these reagents it is straight forward to make either 11C-carboxylic
acids via quenching with water or 11C-carbamides if reacted with an amine. These carboxylic
acids can be converted to more reactive acid chlorides via reaction with thionyl chloride chlo-
rinating reagent, thereby allowing further chemical transformations. Perhaps the most inter-
esting applications of 11CO2 is the formation of ureas
33 since they are particularly prevalent
in biological molecules. These have been prepared using a triphenylphosphine precursor to
form 11C-phenylisocyanate before reaction with amines to give the 11C-urea (Scheme 1.2).34
Similarly to this work on ureas, 11C-carbamate molecules have also been synthesised using a
strong bulky base to trap and react the 11CO2 with primary and secondary amines.
35,36
Scheme 1.2 Formation of 11C labelled ureas from 11CO2 with triphenylphosphine and an
amine
2.3 11C-carbon monoxide
11C-carbon monoxide can be synthesised in a short time frame by reducing 11CO2 over either
molybdenum or zinc at 850 oC or 450 oC respectively.37 The major drawback of 11CO is
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its poor solubility in many common organic solvents, making it difficult to trap and conse-
quently react. This problem has been addressed by a number of approaches; high pressure
systems using HPLC or autoclaves,38,39 chemical trapping agents such as boranes40 or cop-
per tris(pyrazole)borate complexes41–43 and microfluidic systems44,45 which improve the mass
transport and diffusion of the 11CO gas in the liquid phase. The majority of aromatic car-
bonylations reported use a palladium catalyst17 although there have also been examples of
rhodium catalysed carbonylations too.46,47 A wide range of carbonyl containing tracers can
be labelled including ketones, imides, esters, amides, carboxylic acid and acrylamides. Aside
from transition metal catalysed reactions there have also been reports of ultra violet (UV)
light mediated reactions. A distinct advantage of this method is the ability to label aliphatic
positions in target molecules rather than aromatic.48–51
2.4 11C-carbon disulfide
11C-carbon disulfide has been synthesised from 11CH3I using both P2S5 and elemental sulfur
in a furnace with excellent RCY and RCP in a short reaction time.52,53 Thus far it has been
reacted with primary and secondary amines to form dithiocarbamates and isothiocyanates.
It holds promise as being a useful radiolabelling reagent in the field of PET and radiotracer
development, in particular the formation of complex sulfur containing heterocyclic ring com-
pounds, allowing radiolabelling of molecules and in positions not currently possible with
other radiolabelling reagents available.
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2.5 Other 11C precursors
2.5.1 11C-Hydrogen cyanide
11C-Hydrogen cyanide can be synthesised via the high temperature reaction of 11CH4 with
ammonia in the presence of an platinum catalyst.54 It can be used to attach a labelled
nitrile group to a target, the nitrile group is present in a number of important drug
molecules and occurs commonly in biologically relevant compounds. Examples of the in-
troduction of the [11C]nitrile group using [11C]hydrogen cyanide include the formation of
[11C]methyl-2-cyanoisonicotinate and [11C]cyano-1-succinonitrile.55 Palladium mediated re-
actions can also be used to introduce the 11CN group into the tracer molecule.56 Aside from
direct reactions with the precursor and [11C]hydrogen cyanide, there are examples where the
[11C]hydrogen cyanide has been converted to a more reactive species such as tetrabutylam-
monium [11C]cyanide, which when reacted with N-activated aziridine-2-carboxylates forms
a [11C] labelled amino acid.57 [11C]hydrogen cyanide can also be converted to [11C]CuCN
which reacts readily with aryl halides via the Rosenmund-von Braun reaction.58,59 Once the
nitrile group has been used to label a molecule there are a number of possible reactions to
convert the group into other potentially more stable [11C] labelled functional groups such as
amides,56 guanidines60 and thiocyanates.61,62
2.5.2 11C-Phosgene
[11C]Phosgene can be prepared from the reaction of 11CH4 with a chlorinating reagent such
as Cl2 gas to form
11CCl4 before an oxidation step over an iron catalyst,
63 this however is not
a straight forward synthesis. More recently a room temperature method has been developed
which converts 11CCl4 to [
11C] phosgene by passing it through a pretreatment tube of a gas
detection system, RCY of up to 80% were reported.64 Despite its synthetic difficulty it is
a versatile carbonyl labelling reagent due to its fast reactivity and selectivity, with a wide
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range of carbonyl functionalities having been reported. These include symmetrical and un-
symmetrical ureas, carbonates, carbamate, carbamoyl chlorides, amides and uric acids.65,66
The majority of these functional groups are formed through the carbamoyl chloride interme-
diate which is also highly reactive towards many different functionalities and reagents.
3 Carbon disulfide reactivity
Carbon disulfide is a commonly used reagent and solvent in organic chemistry. It is anal-
ogous to its isoelectric counterpart carbon dioxide. However it also has clear differences in
its physical and chemical properties. Most apparent is that CS2 is a volatile liquid at room
temperature rather than a gas. Due to the weaker C=S bond it is also considerably more
reactive than CO2. CS2 is widely used in chemical industry for the formation of dithiocarba-
mates, xanthates, and thioureas (Scheme 1.3).52,67 The use of carbon disulfide as a solvent
was common for the industrial extraction of oil and waxes as well as uses in the rubber and
polymer industries, however due to its toxicity it is now used less frequently. Its low b.p.
(46.2 oC) allows for its easy removal. The most common use of CS2 as a solvent is for the
Friedel-Crafts and halogenation reactions.68,69
Scheme 1.3 Reaction of carbon disulfide with an alcohol to form a xanthate salt and
reaction with an amine to form dithiocarbamate salt and subsequently thiourea with heating.
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3.1 Synthesis of carbon disulfide
Traditionally carbon disulfide was produced by heating sulfur with charcoal or coke.70 This
process was improved in the 1940’s in the reaction between methane and sulfur at a temper-
ature of 600 oC over a silica or alumina catalyst, and is still currently used on an industrial
scale known as the Thacker process.71 Annually approximately 1 million tonnes is produced
with around 50% being used in China, the primary use being for the production of rayon
fibre.72 The synthesis of 11CS2 has recently been reported by reaction of
11CH3I over P2S5 at
380 0C for its potential use as a radiolabelling reagent.52
3.2 Reaction of carbon disulfide with 10 amines and ammonia
The reaction of carbon disulfide and amines typically form dithiocarbamate salts. Dithio-
carbamates are versatile organosulfur compounds that can be transformed into a wide range
of more complex sulfur containing molecules depending on the conditions and reagents. The
reaction of a primary or secondary amine in the presence of a base; either a hydroxide salt
or an excess of amine, will proceed quickly to form the dithiocarbamate salt. Mechanistic
studies show that the rate of the formation of the salt is proportional to the pKa of the amine
in inversely proportional to the pH of the solution.73
Reaction of these dithiocarbamate salts with an alkyl halide results in the formation of the
corresponding neutral alkylated esters (Scheme 1.4).52 Alternatively it is possible to form
isothiocyanates (Scheme 1.4) by a desulfurylation reaction using a range of reagents.52,74–76
Scheme 1.4 Formation of an isothiocyanate from the dithiocarbamate salt via the reaction
with POCl3 and the formation of an ester by reaction with methyl iodide.
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When an excess of primary amine is reacted with carbon disulfide, the dithiocarbamate salt is
formed with the corresponding primary ammonium counter ion. Heating this salt undergoes
a rearrangement whereby hydrogen sulfide is eliminated and the symmetrical thiourea is
formed (Scheme 1.5).77 Alternatively, if an excess of another amine (primary or secondary)
is added prior to heating then the unsymmetrical thiourea constituting of both amines will
be formed (Scheme 1.6), however mixtures are likely.78 In a similar way that two different
amines form thiourea upon heating, diamines can also react with carbon disulfide to give
cyclic thioureas.79 Analogous to the formation of cyclic thioureas from diamines, the reaction
of 2-amino alcohols with carbon disulfide initially forms a dithiocarbamic acid before cyclising
in situ to form the corresponding oxazolidine-2-thione upon the loss of hydrogen sulfide,80
or the alternative thiazolidine-2-thione upon the loss of water (Scheme 1.7).81
Scheme 1.5 Reaction of carbon disulfide with an excess of cyclohexylamine to form dithio-
carbamate salt followed by the symmetrical 1,3-dicyclohexylthiourea.
Scheme 1.6 Reaction of carbon disulfide with an excess of benzylamine to form dithio-
carbamate salt followed by the addition of an excess of piperidine to give the unsymmetrical
thiourea product.
The reactivity of ammonia with carbon disulfide differs to that of primary amines. As with
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Scheme 1.7 Reaction of carbon disulfide with 2-amino alcohols to form dithiocarbamic
acid followed by the formation of oxazolidine-2-thione upon the loss of hydrogen sulfide or
thiazolidine-2-thione upon the loss of water.
primary amines the dithiocarbamate salt is formed, in this case ammonium dithiocarbamate.
However heating will not give the thiourea product, instead ammonium thiocyanate is formed
with the elimination of hydrogen sulfide (Scheme 1.8).
Carbon disulfide will also react with a wide range of other nitrogen containing molecules;
including hydrazines, imines, azides and dithiocarbamic acids to form various other salts,
thiones and heterocyclic compounds.67
Scheme 1.8 Formation of ammonium thiocyanate from the reaction of carbon disulfide
and ammonia
3.3 Reaction with inorganics
Carbon disulfide has a wide reactivity within organic chemistry, however it also has an
interesting reactivity with inorganic elements. It will react with all of the halogens, however
only with fluorine without the use of a catalyst. The products depend on the catalyst
used however usually consist of a mixture of haloalkanes. The reactivity with compounds
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containing phosphorous, silicon, germanium and tin has been well documented within the
literature;82–84 they typically involve bond insertions, and in the presence of other reactive
functionalities cyclisation reactions can take place.
Carbon disulfide is also known to react with a range or transition metals. It is capable
of forming several modes of coordination with one or more transition metal centres, along
with a variety of insertion or disproportionation reactions.8,85 these complexes can form in
a wide range of configurations, bonding through both the carbon and sulfur atoms. This is
dependant on the charge, periodicity and group of the transition metal.
3.4 Reaction with alkynes, alkenes and dipolar species.
The reaction of carbon disulfide and alkynes vary depending of the structure of the alkyne,
most commonly forming sulfur containing heterocycles. Benzyne and cyclic alkynes react
readily due to the conformational strain on the alkyne bonds whilst linear structure are
more stable and require more forcing reaction conditions in order to react.86,87 Reactions
with alkenes are less common, largely due to the severe conditions that are necessary for a
reaction to take place. Such reactions take place in the gas phase at temperature in excess of
700 oC or at high pressures.67 Generally carbon disulfide will react readily with 1,3-dipolar
species, such as imines (Scheme 1.9), ylides, azides and nitrones. This involves the addition of
the dipolar reagent across the C=S bond forming a 5 membered heterocyclic species. In some
cases this heterocyclic system may be unstable and break apart to form an allylic product.88
3.5 Reaction with carbon nucleophiles
Due to the weaker bond strength of C=S (138 kJ/mol) compared to C=O (192 kJ/mol),
carbon disulfide is more susceptible to attack from nucleophilic reagents than carbon dioxide
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Scheme 1.9 Reaction of carbon disulfide with a 1,3-dipolar imine species to form a hete-
rocycle.
resulting in a much wider reactivity. This added reactivity also reduces the tendency of
reaction reversibility compared to carbon dioxide or carbonyl sulfide.67
Carbon atoms that have acidic protons which can be removed by a base to form a carbanion
are susceptible to nucleophilic attack by carbon disulfide, these can include ketones, imines,
nitriles.89,90 The products formed vary and can be controlled with careful selection of reagents
and conditions, such as dithiocarboxylic esters, ketene dithioacetals and dithiocarboxylic
acids.
Organometallic reagents act as stable carbanions which are able to attack carbon disulfide.
Grignard reagents react readily with carbon disulfide forming first the dithiocarboxylic acid
magnesium salt before forming the dithiocarboxylic acid (Scheme 1.10) in the presence of
a proton source.91 Yields for these reactions are often less than 50% due to a range of side
products, however in an appropriate solvent such as THF and in the presence of a haloalkane,
these side-products can be minimised. A catalytic amount of copper(I) halide can also aid
the reaction while also reducing side-products.92 As well as Grignard reagents, organolithium
compounds have been used in the synthesis of dithioester molecules, these reaction are also
copper(I) halide catalysed.93
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Scheme 1.10 Reaction of carbon disulfide with a Grignard reagent to form a dithiocar-
boxylic acid.
3.6 Reaction with alcohols
The reaction of alcohols with carbon disulfide in the presence of a base such at potassium
hydroxide yields a xanthate salt. The stability of these xanthates depends on their level
of substitution. Xanthates from primary and secondary alcohols are stable in an aqueous
medium while xanthates of tertiary alcohols hydrolyse.94 The reaction of xanthate salts with
an acid gives the corresponding xanthic acid, or when treated with haloalkanes xanthate
esters are formed. Xanthate esters have been exploited for their ability to form alkenes via
thermal decomposition, which can be of use for more complex alkenes or those with sensitive
functionalities.67
4 Microfluidics: Properties and advantages
Microfluidics is now a well-established field which is used widely in many areas of chemistry.
The technique involves using reactors consisting of a network of small channels typically
10 - 500 µm in diameter,95 designed to allow reagents to be brought together in a specific
sequence, mixed and reacted over a set time frame under a continuous flow. Fluid flow
is achieved either electrokinetically or hydrodynamically. Due to the very narrow channel
diameter the fluid dynamics behave differently to macro-scale channels and flow systems, but
far more predictably. In channels of this size it is more straightforward to tune the Reynold’s
number (Fig. 1.7) by adjusting flow rates so that the viscous forces dominate over the inertial
forces, resulting in a laminar flow regime (Re <2000). Despite laminar flow, mixing can be
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exceptionally fast in the micro-channels owing to the small diffusion distance.
Re =
inertialforces
viscousforces
=
ρvL
µ
=
vL
ν
Fig. 1.7 ρ = fluid density, v = velocity fluid through cross-sectional area, L = channel
length, µ = dynamic viscosity, ν = kinematic viscosity
There are a number of benefits associated with any miniaturised reaction vessel, such as
improved mass transfer, improved heat transfer, facile pressure control, safer synthesis of
dangerous compounds, localised temperature control, exclusion of air and moisture for sensi-
tive chemistry, easy automation, good reproducibility, minimal space requirements, reduced
solvent volumes, minimum reagent usage and reduced impurity profile from the strict control
of reaction conditions.96,97 A key factor which contributes to many of these improvements
is the high surface area to volume ratio which generally range from 10000 to 50000 m2m−3.
However many of these advantages have been brought into question by studies directly com-
paring flow and batch reactions and is an ongoing discussion.98,99
Aside from standard single phase experiments it is possible to conduct both liquid-liquid
and gas-liquid phase reactions in microfluidic reactors with relative ease. These liquid-gas
phase reactions require good liquid-gas contact through the length of the channel. There
are a number of different flow regimes which can be achieved by adjusting the relative flow
rates of the two phases: Segmented flow, where small droplets, typically a few picolitres are
separated by the gas phase, allows good gas liquid interaction along the whole length of the
reaction channel, leading to an efficient reaction process. Alternatively an increased relative
Fig. 1.8 Image of a simple microfluidic reactor chip.
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gas flow will result in an annular flow regime where gas and liquid flow through the channel
in a chaotic manner.
Due to the high surface area nature of microfluidics, the material choice is an important
consideration when choosing or designing a microreactor. There are a number of materials
which microreactors can be made from, the most simple of these reactors can consist of a
pump and a single length tubing (Fig. 1.9). Microfluidic reactors can vary from a simple
continuous channel to elaborate pieces of micro engineering with moving parts and complex
flow systems, the more complex the system however means a higher cost of prototyping and
higher production costs. The common materials used for microreactors are glass, quartz,
silicon, ceramics, steel, PDMS and other polymers. Polymer chips are particularly attractive
as they are cheap and fast to make, complex designs can be made relatively easily, and
can be gas permeable if desired. However a major downside to them is that they are often
susceptible to degradation with continuous use of organic solvents so only have a short life
span. With the rapid growth of microfluidics and flow chemistry commercially available
devices are commonplace.
Fig. 1.9 Image of a simple microfluidic reactor made from PTFE tubing.
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4.1 Use of microfluidics in PET
The intrinsic properties of microfluidics lend themselves very well to radiochemical synthesis
for the production of PET tracers. The fine control over pressure, temperature and mass
transport facilitate shorter reaction times which is key when dealing with isotopes with a
short half life. The suitability towards small volumes match the quantities of radioisotopes
produced in the cyclotron targets in addition to reducing the use of expensive precursor
reagents. The straightforward automation of the systems may allow operation by a non
chemist which is important for the technique to be used more commonly and for costs to be
reduced. Furthermore the compact size of the devices enables self shielding of the device,
possibly removing the need of a hot cell which take up valuable space which is often not avail-
able in hospital environments. Unsurprisingly these advantages have been seen by many and
a variety of examples have been demonstrated over the last decade, including commercially
available capillary based microfluidic units100–102 and also lab-on-chip devices.103 Despite the
advantages of microfluidic systems they face strong competition from the better established
automated synthesis modules such as the GE FASTlab2 or Trasis All in One universal syn-
thesiser. These have been proven to be reliable, operate at a high efficiency, are straight
forward to use, have a relativity low cost of consumables and perhaps most importantly are
in accordance with good manufacturing practices (GMP) for clinical use. This competition
however has not discouraged research groups from pursuing the developments of microfluidic
systems for PET radiotracer development.
The first example of the use of microfluidics for the radiolabelling of a PET tracer was
reported in 2003.104 Shortly after this a number of proof of concept reactions were reported
for the synthesis of both 18F and 11C radiotracers, mostly consisting of relatively straight
forward microfluidic systems. One of the key early developments in the use of microfluidics
for radiotracer design was the fully integrated synthesis of [18F]FDG (Fig. 1.10).105 Although
RCY was lower than the conventional synthetic method at the time (38% compared to
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70% respectively) and the dose produced was not sufficient for use in humans, it clearly
demonstrated the potential of microfluidics in radiochemical synthesis.
Fig. 1.10 The first fully integrated microfluidic device for the total synthesis of the radio-
tracer [18F]FDG. Taken from105
Since the synthesis of [18F]FDG on a microfluidic platform a number of other radiotracers
have also been synthesised. These include [18F]Fallypride which is a dopamine D2/D3 recep-
tor, thermal degradation during its traditional batch type synthesis increases the purification
time and number of side products making it less desirable as a clinically used tracer. Im-
plementation of a microfluidic system has achieved a 88% RCY in 94 seconds, suitable for
clinical use.106,107 [18F]Fluoroisonidazole is a radiotracer used to investigate tumour hypoxia,
using microfluidics it was possible to synthesis the tracer in yields of 60%, considerably better
than anything previously reported.103,106,108
Aside from [18F] fluorination reactions carried out in microfluidic systems there have also been
a number of examples of [11C] labelling reactions being carried out in a MFD, however far
fewer examples are available. Palladium catalysed carbonylations have been carried out using
a gaseous flow of 11CO in an annular flow of the precursor solution to give a range of amides
and lactones.45,109,110 This same work was developed into the synthesis of the neuropeptide
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receptor antagonist [11C]MK-0233, although similar RCY to the batch reaction were achieved
there was a considerable improvement in terms of safety as the 11CO was better contained.
The dopamine receptor [11C]Raclopride has also been synthesised using a microfluidic system
using two distinct labelling methods. Initially reported was methylation using 11CH3I under
continuous flow the method reduced synthesis time by 33% and required just 5% of the
MeI compared to the conventional preparation.111,112 A second approach to the synthesis of
[11C]Raclopride has been reported using the [11C]carbonylation method using a palladium
catalyst method however the more active palladium-aryl catalyst species was isolated and
used, RCY of 57% were obtained with a RCP of 94%.17 The same study also demonstrated
the synthesis of the radiotracers [11C]olaparib and [11C]JNJ31020028 in yields of 75% and
25% respectively.
5 Research objectives
As the use of PET continues to grow there is an ever increasing demand for the development
of novel PET tracers. The field is currently dominated by 18F radiotracers and in partic-
ular [18F]FDG. However there are instances where 18F radiotracers are not suited and 11C
radiotracers are still needed. The range of 11C radiolabelling techniques currently available
to researches is presently very limited, realistically confined to methylations and carbonyla-
tions. With the recent development of 11CS2 as a radiolabelling reagent it could open up
new radiolabelling methods, potential new radiolabelling positions and consequentially the
possibility new radiotracers which previously would not have been possible to label.
The aim of this research is to investigate the potential of 11CS2 as a radiolabelling reagent.
Initially to investigate its synthesis and to improve the current method into one that is faster,
higher yielding, uses less toxic reagents and is ultimately reliable and reproducible. Following
the optimisation of the 11CS2 synthesis it will be necessary to explore the reactivity of
11CS2
27
and its incorporation into molecules as a radiolabel. The focus will be on the reaction
with amines to form dithiocarbamates and thioureas. Once the synthesis of thioureas has
been established the chemistry will be further developed into the synthesis of two known
biologically active molecules and developed as radiotracers. Microfluidics will also be used in
the development of 11CS2 as a radiolabelling reagent. Using cryogenic conditions
11CS2 will
be trapped on the surface of the channel wall prior to a reagent solution being passed along
the channel and reacting with the immobilised 11CS2 as it makes contact.
A second potential radiolabelling regent (NH4S
11CN) will also be investigated as a potential
nucleophilic method of radiolabelling molecules, an approach which is not currently readily
accessible using the 11C radiolabelling reagents and methods described in the literature. Using
the thiocyanate group further reactions will be explored in order to form more complex sulfur
containing heterocyclic structures more commonly found in biologically active molecules.
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Chapter 2
Production of 11CS2 and attempted
synthesis of 11COS
1 Synthesis of 11CS2
11CS2 was first described as a potential radiolabelling reagent by Miller et al. in 2012.
52 The
first report of 11CS2 in the literature was by Nozaki et al.
113 in 1984 via a microwave discharge
method, however 11CS2 was produced in very low yields (10%), along with a mixture of other
radiolabelling compounds and was not reacted on to form any further radiolabelled molecules.
1.1 Synthesis of 11CS2 from methyl iodide
Miller et al. reported the first viable synthesis of 11CS2 via a high temperature gas phase
reaction of 11CH3I and P2S5, a commonly used thionating agent. This approach was loosely
based on previous methods for the formation of 13CS2
114 and 14CS2 (Scheme 2.1).
115
The first stage of the 11CS2 synthesis involved the conversion of the
11CO2 to
11CH3I. This
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Scheme 2.1 Formation of 11CS2 from
11CO2
was carried out in a Synthra automated gas phase 11CH3I unit. The
11CH3I stream was then
carried from the Synthra unit located in a mini-cell to the hotcell using helium carrier gas
(Fig. 2.1). Once the 11CH3I has reached the hotcell the location of the radioactive stream is
monitored by pin diodes located at specific points adjacent to the equipment (Fig. 2.2), thus
the flow of radioactivity was followed from entry in to the hotcell, through the preheated
(380oC) glass Omnifit column containing a mixture of P2S5 and sand in a Carbolite oven
to yield carbon disulfide (Scheme 2.1) and finally into the collection vial (Fig. 2.3). These
methods were fast and gave good RCY and RCP 87% and 93% respectively. The main
drawback involved the handling of the P2S5. It has a strong sulfurous smell due to its
hydrolysis with atmospheric water to form hydrogen sulfide gas and phosphoric acid, this
has obvious safety concerns which should be minimised or eliminated when possible. It was
also apparent that older samples of P2S5 led to depletion in radiochemical yields of
11CS2,
possibly due to its hydrolysis and the formation of phosphoric acid over time. The secondary
issue regarding the use of P2S5 was the difficulty of cleaning the glass columns once they had
cooled. The remaining sand and reagents formed a hard solid mass that proved incredibly
difficult to clean and remove from the glass tube without damaging the column. These
reasons led us to explore other methods of producing 11CS2 from
11CH3I. The obvious choice
was elemental sulfur itself as it is non-toxic, odourless, straightforward to handle and does
not hydrolyse.
30
Fig. 2.1 Schematic of the Synthra MeI production unit
Fig. 2.2 Monitoring the location of radioactivity by pin diodes. The black line indicates
pin diode located next to the furnace, point (a) indicating the peak in activity in the furnace.
The purple line indicates the pin diode next to the collection vial, point(b) indicating the
peak and then plateau of the activity in the trapping solution.
Fig. 2.3 Schematic of the apparatus set up for the production of 11CS2.
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1.1.1 Improved production of carbon disulfide
Initial experiments to produce unlabelled carbon disulfide in the synthesis lab involved an
adaptation of the Thacker process.71 A stream of nitrogen gas controlled by mass flow meter
was bubbled through through a vial containing methyl iodide, the outlet led to a quartz tube
connected by SwagelokTM fittings. The quartz column contained 1 g of sulfur, held in place
by quartz wool, then 1 g of pre dried silica also held in place by quartz wool , the role of the
silica was to act as a catalytic surface for the reaction to take place. The end of the quartz
column led to a collection vial, connected by SwagelokTM fittings and PTFE tubing, the vial
contained acetonitrile cooled in an ice bath where the product trapped (Fig. 2.4).
Fig. 2.4 Apparatus set up for the production of carbon disulfide from methyl iodide with
a cross sectional view through the furnace.
The furnace was preheated to 700 oC and flow of nitrogen gas started at 5 mL/min. The
sulfur was seen to melt from a yellow solid to a deep red liquid (Fig. 2.5). Purple vapour was
seen in the quartz tube indicating formation of iodine and hence the decomposition/reaction
of methyl iodide, bubbling through the collection vial was observed and maintained for 25
minutes. 13C NMR of the collected sample showed a single resonance at 192.6 ppm indicating
that carbon disulfide had successfully been produced, however the reaction was not quantified
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(a) View down the sulfur and silica column
inside the furnace
(b) Image of furnace with the silica section
of the quartz tube in the heated area
Fig. 2.5 Photographs of furnace oven system for reactions of methyl iodide.
at this stage.
Further improvements were made to optimise the production of carbon disulfide. The sulfur
and silica sections were replaced with a mixture of sand (2 g) and sulfur (1 g). The tempera-
ture of the furnace was lowered to 500 oC and the 13C NMR spectrum of the collected sample
once again indicated the formation of carbon disulfide. 500 oC was chosen for two reasons.
It was desirable to use the lowest functioning temperature as it allows the use of the more
commercially available and cheaper glass columns rather than quartz columns. Secondly to
ensure sure that there was sufficient quantities of sulfur (b.p. 445 oC) in the gas phase when
the methyl iodide passed through the column. The substitution of the sand for the silica had
a number of justifications. The silica was originally present as a catalyst for the conversion
however its roll was not obviously apparent, it was decided that a solid surface of some kind
was necessary for two reasons, primarily as a surface where the reaction could take place in
order to mediate the reaction and also to act as a support to prevent the flow of carrier gas
flushing the gaseous sulfur out of the furnace and into the tubing leading to the vial before
the 11CH3I has reached the furnace. The cleaning of the used column also proved to be more
straightforward than previous reactions using P2S5, the sulfur had distilled out of the sand
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and formed a glassy solid further along the column that could be easily removed. Once the
glass wool had been removed the sand could simply be poured out into waste.
1.1.2 Radiolabelling via the sulfur route
The quantities of methyl iodide used in these experiments are orders of magnitude larger
than what is used in the radiochemistry lab, therefore it can be reasonably expected that
quantitative or close to quantitative conversion would be seen in the radiochemistry setting.
The initial radiochemistry experiment to produce 11CS2 from sulfur aimed to mimic the
experiment in the synthetic lab as closely as possible. Cyclotron bombardment of 20 µA
for 5 minutes to give 11CO2; this was converted to
11CH3I in the Synthra
TM unit before
being delivered into the hot cell in a helium carrier gas at 10 mL/min, the gas stream passed
through the preheated column containing the sand/sulfur mix before being trapped in the
collection vial containing acetonitrile. Radio HPLC of the acetonitrile solution indicated
quantitative conversion to 11CS2 with no
11CH3I present (Fig. 2.6). The time between end of
bombardment in the cyclotron and complete delivery of activity into the collection vial was
typically just 15 minutes.
Fig. 2.6 Radio analytical HPLC of 11CS2 showing complete conversion with no radioactive
side products.
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1.1.3 Optimisation of 11CS2 production.
A range of reaction temperatures were investigated to determine the optimum temperature
for the conversion of 11CH3I to
11CS2. Temperature points of 300, 320, 340, 400 and 500
oC
were tested and the relative 11CH3I to
11CS2 conversion measured by radio analytical HPLC.
The results showed that there was a steady increase in conversion from 11CH3I to
11CS2 as
the temperature was increased from 300 oC to 400 oC. At 400 oC the conversion to 11CS2
was 100% (Fig. 2.7). 400 oC is below the boiling point of sulfur (445 oC), however due to
its low vapour pressure there must be sufficient sulfur vapour to react with the 11CH3I. This
lower temperature means that the sulfur does not distil through the heated section of the
column as it does at 500 oC; the column can therefore be reused multiple times without the
need to replace it. Hence it was determined that the optimum temperature to carry out the
conversion of 11CH3I to
11CS2 in the presence of sulfur is 400
oC.
Fig. 2.7 Plot showing the conversion of methyl iodide to carbon disulfide as a function of
temperature as measured by radio analytical HPLC.
Subsequent improvements to the synthesis include increasing the flow rate of the helium
carrier stream to 50 mL/min, this reduces the delivery time from the mini cell to hot cell
by 5 minutes and results in a time from EOB to full delivery of activity in the vial of 10
compared to 15 minutes, resulting in greater overall RCY. The optimum conditions for the
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conversion of 11CH3I to
11CS2 were therefore determined to be a furnace temperature of 400
oC and a helium flow rate of 50 mL/min.
1.2 Synthesis of carbon disulfide from methane
The short 20 minute half-life of 11C precludes long reaction times, thus any process that can
speed up reactions or reduce production times for 11C radiotracers are particularly valuable.
Since the production of 11CS2 precedes via
11CH3I, which takes 10-12 minutes to produce,
bypassing this stage would be highly advantageous. Hence the direct reaction of 11CH4
to 11CS2 could potentially save significant time in synthesis. This would enable
11CS2 to
be synthesised in just one step from cyclotron bombardment saving up to 10 minutes and
permit more elaborate labelling experiments. Carbon disulfide has been made industrially
from methane since the 1940’s71, by the reaction of sulfur with methane gas at 700 oC with
out a catalyst or at 500 oC in the presence of a silica or alumina catalyst. The system was
therefore adapted to replicate these conditions on a small scale.
Initial experiments were carried out in the synthesis lab using a furnace and quartz tube
packed sulfur and silica. The quartz tube was packed with silica gel (1 g) held in place with
two plugs of quartz wool, then sulfur (1 g) separated by a gap also held in place by plugs
Fig. 2.8 Quartz tube packed with sulfur and silica
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of quartz wool (Fig. 2.8). The quartz tube was attached to sections of PTFE tubing with
SwagelokTM connections. The methane inlet was controlled by a mass flow meter and the
outlet of the reactor placed in a cooled sample of acetonitrile-d3 for NMR analysis.
Experiments were conducted over 2 temperatures (650 and 700 oC) using 2 different methods.
Firstly with the sulfur located outside the furnace and heated to boiling with a heat gun; and
secondly, both the sulfur and silica placed in the furnace. Due to the flammable nature of
methane and the auto ignition temperature of sulfur at 232 oC it was of vital importance to
ensure that the system was free of oxygen. The system was sealed other than the exit line into
the acetonitrile-d3 vial. Prior to heating and flow of methane the whole system was purged
with nitrogen. While the system was purging with nitrogen the furnace was turned on and
heated to 650 oC, during this heating water was observed to condensate on the quartz tube.
Once at the desired 650 oC temperature the silica was left in the heat for 3 minutes, while
the sulphur was still outside the heated area of the furnace (Fig. 2.9). The methane flow was
started at a flow rate of 1 sccm through the heated column. Once the flow had started and
bubbling was observed in the collection vial a heat gun was used to heat the sulphur to boiling
point, turning from its characteristic yellow to a deep red liquid. This heating was maintained
for 30 minutes with all gasses passing through the cooled acetonitrile-d3 trap. However
13C
NMR spectrum showed no evidence of carbon disulfide formation. Similarly the 1H NMR
spectrum showed no signs of hydrogen sulfide, a characteristic by-product expected for this
reaction. The reaction was repeated again at a higher temperature of 700 oC however no
evidence of a reaction was observed.
The experiment was redesigned so that the sulfur and silica are adjacent and both situated
inside the furnace during gas flow. Prior to packing of the column the silica gel was dried in
the oven overnight to remove any moisture which may condense in the column. The column
was once again flushed with nitrogen and the furnace heated to 700 oC. The silica catalyst
was preheated in the furnace before the sulfur was also heated. As the sulfur was moved
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Fig. 2.9 Photograph of furnace with the silica section of the quartz tube with sulfur.
into the furnace the methane flow was started at 1 sccm and the outlet flow collected in
cooled acetonitrile-d3. Flow was maintained for 25 minutes.
13C NMR analysis of the sample
indicated the successful formation of carbon disulfide with a peak at 192.6 ppm, 1H NMR
spectrum also indicated the formation of hydrogen sulfide with a characteristic peak at 1.08
ppm.
1.2.1 Attempted synthesis of 11CS2 from
11CH4
In an similar manner to the synthetic lab, sulfur (1 g) and silica (1 g) were mixed together
and packed into a quartz column, held in place by quartz wool. The lines were flushed
with helium to remove any oxygen from the system while the column was heated to 750 oC.
11CO2 was produced in the cyclotron and delivered into the Synthra unit in the mini cell. The
Synthra unit ran a modified shorter program which bypassed the 11CH3I synthesis. Therefore
11CH4 was delivered directly into the hot cell at 10 mL/min in a stream of He carrier gas.
The 11CH4 passed through the column at 750
oC as a short bolus of activity as detected
by an adjacent pin diode, the gasses were trapped in acetonitrile. A spiked radio analytical
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HPLC of the trapping solution showed some conversion to 11CS2 from
11CH4 (Fig. 2.10),
approximately 50% by radio analytical HPLC. Unfortunately; the amount of activity in the
collection vial was very low (6 MBq), while a large quantity passed through the vial and into
the waste collection bag, 11CS2 is known to trap well in acetonitrile so it is likely that this
activity could be attributed to untrapped and unreacted 11CH4. During the production of
11CS2 from
11CH3I the
11CH3I is released steadily over a period of approximately 2 minutes
from the porapak, however in the moderated program to synthesise 11CH4 the entire bolus
of activity was released in just a few seconds. It is possible that this was too concentrated
and passed through the column too quickly resulting in a poor yield of 11CS2.
Fig. 2.10 HPLC of the trapped outlet of the reaction with 11CH4 and sulfur at 750
oC.
The peak at 6.6 minutes corresponding to 11CS2
In a repeat experiment with a slower flow rate of 1 mL/min, intended to give the 11CH4
a longer residence time, however in this instance no 11CS2 was observed. Reasons for the
failure of this reaction are not currently understood as the only variable was the flow rate.
1.3 Attempted in-target synthesis of 11CS2
Previously attempted methods of forming 11CS2 involved chemical reactions, starting with
either 11CO2 or
11CH4 from the cyclotron and carrying out a number of steps to form
11CS2.
However the ideal situation would be to produce 11CS2 directly in the cyclotron target,
eliminating a large number of steps which would save valuable time. Our previous method of
converting 11CO2, to
11CH4, to
11CH3I, to
11CS2 takes approximately 10 minutes. Reducing
this delivery time would be of great benefit the RCY of the final product. Production
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in-target would also be expected to greatly improve specific activity; since the chance of
contamination from atmospheric CO2 would be reduced. This is largely due to the presence
of atmospheric 12CO2 in the delivery lines from the cyclotron, which dilutes the
11CO2 hence
reducing specific activity. If 11CS2 were to be delivered from the cyclotron rather than
11CO2,
then this dilution factor would not be a problem and would would be expected to give higher
specific activities.
The initial experiment involved bombarding a simple aluminium target containing sulfur
(50 mg) purged with nitrogen gas. During bombardment the target temperature typically
reaches 200-250 oC, the temperature shortly after bombardment was found to be 180 oC. High
temperatures are necessary in order to ensure that the sulfur would vaporise so that it would
be available to react with once the 11C had formed, upon opening the target it was apparent
that the sulfur had been evenly distributed around the target chamber indicating that it was
vaporised during bombardment (Fig. 2.11). This high temperature however melted the nylon
fitting connecting the delivery line to the target, meaning that the target gas could not be
collected and analysed. However measuring the decay profile of the target indicated that the
primary isotope was 11C, or any other isotopes were short lived and had decayed prior to
measurement. This was a positive result as it was hypothesised that the presence of sulfur
in the target could potentially lead to the formation of unwanted longer lived isotopes such
as 34mCl (S(α,x)34mCl) from the bombardment of sulfur by emitted alpha particles.116
The reaction was repeated with the addition of a jet of compressed air focused on the nylon
fitting to locally cool the specific area of the target and prevent the fitting from melting.
The target was bombarded at 5 µA for 5 minutes. The target chamber was released and
the gaseous content bubbled through a vial of DMSO, the vent of the DMSO vial lead to an
ascarite trap which then led to a collection bag (Fig. 2.12). The activity of all three traps
were measured, 11 minutes after bombardment the activity measured was 315.7 MBq and
675.7 MBq respectively for the DMSO and ascarite trap. This gives a percentage trapping
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Fig. 2.11 Image showing distribution of sulfur around target chamber after bombardment.
of 32 % in the DMSO. A number of further readings were taken and the DMSO vial was
flushed with He gas to remove any gas in the head-space. After 47 minutes the radioactivity
readings were 72.8 MBq and 191.0 MBq respectively, showing a trapping of 27.6 % in the
DMSO. This drop in trapping is not unexpected after flushing due to displacement of 11CO2.
Despite the target being purged with nitrogen multiple times it would not be possible to
remove all of the oxygen from the target chamber, therefore if some oxygen is present, 11CO2
will form. Due to low solubility of carbon dioxide in DMSO (0.05 g/100 g @20 oC) any 11CO2
would be removed from the vial head-space during flushing. The decay pathways can be seen
in (Fig. 2.13). From this plot it is possible to calculate the half-lives of the radioactivity
present, with a value of 20.38 minutes expected for 11C. The DMSO showed a value of 16.9
minutes, lower than the 11C value however not unexpected as some activity was removed in
the flushing process, which would give a falsely short half-life. The ascarite vial showed a
half-life of 19.8 minutes, again slightly short but within reasonable error (3% discrepancy)
considering the accuracy of the measuring technique. The γ emission of the DMSO was also
measured which showed 511 MeV emission, indicative of pure β+ from 11C.
In a repeat of the previous experiment the DMSO volume was increased to 10 mL and a
beam time of 10 min rather than 5 min previously, at 5 µA. The chart (Fig. 2.14) shows a
similar decay to that of the previous experiment. Initial readings showed a 26.9 % in the
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Fig. 2.12 Schematic of the apparatus used to trap the target gasses
Fig. 2.13 Decay plot of the ascarite and DMSO traps over time
42
vial, slightly lower than previously. With a final trapping of 14.1 % after 80 minutes and two
flushes of air.
Fig. 2.14 Decay plot of the repeat experiment of the ascarite and DMSO traps over time
The half-life of the DMSO vial was calculated to be identical to the previous experiment
at 16.9 min. The ascarite trap half-life was calculated to be higher than expected at 24.8
minutes. This higher than expected value is due to the head-space of the DMSO vial being
flushed through the ascarite vial where it is trapped. Therefore more activity is being added
to the vial, hence the uncharacteristically long half-life.
In a further experiment for the in-target formation of 11CS2 several changes were made to
the experiment. The target was adapted to incorporate a counter flow water cooling system
to prevent the target from overheating and allowing a higher beam current to be used if
necessary. The DMSO trap was changed for acetonitrile, this was done for two reasons,
firstly so that samples can be analysed by HPLC, but more importantly it was thought that
the presence of water in the DMSO may increase the solubility of CO2 and CO which could
confound activity measurements. The target was loaded with sulfur (50 mg), purged with
nitrogen 6 times before bombardment (10 µA for 5 minutes). The target was released and the
gas bubbled through the acetonitrile, ascarite and finally into a waste collection bag. Initial
readings showed trapping of 14.6 %, 57.5 % and 27.8 % for the acetonitrile, ascarite and bag
respectively. Decay profiles of the traps showed the acetonitrile trap to have a half-life of
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19.8 minutes and the ascarite 20.17 minutes, again consistent with 11C.
The experiment was repeated using exactly the same conditions, however this time the ace-
tonitrile sample was taken for radio analytical HPLC analysis. Two aliquots were taken, first
a neat injection, showing a radioactive peak at 1.07 minutes. Secondly a co-injection with a
carbon disulfide reference, as expected the radioactive peak remained the same at 1.07 min-
utes however the carbon disulfide did not co-elute. The carbon disulfide had a retention time
of 2.30 minutes with a clear sharp peak. This indicated that the radioactive 11C material
trapping in the acetonitrile was not carbon disulfide. After HPLC analysis the acetonitrile
trap was degassed for 5 minutes, prior to degassing the radioactivity was measured at 363.5
MBq. After 5 minutes of degassing the activity had dropped to 136.7 MBq. Equating to a
decay corrected drop of 170.0 MBq, 55%.
Despite having evidence that 11CS2 was not being formed under the current conditions it was
still of interest to determine whether CS2 would be stable under bombardment. Therefore 10
µL of carbon disulfide was added to a clean target and bombarded it at 5 µA for 5 minutes.
Upon inspection of the target the carbon disulfide had clearly decomposed, possibly to carbon
and sulfur however analysis of the residue was not possible (Fig. 2.15). The havar foil was
also noticeably deformed due to the rapid pressure build-up. This indicated that carbon
disulfide is clearly not stable under bombardment and it would therefore not be possible to
make in target.
Fig. 2.15 Image of decomposed carbon disulfide inside target after bombardment, showing
carbon and sulfur matrix. Also an image of the deformed havar foil.
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2 Unknown 11C product formation
The radio analytical HPLC data shows that 11CS2 had not been formed and that
11CS2 is
not stable under bombardment. However it was important to understand what was forming
in target if not 11CS2. Despite purging the target repeatedly with nitrogen, some oxygen will
still be present in the target. Due to the very small scale of the reactions taking place even
a trace of oxygen will be sufficient for some 11CO2 or
11CO. This can be seen as the activity
collected in the ascarite trap. This may attribute to the activity seen in the waste bag, as
ascarite does not trap CO well.117 However in experiments carried out, activity is still present
in the acetonitrile trap even after degassing of the solution. Both carbon dioxide and carbon
monoxide are known to be only sparingly soluble in organic solvents.118 This indicates that
another product is present, which is not carbon disulfide, carbon dioxide or carbon monoxide
and is trapping well in the acetonitrile trap.
The next experiment carried out was to determine how well the acetonitrile would trap carbon
dioxide and carbon disulfide. The target was cleaned well to remove any residual sulfur from
the inside. The target was loaded, purged with nitrogen and bombarded at 5 µA for 2
minutes. Upon collection of the gas the activities in each were 98.10 MBq, 130.70 MBq and
49.22 MBq for the acetonitrile, ascarite and bag respectively. Corresponding to 35%, 47%
and 18%. The acetonitrile solution was then degassed for 5 minutes and the radioactivity
measured again, it had dropped to 1.08 MBq. With decay correction the expected activity
would be 46.44 MBq, therefore a 98 % reduction in radioactivity was seen by degassing for just
5 minutes. This shows that any significant amount of activity remaining in the acetonitrile
vial after degassing can not be attributed to 11CO2 or
11CO.
A control experiment was also run in a clean target, never exposed to sulfur or carbon
disulfide. 11CO2 was produced in a target via bombardment of nitrogen in the presence of
4% oxygen and passed through the 3 trapping sections. The acetonitrile vial trapped 10.2
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MBq, 33% of the total activity, the ascarite trap 21.1 MBq (67%) and the bag 0.1 MBq,
(0.2%). This indicates that ascarite is extremely effective at trapping 11CO2 and any activity
that was passing through the trap in previous experiments was not 11CO2. The acetonitrile
vial was degassed for 2 minutes, prior to degassing the radioactivity was measured at 5.1
MBq. After 2 minutes of degassing the activity had dropped to 1.1 MBq. Equating to a
decay corrected drop of 3.5 MBq, 76%. This is not as large as the drop seen in the previous
11CO2 /
11CO forming experiment (98%), partially due to the lower levels of radioactivity
(278 MBq compared to 31 MBq). However this drop in activity after degassing is considerably
larger than the drop seen after the target containing sulfur was degassed(45%).
From this series of experiments (Table 2.1) it is possible to conclude a number of important
points. 11CS2 is not being formed and is not stable under bombardment.
11CO2 does not
pass through an ascarite trap, so any radioactivity collecting in the bag is a different gas.
Radioactivity in the form of 11CO2 or possibly
11CO is easily degassed from an acetonitrile
solution.
Table 2.1 Table showing the relative trapping of radioactivity before and after degassing
of 3 different target experiments.
Run MeCN
trapping
(%)
Ascarite
trapping
(%)
Bag Trap-
ping (%)
Waste (%)
11CS2 15 58 28 0
11CS2 degassed 7 58 28 8
11CO2 33 67 0.2 0
11CO2 degassed 8 67 0.2 25
Control 11CO2 35 47 18 0
Control 11CO2 degassed 1 47 18 34
These findings allow us to hypothesise that another carbon containing molecule is forming in
the target and trapping well in acetonitrile which is not 11CS2,
11CO2 or
11CO. It is a logical
assumption that what is in fact forming is 11COS given the elements we have present in the
target. Due to the low levels of oxygen in the target it is likely that 11CO is forming initially
then reacting with the sulfur at high temperature to form carbonyl sulfide.119 Hence out of the
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cyclotron target we get a mixture of 11CO, 11CO2 and
11COS. With further experimentation
over the target design, oxygen concentration and beam power it may be possible to produce
11COS in greatly improved yields. To the best of our knowledge carbonyl sulfide has not
previously been synthesised with a 11C radiolabel. Although not the anticipated product
11COS may itself be an interesting radiolabelling reagent for the development of PET tracers.
2.1 COS: physical and chemical properties
Although the reactivity of carbonyl sulfide is not as well documented as carbon dioxide or
carbon disulfide it has interesting properties and reactivity which lie between the two.120 It
is a gas at room temperature with a boiling point of -50.2 oC and is soluble in a range of
organic solvents, in particular toluene. In water COS slowly decomposes by hydrolysis into
hydrogen sulfide and carbon dioxide.121 Despite being a gas at room temperature its high
solubility makes it considerably easier to handle when compared to carbon dioxide or carbon
monoxide. Much of the literature surrounding carbonyl sulfide concerns environmental and
industrial processing studies rather than small scale laboratory work, however this is not to
say that it is not a useful reagent in the synthesis lab.
Many amines react readily with COS to form thiocarbamate salts. From these salts it is
possible to form ureas.122 This could prove to be a faster more efficient way to access radiola-
belled ureas than other previous methods such as using copper(I) mediated 11CO reactions.41
α-aminonitriles react readily with carbonyl sulfide to form substituted thiazole rings com-
monly found in pharmaceuticals,121,123 in fact carbonyl sulfide can be used in the formation
of a variety of heterocycles along with thiazoles including thiadinazin-4-ones, benzothiepanes
and β-lactam antibiotics.124 Carbonyl sulfide also readily coordinates to a wide range of tran-
sition metal centres, the elimination of sulfur from these metal-COS complexes is relatively
facile, this has proven to be interesting with potential applications towards carbonylation re-
actions.85 Grignard reagents are also known to react with carbonyl sulfide to form thioacids
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and trisubstituted alcohols in varying proportions.125
3 Conclusions
Prior to this work a production route to 11CS2 had been established but not optimised. The
newly discovered method has eliminated the use of toxic P2S5, replacing it with sulfur. The
method is reproducible and quantitative. The experimentation with temperature and flow
rate has lead to conditions which allow the continuous use of a column for multiple runs.
The method development of producing 11CS2 from
11CH4 to save time on synthesis has show
positive results with the successful formation of carbon disulfide in the synthesis lab as shown
by 13C NMR spectroscopy. Formation of 11CS2 from
11CH4 has also been observed in the radio
chemistry lab however only low radiochemical yields were observed. This method requires a
considerable amount of development before it would be viable to replace the current method
from 11CH3I.
Experiments carried out with the aim of producing 11CS2 in the cyclotron target proved that
this is not possible. However further analysis of the data obtained suggested that rather than
11CS2,
11COS may in fact be forming. This has yet to be quantified or fully characterised
however the current evidence suggests this. 11COS has interesting chemistry and the potential
to be a useful and versatile radiolabelling precursor. Work is ongoing in this area.
4 Future work
With the method developments described above the production of 11CS2 is efficient and
facile with virtually no time penalty from 11CH3I and excellent RCY. However with further
method development the use of 11CS2 as a radiolabelling method may be more appealing as
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a competitive labelling strategy.
The synthesis of 11CS2 from
11CH3I is reproducible and high yielding, the main disadvantage
is the limited use of each column, requiring re-packing with each production. If 11CS2 were
to be incorporated into a fully automated unit then a reusable system would need to be
developed. The amount of sulfur used in each production is on the scale of nanomolar, so
there is little concern for the sulfur being used up. The main drawback lies with the sulfur
distilling out of the heated section of the column and cooling depositing at the ends next to
the fittings. This issue of distillation may be solved simply by control of the temperature as
shown in Fig. 2.7, or by changing the direction of flow. It would be necessary to carry out
multiple productions at a set temperature of 400 oC to determine the longevity of 11CS2 at
this temperature.
Initial experiments in the radiochemistry lab show that production of 11CS2 from
11CH4 is
possible however quantitative formation of 11CS2 from
11CH4 has not yet been achieved.
Studies need to be carried out in the control of flow rates and the rate of release of 11CH4.
Recent work carried out by Marks et al.126 show that a key factor to this transformation
is likely to be the choice of catalyst. RuS2 and MoS2 have been shown to be efficient at
oxidation of CH4 to CS
2. Hence further experiments using these catalysts are necessary to
try and improve the yield of 11CS2.
Further in target experiments are necessary in order to synthesise and characterise the hy-
pothesised 11COS being produced. This would require a ’cold’ reference sample to confirm
its radio analytical HPLC and radio analytical GC elution time. Aside from its synthesis in
target it is important to explore the synthesis of 11COS via the reaction of 11CO and S in
a chemical reaction, which could be performed in a more accessible hot cell. Assuming the
successful formation and characterisation of 11COS it would be necessary to investigate the
potential of 11COS as a radiolabelling reagent in a series of model reactions.
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Chapter 3
11C thiourea radiochemistry
The thiourea functional group consists of two amine groups connected to a central thio-
carbonyl. Thioureas are common structural features in many larger organic molecules and
heterocyclic structures. Commercially they are used dyes, photographic film, elastomers,
plastics and textiles. They are also present in insecticides, preservatives, rodenticides and a
range of pharmaceuticals.77 The formation of thioureas is one of the most well documented
reactions using carbon disulfide.127,128 Carbon disulfide reacts readily with many primary
amines at room temperature to form dithiocarbamate salts with an ammonium counter ion
when there is a large excess of amine. Heating of these salts results in the rearrangement
and formation of the symmetrical thiourea (Scheme 3.1).
Scheme 3.1 Reaction of carbon disulfide with a primary amine to give the dithiocarbamate
salt and then thiourea.
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1 Thioureas
Due to the speed, efficiency and potential application for PET imaging the reactivity of
carbon disulfide with a range of primary amines for the formation of thioureas was explored.
Before attempting radiolabelling it was necessary to optimise the reaction conditions in the
synthetic lab. As well as optimisation, a small library of non-radioactive thioureas were either
prepared or purchased as standards. Nine different primary amines (Table 3.1), a range of
mono and diamines, were selected and their reactivity with carbon disulfide explored. Due
to the complex nature of radiochemistry it was important to ensure labelling protocols were
technically straightforward and fast. Typically reactions to form thioureas would be carried
out with stoichiometric quantities of carbon disulfide and amine in the presence of a strong
base such as sodium hydroxide, which acts as the counter ion when the dithiocarbamate
salt is formed. However under radiolabelling conditions when the 11C precursor is in high
dilution, the amine is always going to be in a vast excess and not under stoichiometric reaction
conditions. Therefore during the preliminary reactions to form thioureas in the synthesis lab,
reactions were carried out with no added base, but instead an excess of amine. This excess
of amine acted as both the base and the counter ion. Reactions were typically carried out
under reflux of amine and carbon disulfide in acetonitrile for 2 hours to give the thiourea
product. The reaction is proposed to proceed via conversion of the dithiocarbamate salt to
the corresponding isothiocyanate upon heating with release of hydrogen sulfide gas, followed
by reaction with a free amine to give the corresponding thiourea (Scheme 3.2).53
1.1 11C thioureas
11CS2 was synthesised as previously described in Chapter 2 and trapped in a solution of
acetonitrile and the primary amine (5 mg). Once the adjacent pin diode indicated that
trapping in the vial was complete the flow was stopped and the vial transferred to a pre-heated
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Scheme 3.2 Proposed mechanism for the formation of thiourea from carbon disulfide and
two equivalents of amine via dithiocarbamate and isothiocyanate intermediates.
block at 95 oC for 10 minutes. Analytical radio HPLC showed complete conversion of the
amines to the thioureas (Fig. 3.1) with radiochemical purities of in excess of 99% (Table 3.1),
with the exception of two cases. The examples which did not reach completion were aniline
derivatives containing a phenyl amine group which formed phenyl thioureas (entry 4, 6).
These reactions were much slower than others, taking approximately 20 minutes to form the
thioureas. Complete conversions were achieved by trapping in DMSO and heating to 150 oC
for 10 minutes. This higher temperature and change in solvent was sufficient for the thioureas
to form quantitatively in 10 minutes, also with excellent radiochemical purity. All of these
reactions were repeated at least 3 times to ensure reproducibility and accuracy of the results.
Full HPLC data can be seen in the Appendix.
Five of the thioureas that were synthesised were linear and symmetrical (entry 1 - 5) while
four formed heterocyclic structures (entry 6 - 9). HPLC data indicated no formation of the
linear product in the case of the heterocycles despite the huge excess of amine present, this
is likely due to the proximity of the second amine and the entropic advantage of ring closing
reactions.129 These effects may also account for the ease of reaction in the case of entry 9.
Despite the starting amine (2-aminobenzylamine) containing a phenyl amine the reaction
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Table 3.1 Precursors, products and radiochemical yields of thioureas labelled using 11CS2.
For experimental details see Chapter 7 Section 3.1.
Entry Amine Precursor Thiourea RCY
1 >99
2 >99
3 >99
4 >99
5 >99
6 >99
7 >99
8 >99
9 >99
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Fig. 3.1 Radio analytical HPLC trace of the 11C radiolabelled 1,3-diphenyl-2-thiourea prod-
uct above the UV HPLC trace of the unlabelled reference compound.
still proceeded to completion in 10 min at 95 oC in acetonitrile, unlike other phenyl amine
containing molecules which required the higher temperature of 150 oC in DMSO to reach
completion within 10 minutes.
Thiourea functional groups are present in a number of biologically active molecules,130–132
hence it was of interest to develop radiolabelling methods towards more complex struc-
tures. An example of this is the reaction of thioureas with an alkyl halide to form an
isothiourea (Scheme 3.3). The thiocarbonyl group of the thiourea attacks the alkyl halide
resulting in a simple halide substitution reaction (Scheme 3.4). As a preliminary example
the reaction of 1,3-dicyclohexyltiourea 5 and benzyl bromide was examined. Once [11C] 1,3-
dicyclohexyltiourea had been formed from the reaction of cyclohexylamine and 11CS2, benzyl
Scheme 3.3 The one pot synthesis of benzyl N,N’-dicyclohexylcarbamimidothioate (10)
by the reaction of radiolabelled 1,3-bis(cyclohexyl)-thiourea (5) with benzyl bromide.
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bromide (10µL) was added to the solution while still heating. Heating was continued for a
further 10 minutes before a sample was taken for HPLC analysis which showed quantitative
conversion to the benzyl isothiourea product benzyl N,N’-dicyclohexylcarbamimidothioate
(10) (Fig. 3.2). This method demonstrates a new fast and efficient route to labelling more
complex organic molecules that have not been possible to label to date.
Scheme 3.4 Proposed mechanism for the formation of isothiourea structures.
Fig. 3.2 Radio HPLC data of the 3 step, one pot formation of the isothiourea, benzyl
N,N’-dicyclohexylcarbamimidothioate (10).
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2 CXCR4 inhibitor - IT1a/IT1t
The isothiourea functional group is present in a range of biological molecules. Recently a
series of isothiourea molecules were tested as CXCR4 inhibitors. Of this series IT1a and
IT1t were found to be potent and selective CXCR4 inhibitors (Fig. 3.3).133 As previously
discussed the isothiourea backbone is readily accessible from thioureas. Hence the CXCR4
inhibitors present as target molecules to test 11CS2 labelling reactions.
Fig. 3.3 CXCR4 inhibitors IT1a and IT1t.
CXCR4 is a type 4 chemokine receptor overly expressed in at least 23 different types of
cancer. Due to its over expression and its interaction with the chemokine CXCL12 it plays
a role in metastasis of cancer throughout the body. CXCR4 is also a co-receptor for certain
strains of human immunodeficiency virus-1 (HIV-1) allowing entry of the virus into white
blood cells. These roles of CXCR4 make it an attractive target for medical imaging and in
particular PET imaging.134,135
IT1a and IT1t are both isothiourea molecules based on a 1,3-dicyclohexyltiourea backbone,
they have very low IC50 values for the CXCR4 receptor of 48 nM and 8 nM respectively
and were highly selective towards the CXCR4 receptor in human cell lines. Crystal structure
studies have been carried out on IT1t bound to the CXCR4 receptor showing the key interac-
tions which led to its high efficacy. The IT1t ligand occupies part of a pocket defined by side
chains from helices in the CXCR4 structure. The nitrogens of the symmetrical isothiourea
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group are both protonated with a net positive resonance charge; one of them forms a salt
bridge with a side chain of the CXCR4. The importance of both nitrogens is supported by a
reduction in binding affinity of 100-fold upon methylation of one of them. Both cyclohexane
rings fit into small subpockets and so make hydrophobic contacts with CXCR4. Connected
by a short flexible linker, the imidazothiazole ring system makes a salt bridge between the
protonated imidazothiazole nitrogen and a further helical structure of CXCR4.136 this indi-
cates that all aspects of the IT1a and IT1t structures are of key importance to their high
efficacy and binding.
We have previously demonstrated that [11C] 1,3-dicyclohexyltiourea can be formed and re-
acted with benzyl bromide to form the isothiourea analogue. The heterocyclic groups present
in IT1a and IT1t are more complex than the simple benzyl group in previous experiments
however the reactivity was expected to be comparable.
2.1 Heterocyclic precursor synthesis
Initially despite its higher IC50 of 48 nM compared to 8 nM, IT1a was chosen as the target
molecule due to its ease of synthesis. With the synthesis of the thiourea well established
the next step was to synthesise the more complex heterocyclic precursor. The heterocyclic
precursor can then be reacted with the 1,3-dicyclohexyltiourea to form our target molecule
(Scheme 3.5).
Scheme 3.5 Formation of IT1a from 1,3-dicyclohexyltiourea and a heterocyclic precursor.
The first step involved the reaction of 1,3-dichloro-propan-2-one with 2-imidizolidinethione re-
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fluxing in acetonitrile for 16 hours to yield the chlorinated precursor molecule 3-chloromethyl-
5,6-dihydro-imidazo[2,1-b]thiazole (11) (Scheme 3.6).133
Scheme 3.6 Formation of 3-chloromethyl-5,6-dihydro-imidazo[2,1-b]thiazole (11) from 1,3-
dichloro-propan-2-one and 2-imidizolidinethione
This purified product (3-chloromethyl-5,6-dihydro-imidazo[2,1-b]thiazole) was reacted with
1,3-dicyclohexyltiourea in acetonitrile under reflux for 20 hours to give the IT1a reference
product in good purity. This 20 hour reflux is clearly outside the time frame for 11C labelling.
Therefore it was necessary to try and reduce the time of this reaction step. Experiments were
carried out whereby the reaction time was reduced to just 2 hours, however in this short time
only a very small amounts of product were observed. Even with the effects of the pseudo
first order reaction kinetics in the radiochemistry labs yields may be problematic. Attempts
were also made at heating in DMSO at the higher temperature of 150 oC for a shorter time
period, however extremely low yields were again observed.
To overcome this problem it was necessary to replace the chloride of the heterocyclic precursor
with a better leaving group in order to increase the rate of a reaction to a workable time
for the radiochemical lab. In an initial attempt of this, a similar method to the previous
heterocyclic precursor reaction was carried out. 1,3-dibromo-propan-2-one was refluxed with
2-imidizolidinethione in acetonitrile for 16 hours to yield the brominated precursor molecule.
NMR analysis of the product showed only small quantities of the product and high levels of
impurities which proved difficult to purify. This low yield was attributed to the low purity
of the purchased 1,3-dibromo-propan-2-one starting material. Short path distillation of the
starting material failed to significantly improve its purity, resulting in little improvement
of the purity of the product. 1,3-dibromo-propan-2-one is know to be light and moisture
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sensitive which may account for the failure of the reaction (Scheme 3.7).
Scheme 3.7 Failed formation of 3-bromomethyl-5,6-dihydro-imidazo[2,1-b]thiazole from
1,3-dibromo-propan-2-one and 2-imidizolidinethione
As an alternative method to synthesise the brominated heterocyclic precursor, while avoiding
using 1,3-dibromo-propan-2-one, a halide substitution reaction was carried out. The chlo-
rinated heterocyclic precursor was brought to reflux in acetonitrile with a large excess of
lithium bromide for 24 hours. The 1H NMR spectrum of the product (12) showed a shift
in the methyl protons adjacent to the halide indicating a 90% conversion to the brominated
heterocyclic precursor (Scheme 3.8).
Scheme 3.8 Formation of 3-bromomethyl-5,6-dihydro-imidazo[2,1-b]thiazole (12) by
halide substitution of 3-chloromethyl-5,6-dihydro-imidazo[2,1-b]thiazole with lithium bro-
mide.
The iodinated analogue was also synthesised, again via a halide substitution reaction. Using
the Finkelstein reaction, the chloro heterocyclic precursor was brought to reflux with sodium
iodide in acetone. The reaction is driven by the poor solubility of the sodium chloride
salt in acetone. Similar methods were used to synthesise the dimethyl derivative as seen
in IT1t. 2-Methylpropane-1,2-diamine was reacted with carbon disulfide in acetonitrile to
yield 4,4-dimethyl-2-imidazolidinethione. This was then refluxed with 1,3-dibromo-propan-2-
one in acetonitrile forming the chlorinated di-methyl heterocyclic precursor. This precursor
underwent halide substitution with sodium iodide in acetone to give the final iodinated di-
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methyl heterocyclic precursor.
2.2 Isothiourea formation
Once the heterocyclic precursors had been synthesised, purified and analysed it was necessary
to couple the precursor to 1,3-dicyclohexyltiourea to form the IT1a and IT1t compounds.
IT1a had been successfully synthesised previously using the chlorinated heterocyclic precursor
however in a time frame unsuitable for radiochemistry.
The iodinated heterocyclic precursor was brought to reflux with 1,3-dicyclohexyltiourea in
acetonitrile for 1 hour (Scheme 3.9). 1H NMR analysis of the product showed close to full
conversion to the IT1a product. This is a huge improvement compared to 16 - 20 hours
needed for the reaction with the chlorinated heterocyclic precursor, a further reduction in
reaction time would be further desired for radiolabelling applications. It had been previously
reported that the addition of silver salts can aid in halogen abstraction reactions, silver ions
are able to form strong Lewis acid-base interactions with halide ions creating salts that are
often insoluble in organic solvents.137 This abstraction of the halide would allow the alkylation
step to proceed faster. In situ addition of silver triflate salt to the iodinated heterocyclic
precursor and 1,3-dicyclohexyltiourea showed that after just 10 minutes of reflux a yield of
86% IT1a was obtained. Following this an analogous reaction was carried out using the
iodinated di-methyl heterocyclic precursor in order to synthesise IT1t.
Scheme 3.9 Formation of IT1a from 3-iodomethyl-5,6-dihydro-imidazo[2,1-b]thiazole and
1,3-dicyclohexyltiourea
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2.3 Radiochemical synthesis of IT1a and IT1t
While it is often standard procedure to optimise the reactions prior to the radiochemical lab,
the chemistry often behaves very differently in synthetic and radiochemical labs. Therefore
carrying out both ’hot’ and ’cold’ chemistry in parallel can give added insight to a reaction.
During the thiourea experiments it was confirmed that [11C]1,3-dicyclohexylthiourea could be
synthesised in a high radiochemical purity and in a fast time frame, just 15 minutes between
EOB and thiourea product. The formation of isothioureas had also been confirmed in the
reaction with benzyl bromide. The next, and key step was to perform the alkylation reaction
on the labelled thiourea with the heterocyclic precursor.
In an initial reaction 11CS2 was produced as previously reported and trapped in a solution
of acetonitrile containing cyclohexylamine. Once trapping in the vial was complete the vial
was moved to a preheated block at 95 oC for 5 minutes. After this time a sample was taken
for HPLC to confirm formation of the thiourea product.
The initial alkylation reaction involved the reaction of the [11C]1,3-dicyclohexylthiourea with
the chlorinated heterocyclic precursor. Despite the slow reaction time due to the poor chlo-
ride leaving group it was thought that the favourable reaction kinetics in a radiochemistry
environment may increase the rate of reaction sufficiently to see some product formation.
However, unfortunately after 12 minutes of heating no product formed as seen by radio
analytical HPLC.
The reaction of the iodinated heterocyclic precursor was then investigated. [11C]1,3-
dicyclohexylthiourea was produced as previously mentioned and a suspension of the iodinated
heterocyclic precursor in acetonitrile was added to the vial. Heating at 95 oC was continued
for 12 minutes. After this time HPLC showed that no product had formed. It was thought
that this lack of reactivity may be due to the poor solubility of the iodinated heterocyclic
precursor in acetonitrile. Therefore the reaction was repeated, however carried out in DMSO
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at 130 oC rather than acetonitrile at 95 oC. The iodinated heterocyclic precursor was soluble
in DMSO however HPLC once again showed no product formation.
Following the formation of the brominated heterocyclic precursor in the synthetic lab it could
be reacted with [11C]1,3-dicyclohexylthiourea in DMSO at 130o in an attempt to form the
IT1a product. However no product was seen on the HPLC trace (Fig. 3.4).
Fig. 3.4 Radio analytical HPLC of IT1a experiment showing no product peak juxtaposed
to an UV HPLC trace of the IT1a reference sample.
A further attempt at forming IT1a was made using the iodinated heterocyclic precursor, this
time silver triflate salt was also added to the reaction mixture as a halide scavenger, which
was showed to greatly increase the reaction rate in the synthesis lab. After 10 minutes of
refluxing in acetonitrile the solution was analysed by HPLC. Once again no product was seen
to form.
Work was continued by other group members and it was thought that a possible explanation
for the continued failure of the reactions may be the presence of the excess cyclohexylamine
starting materials in the reaction mixture. To overcome this an automated reformulation
step was introduced after the formation of the [11C]1,3-dicyclohexylthiourea to remove the
cyclohexylamine preventing any competing reactions. Initially this reformulation of the reac-
tion mixture seemed promising, as when the iodinated di-methyl heterocyclic precursor was
reacted with the pure thiourea in acetonitrile, radio HPLC indicated a small peak co-eluting
with the cold IT1a reference material. However upon further HPLC analysis this peak was
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not the desired IT1a product.
3 Tanaproget
Tanaproget (Fig. 3.5) is a non-steroidal progestin inhibitor with a high progesterone recep-
tor (PR) affinity138–140 which has previously undergone clinical trials as a contraceptive.141
A derivative of Tanaproget has previously been labelled with 18F for use in PET studies
(Fig. 3.6).142 However it involved a 3 step radiolabelling synthesis, first heating of the pre-
cursor with n-Bu4N[
18F]F in tert-amyl alcohol at 130 oC for 20 min followed by 160 oC
for 10 min and finally treating with Lawesson’s reagent (2,4-bis(4-methoxyphenyl)-1,3,2,4-
dithiadiphosphetane-2,4-dithione) in toluene at 130 oC for 30 min. This complex reaction
gave very poor decay corrected RCY of just 5%.
Fig. 3.5 Tanaproget
Fig. 3.6 18F radiolabelled tanaproget.
The Tanaproget molecule contains a heterocyclic O-thiocarbonate group, consisting of thio-
carbonyl group adjacent to an amine and ester. It was hypothesised that this molecule could
readily be radiolabelled with no alteration to the structure using 11CS2 in a one step reaction.
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In previous reactions using 11CS2, only thioureas had been formed. The ring forming examples
of these thiourea formations showed an entropic advantage towards ring closure as seen in
entry 9 Table 3.1. This indicated that once the 11CS2 has reacted with the phenyl amine, it
would readily react with the alcohol to form the ester and close the ring under the correct
conditions.
The initial experiment to test this was to react carbon disulfide with 2-aminobenzyl alcohol
to see if the O-thiocarbamate would be formed. Due to the phenyl amine it was necessary
to carry out the reaction in DMSO at 150 oC, as with other aniline derivatives. Reaction of
carbon disulfide and 2-aminobenzyl alcohol in DMSO showed formation of the 1,4-dihdro-2H-
3,1-benzoxazine-2-thiol product (9) after 1 hour. Once the reaction had been carried out in
the synthesis lab and a pure reference sample of the product obtained the reaction was carried
out in the radiochemistry lab. 11CS2 was produced as previously described and trapped in
a solution of DMSO containing 2-aminobenzyl alcohol (Scheme 3.10). Once trapping was
complete the vial was moved to a heater set at 150 oC. After 10 minutes of heating, a
sample was taken for HPLC. A co-injection with the ’cold’ reference compounds showed that
[11C]1,4-dihdro-2H-3,1-benzoxazine-2-thiol had been successfully synthesised (Fig. 3.7).
Scheme 3.10 Formation of [11C]1,4-dihdro-2H-3,1-benzoxazine-2-thiol (9) from the reac-
tion of 2-aminobenzyl alcohol and 11CS2
The success of this O-thiocarbamate forming reaction indicated that the synthesis of
[11C]Tanaproget from it acyclic aminobenzyl alcohol precursor should be possible. 11CS2
was produced in the furnace and delivered into a vial containing the acyclic precursor in
DMSO (Scheme 3.11). Once trapped the vial was transferred to a heating block at 150 oC.
After 5 minutes of heating the solution was analysed by HPLC (Fig. 3.8). This showed 54%
conversion to [11C]Tanaproget, while the other 46% remained as unreacted 11CS2, with no ap-
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Fig. 3.7 Radio HPLC trace of 3,4-dihydro-2(1H)-quinazolinethion HPLC above a UV trace
of a ’spiked’ co-injection with the reference compound.
parent side products formed. This result was encouraging, confirming that [11C]Tanaproget
could be synthesised in a simple 1 step reaction from 11CS2.
Scheme 3.11 Formation of [11C]tanaproget from the reaction of the acyclic tanaproget
precursor and 11CS2
Fig. 3.8 Radio HPLC trace Tanaproget showing product and remaining 11CS2
As the synthesis had been successful it was important to optimise the reaction and try to
improve the RCY. Initially the optimal temperature was examined, the reaction was repeated
as before however the vial was heated at 120 oC rather than 150 oC, aliquots for HPLC
analysis were taken at various time points; after 2 minutes of heating no product was seen
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to form, after 13 minutes the product peek was at less that 1%. The temperature was then
increased to 150 oC, after 12 minutes at 150 oC or 25 minutes in total another aliquot was
taken. This showed a product peak of still less than 1%, a final HPLC after a further 12
minutes showed the same. Closer examination of the HPLC data showed that on the 254 nm
UV chromatograph a non radioactive peak was appearing with time. This indicated that at
120 oC the acyclic tanaproget precursor decomposes in DMSO, preventing the formation of
the [11C]Tanaproget product.
Knowing that the reaction must be carried out at a higher temperature it was necessary
to find the optimal time for the reaction. As previously 11CS2 was delivered into a vial of
DMSO containing the acyclic tanaproget precursor, then moved to the heating block at 150
oC. Aliquots were taken at various time points for HPLC analysis to determine the RCY,
at 2 minutes 13% was seen, at 12 minutes 91% conversion was seen and at 24 minutes 99%
conversion to the [11C]Tanaproget product was seen (Fig. 3.9). At this temperature product
formation was sufficiently fast compared to the precursor decomposition. Despite the 99%
yield a 24 minute reaction time would not be suitable in the interest of the half-life. In order
to maximise both yield and specific activity a time of 10 minutes was chosen for further
[11C]Tanaproget forming reactions.
In an effort to further improve the processing speed of the reaction an attempt was made at
trapping 11CS2 in a vial containing DMSO and the acyclic tanaproget precursor which was
preheated at 150 oC. However this resulted in very poor trapping of the 11CS2. Therefore
trapping of the 11CS2 was necessary at room temperature followed by rapid heating of the
solution to 150 oC, if this heating is not fast enough then decomposition of the acyclic
tanaproget starting material is observed resulting in poor RCY.
Using a semi automated Eckert and Ziegler Modular-Lab system and optimised conditions it
was possible to produce [11C]Tanaproget in high RCY (75%) and excellent RCP (>99%), after
semi-preparative HPLC with a total reaction time from EOB of 34 minutes the radioactivity
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Fig. 3.9 Radio HPLC following the progression of the formation of Tanaproget over time.
was measured at 0.91 GBq with a specific activity of 57 GBq µmol−1, a specific activity
which is suitable for preclinical imaging (Fig. 3.10).
Fig. 3.10 Radio analytical HPLC of Tanaproget after isolation
4 Conclusions
Preliminary investigations into using 11CS2 as a radiolabelling reagent involved reactions with
a range of amines to form thioureas to give an understanding of its chemistry and reactivity.
The series of radiolabelled thiourea formed included symmetrical thioureas, asymmetrical
thioureas cyclic thioureas and also a cyclic thiocarbamate. Thus enabling easy access to
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a series of molecules that cannot be radiolabelled in any other way. These all formed in
excellent RCP and RCY and in most cases were quantitative.
Following the formation of the thiourea series, 1,3-dicyclohexyl thiourea was taken for further
development. Once radiolabelled it was reacted with benzyl bromide to give the isothiourea
product (benzyl N,N’-dicyclohexylcarbamimidothioate) in excellent radiochemical yields and
purity. The formation of this isothiourea structure was used for the development of the
CXCR4 inhibitors IT1a and IT1t. The radiochemical synthesis of 11C IT1t and IT1a proved
exceptionally challenging despite the indication of successful ’cold’ experiments using either
bromo or iodo precursors. Unfortunately neither target molecule could be prepared.
Using the cyclic dithiocarbamate developed previously the progesterone receptor agonist
Tanaproget was chosen as a potential radiotracer. Using an acyclic tanaproget precursor
based on the 2-aminobenzyl alcohol backbone, it was reacted with 11CS2 to give good RCY
with an isolated radioactivity of 910 MBq, 100% RCP and a specific activity of 57 GBq/µmol.
The method for radiolabelling tanaproget has proved to be fast, efficient and high yielding
and could be suitable as a pre-clinical tracer for cancer imaging.
5 Future work
The development of the [11C] thiourea chemistry has come a long way in a short time, however
in order for it to become a viable labelling technique more work will be necessary. Such as the
formation of more complex thioureas and subsequently more complex organosulfur structures
commonly seen in biological molecules.
The primary aim will be to reassess the synthesis of IT1a/t and understand why the reaction
is unsuccessful in the radiochemistry lab. This could be due to the mixture of precursors and
side products present in the one pot reaction. Further investigation into the characterisation
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of the side product which are being formed is likely to give a better insight as to what is
taking place in the reaction mixture and why the desired product is not forming.
With regards to the [11C] Tanaproget molecule, now the radiochemical synthesis has been
optimised and it can be produced in high yields the next logical step is to carry out pre-
clinical trials in order to determine its effectiveness as progesterone receptor radio-ligand.
Initial studies will involve in vitro analysis to observe uptake, as well as blocking studies.
Following of from this in vivo studies could be investigated.
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Chapter 4
11C thiocyanate radiochemistry
During the synthesis of the thiourea series in Chapter 3, attempts to form 11C thiourea
from the reaction of 11CS2 and ammonia failed. It was assumed that ammonia would react
in an analogous manner to the other amines that were tested; forming a dithiocarbamate
initially and then rearranging to give the thiourea product. Radio HPLC of the reaction
of 11CS2 and ammonia showed a large radioactive signal just after the solvent front, which
initially was misassigned as 11C thiourea. The thiourea reference material was found to elute
at the solvent front due to its high polarity (Fig. 4.1). Despite changing HPLC conditions
the thiourea had short elution times. In order to further characterise this product it was
decided to react with 2-bromoacetophenone in order to form a less polar product and slow
the retention on the HPLC column. The reaction of 2-bromoacetophenone with thiourea
yields 2-amino-4-phenylthiazole (Scheme 4.1) which has an elution time of 2.4 minutes using
isocratic conditions of 45% acetonitrile and 55% ammonium formate pH 8.0 buffer solu-
tion(Fig. 4.1). Under radiolabelling conditions 11CS2 was delivered into a vial containing
acetonitrile followed by the addition of ammonia solution (2 M, MeOH) and heated to 90 oC
5 min. 2-Bromoacetophenone was added and heated at 90 oC for a further 5 minutes. Radio
analytical HPLC under the same conditions as above showed an elution time of 3.6 minutes,
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with no peak present at 2.4 minutes (Fig. 4.2). Indicating that a new, unknown product had
formed in quantitative yields.
Fig. 4.1 Top: Radio analytical HPLC of the expected [11C] labelled thiourea eluting at the
solvent front. Bottom: reference HPLC of thiourea also at solvent front.
Scheme 4.1 Scheme showing the reaction of thiourea and 2-bromoacetophenone to give
2-amino-4-phenylthiazole
Initially it was thought that the large excess of 2-bromoacetophenone under radiolabelling
conditions could be causing two molecules of 2-bromoacetophenone to react with the thiourea
(Scheme 4.2). Test reactions in the ’cold’ lab using a ten fold excess of 2-bromoacetophenone
with thiourea showed exclusive formation of 2-amino-4-phenylthiazole. In other test reactions
ammonia was added as it was thought the presence of excess base may be resulting in the
alternate product formation, however the 2-amino-4-phenylthiazole was formed, seemingly
regardless of conditions and stoichiometries used. Indicating that the reaction to form 2-
amino-4-phenylthiazole was in fact very robust.
All reactions in the synthesis lab had previously used thiourea purchased from commercial
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Fig. 4.2 Top HPLC showing the elution time of 2-amino-4-phenylthiazole, the bottom
HPLC showing the radio HPLC of the radiochemical product.
Scheme 4.2 A possible reaction between thiourea and an excess of 2-bromoacetophenone
giving an alternative product.
sources. In order to determine what the different stages of the reactions are and to mimic
the radiolabelling conditions it was necessary to carry out the whole reaction in the synthesis
lab, starting with carbon disulfide and ammonia solution. Carbon disulfide and ammonia
solution (2 M in MeOH) were added to DMSO and heated to 150 oC, after 6 minutes the
solution turned deep blue in colour, a further 10 minutes resulted in a pale yellow solution. 2-
Bromoacetophenone was then added to the reaction giving an orange colour. HPLC analysis
of this solution showed a peak at 3.6 minutes (Fig. 4.3), consistent with reactions performed
in the radiochemistry labs. Indicating that the alternative product formation was due to the
reaction with carbon disulfide and ammonia.
An in-depth literature search of the reaction of carbon disulfide and ammonia only forms
thiourea under specific conditions, temperatures between 150 and 190 oC and pressures over
40 bar.143 More commonly the reaction of carbon disulfide and ammonia results in the forma-
tion of ammonium dithiocarbamate and when heated this decomposes to form ammonium
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Fig. 4.3 HPLC of the crude reaction mixture between carbon disulfide and ammonia with
2-bromoacetophenone, a peak is seen at 3.6 minutes in agreement with the peak seen in
radiochemical experiments (Fig. 4.2).
thiocyanate in high yields (Scheme 4.3).144 When heated to 150 oC the ammonium thio-
cyanate can isomerise to around 30% thiourea. This suggested that our primary product was
in fact, interestingly ammonium thiocyanate and not thiourea as initially thought.
Scheme 4.3 Formation of ammonium thiocyanate from carbon disulfide and ammonia via
the ammonium dithiocarbamate intermediate.
The thiocyanate ion is negatively charged with the charge resonating approximately equally
between the sulfur and nitrogen atoms. As a consequence of this negative charge thiocyanate
is nucleophilic at either the sulfur or nitrogen end. It is a well documented ligand which
is able to form N-bonded thiocyanate complexes or S-bonded isothiocyanate complexes. Its
nucleophilic character allows it to also react with electron poor organic species, readily un-
dergoing nucleophilic substitution reactions at electron poor carbon centres such as alkyl
halides to give the thiocyanate product. Although 11C thiocyanate has been previously re-
ported as a 11C labelling reagent,61,62,145 its potential as a radiolabelling reagent has been
largely unexplored due to its challenging synthesis.
Previously [11C]SCN− was produced via reaction of 11CO2 to 11CH4 and then high tempera-
ture formation of HCN over Pt in an automated gas processing system, followed by reaction
with bromine in triglime at 180 oC to form cyanogen bromide and distilled over antimony
in a nitrogen stream before being trapped in water containing sodium sulphide nonahydride
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and kryptofix as an ion activating agent to give the thiocyanate ion in the form of NaS11CN.
This process has many steps with potential losses at each of them and takes a total of 21
minutes.
The 11CS2 method to [
11C]SCN− has several distinct advantages including fewer steps, it does
not require distillation and is faster. Further reactivity with a range of molecules has also been
explored with the aim of incorporating -SCN in to a molecule as either a thiocyanate group,
or further reacting it to form the biologically prevalent thiazole heterocyclic structure. There
are examples of drug molecules containing a thiocyanate group which have undergone in vivo
studies such as 1-(3,4-dihydroxy-phenyl)-2-thiocyanato-ethanone (Fig. 4.4)146 indicating that
the thiocyanate group can be stable in vivo and is not metabolised too quickly, however the
scarcity of thiocyanate containing molecules used in biological studies suggests they may
not be well suited. Alternatively the thiazole group is found much more commonly and are
considerably more biologically prevalent.
Fig. 4.4 Thiocyanate containing 1-(3,4-dihydroxy-phenyl)-2-thiocyanato-ethanone usin in
in vivo studies.146
Recently the group Halldin group reported −S11CN in the synthesis of the tracer AZD3241
(Fig. 4.5) which is an inhibitor for myeloperoxidase, a candidate drug currently being de-
veloped to delay progression in patients with neurodegenerative brain disorders. The study
synthesises KS11CN from K11CN in acetone with sulfur using microwave radiation.147 The
use of the thiocyanate ion in current research is encouraging as it indicates a desire for better
production methods.
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Fig. 4.5 AZD3241, myeloperoxidase inhibiting radiotracer synthesised using −S11CN.147
1 Halide substitution
Once the synthesis and potential of ammonium thiocyanate had been realised it was nec-
essary to explore the chemistry of the thiocyanate ion and build a small library of labelled
compounds. Since SCN− is a good nucleophile, the logical class of reactions to investi-
gate was halide substitution because of its broad application. Initial the reaction of 2-
bromoacetophenone was investigated (Scheme 4.4).148
Scheme 4.4 Reaction of ammonium thiocyanate with 2-bromoacetophenone to give
phenacyl thiocyanate 13.
A reaction between ammonium thiocyanate and 2-bromoacetaphenone was carried out in
acetonitrile at room temperature, after 30 minutes of stirring the reaction was worked up to
give a white solid. 1H NMR spectroscopy and mass spectrometry confirmed the phenacyl
thiocyanate product. This product was then run on an HPLC using identical conditions to
the previous experiments in the radiochemistry lab, the UV peak eluted at 3.6 minutes. This
elution time was consistent with the radioactive HPLC peak seen in the previous reaction
(Fig. 4.3).
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To confirm the product formation in the radiochemistry lab the reaction was repeated and the
product analysed by HPLC with a co-injection of the reference sample. Ammonia solution
was measured into a vial along with acetonitrile, 11CS2 was bubbled through the vial contain-
ing acetonitrile and ammonia. Once 11CS2 had been trapped the vial was heated to reflux in
acetonitrile for 5 minutes. The vial was removed from the heater and 2-bromoacetaphenone
solution added. After 5 minutes of stirring a sample was take for radio analytical HPLC.
However no peak was observed at 3.6 min, just a large 11CS2 peak at 7.4 min (Fig. 4.6).
At first it was not understood as to why the reaction failed. However upon inspection of
the method it was noted that the ammonia solution was added prior to 11CS2 delivery. The
bubbling of the 11CS2 in He carrier gas made the highly volatile ammonia evaporate before it
was able to react with the 11CS2 to form the [
11C]ammonium dithiocarbamate intermediate
followed by the NH4S
11CN product. It is therefore important to add the ammonia solution
after 11CS2 has been trapped in the acetonitrile. The reaction was repeated with the addi-
tion of ammonia solution post trapping of 11CS2. This led to the successful formation of the
[11C] phenacyl thiocyanate product which eluted at 3.6 minutes on the HPLC and with the
co-injection of the reference sample.
Fig. 4.6 HPLC showing 11CS2 due to the evaporation of the ammonia.
Once a successful S11CN substitution had been achieved it was necessary to expand the
library of labelled molecules. The next molecule chosen to label was benzyl bromide, a simple
nucleophilic substitution would give benzyl thiocyanate 14 (Scheme 4.5). 11CS2 was produced
as before and trapped in acetonitrile. Ammonia solution was then added and heated to reflux
for 5 minutes to form the [11C]ammonium thiocyanate before benzyl bromide was added.
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After a further 5 minutes of heating a sample was taken for radio analytical HPLC which
confirmed that benzyl thiocyanate had formed with a radiochemical purity >95%(Fig. 4.7).
Scheme 4.5 Reaction of [11C] ammonium thiocyanate with benzyl bromide to give [11C]
benzyl thiocyanate 14.
Fig. 4.7 Top: HPLCs showing the radio analytical HPLC trace eluting at 3.6 minutes.
Middle: UV trace of crude reaction mixture. Bottom: UV trace of the co-injection of the
reference sample showing co-elution and product formation.
Following on from the formation of the labelled phenacyl thiocyanate molecule a series of
new 11C phenacyl molecules were prepared via the thiocyanate labelling method. The pro-
cedure followed was analogous to the previous experiments, 11CS2 was produced, trapped in
acetonitrile, ammonia solution added and heated to reflux for 5 min, the phenacyl precursor
was then added to the solution and heated for a further 5 min, an aliquot was then removed
and analysed by radio analytical HPLC. In all cases co-elution with the ’cold’ reference sam-
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ples was used to confirm the identity of the labelled species. Near quantitative conversion
(>95%) to the labelled product was achieved in all cases with the exception of the desyl
chloride precursor entry 20 (Table 4.1), this has a chloride group unlike the other entries
which is a poorer leaving group compared to the bromide. The presence of a second phenyl
group in this example, may also provide some level of steric hindrance reducing which could
also contribute to the lower reaction yield. The quantitative formation of the [11C] phenacyl
thiocyanates from the bromide precursors shows reasonably good functional group tolerance
of the reaction, however other more reactive functional groups would need to be tested to
explore this fully.
Table 4.1 Precursors and products of their labelling with [11C] thiocyanate and their re-
spective RCY.
Entry Precursor Thiocyanate Product RCY %
15 >95
16 >95
17 >95
18 >95
19 >95
20 75
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1.1 Thiazole formation
Whilst the [11C] thiocyanate ion is an extremely useful nucleophilic 11C labelling tool, the
presence of the thiocyanate group in biological molecules; whilst known, is not common, this
is largely due to the reactivity of the group and its tendency to form heterocyclic structures.
Hence it was of interest to convert the thiocyanate group into more biologically relevant
compounds, meanwhile maintaining the 11C label. The known transformation of the phenacyl
thiocyanate functionality into a thiazole group was a good starting point to rapidly form more
complex organic structures (Scheme 4.6).148 Unlike the thiocyanate group thiazoles are found
far more commonly in a biological environment, from naturally occurring products, vitamins,
hormones, licensed drug molecules and new drugs currently under development.149–152 This
gives a promising selection of target molecules for 11C radiolabelling.
Scheme 4.6 Rearrangement of phenacyl thiocyanates with sulfuric acid to give thiazoles.
In order to synthesise the labelled thiazoles the [11C] phenacyl thiocyanate compounds were
first synthesised as described above, from [11C] ammonium thiocyanate and the respective
bromide phenacyl precursor. To this reaction was added a 50% solution of sulfuric acid in
acetic acid. Heating was continued for a further 5 min to give good to excellent yields as
analysed by radio analytical HPLC (Fig. 4.8 Table 4.2).
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Fig. 4.8 HPLCs of 4-(3-nitrophenyl)thiazol-2(3H)-one. Top: Radio analytical HPLC trace.
Middle: UV trace of crude reaction mixture. Bottom: UV trace of the co-injection of the
reference sample showing co-elution and product formation.
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Table 4.2 Precursors and products of the intramolecular rearrangement of thiocyanates to
form thiazoles along with their respective RCY.
Entry Precursor Thiazole Product RCY %
21 >95
22 70
23 73
24 89
25 88
26 >95
2 Aminobenzothiazole formation
Benzothioazoles are very prevalent in biological molecules and have strong medical signifi-
cance,153 as well as appearing in the well known 11C PET imaging agent PiB.10 Benzoth-
iazoles can be readily prepared from the reaction of ammonium thiocyanate and aniline or
other aniline derivatives (Scheme 4.7).154
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Scheme 4.7 Reaction with aniline and ammonium thiocyanate to give aminobenzothiazole.
A series of five aniline derivatives were selected for the synthesis of aminobenzothiazole
reference compounds. The reaction involved first adding the ammonium thiocyanate to a
cooled stirring solution of acetic acid and the aniline derivative. After 10 minutes of stirring
a solution of bromine in acetic acid was added dropwise, upon addition a precipitate started
to form. After the full addition of the bromine and acetic acid solution the mixture was
poured into cold water, this was then brought to pH 11 by addition of NH4OH solution and
the product extracted with ethyl acetate which was dried and removed by vacuum to yield
a solid. Yields for all derivatives were good with the exception of the unsubstituted aniline
reaction which failed to give any product (Table 4.3).155
Table 4.3 Precursors and products of the reaction with anilines and ammonium thio-
cyanate to give aminobenzothiazoles along with their respective yields.
Entry Precursor Aminobenzothiazole
Product
Yield %
27 0
28 40
29 81
30 37
31 92
The radiolabelling of these aminobenzothiazoles was then attempted using a modified pro-
cedure. 11CS2 was trapped in a vial containing acetonitrile. Once activity in the vial had
82
peaked ammonia solution was added and the mixture refluxed for 5 minutes to produce
[11C]ammonium thiocyanate. An aliquot was taken from the vial and injected into a second
vial cooled in a water bath containing acetic acid and the aniline derivative. Stirring was
continued for 3 minutes before a solution of bromine in acetic acid was added to the reaction
mixture. After 5 minutes stirring was stopped and ammonium hydroxide solution added. A
sample was then taken for radio analytical HPLC analysis. Unfortunately HPLC gave no
indication of product formation with the majority of the activity remaining at the solvent
front; most likely attributed to unreacted [11C]ammonium thiocyanate. The failure of this
reaction may be due to the complex nature of the reaction and processes which are difficult
to implement in a radiochemistry lab such as dropwise addition of reagents and cooling of
the reaction mixture.
2.1 Thiourea synthesis
Upon analysis of the reaction pathway it was found that the synthesis of the aminobenzoth-
iazole proceeded through the formation of a thiourea intermediate (Scheme 4.8) once the
thiourea had formed the addition of bromine caused an intramolecular Jacobsen cyclisation
resulting in the formation of the benzothiazole product.156 In an attempt to gain a better un-
derstanding of why the reaction was not successful in the radiochemistry lab it was necessary
to synthesise and isolate these thioureas. Unlike the previous thiourea synthesis discussed in
chapter 3, reactions with an amine and ammonium thiocyanate leads to the formation of an
unsymmetrical thiourea containing a primary and secondary amine.
Scheme 4.8 Reaction with aniline and ammonium thiocyanate to give the thiourea product
before formation of the aminobenzothiazole with the addition of bromine.
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Before the radiochemical synthesis could be attempted it was necessary to synthesise the
reference thioureas. Three of the aniline derivatives were chosen to react with ammonium
thiocyanate to form the unsymmetrical thioureas (Scheme 4.9). Ammonium thiocyanate and
the aniline derivative was added to a solution of 1 M hydrochloric acid. The mixture was
heated to reflux and stirred for 16 hours. The solution was then cooled and cold water added
causing the precipitation of the solid product. 1H and 13C NMR spectroscopy confirmed the
product formation.
Scheme 4.9 Formation of thioureas from the reaction of ammonium thiocyanate and ani-
line derivatives, product 32, 33, and 34.
With pure reference samples it was then possible to proceed with the radiochemical syn-
thesis. To a solution of [11C]ammonium thiocyanate (produced as previously described) in
acetonitrile, the aniline derivative in a solution of 1 M hydrochloric acid was added to the
reaction vial and heated for 10 min. However radio analytical HPLC indicated no signs of
product formation in any of the cases with all of the radioactivity coming through at the
solvent front, most likely unreacted ammonium thiocyanate.
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3 Conclusions
A facile route to the radiolabelling reagent [11C] ammonium thiocyanate has been developed,
this formation of ammonium thiocyanate was serendipitous while attempting to form 11C
thiourea. The 11C thiocyanate ion has previously been reported however its reactivity and
potential as a radiolabelling reagent was largely left unexplored.61,62,145
The nucleophilic nature of the thiocyanate ion has led us to the development of a number
of novel 11C radiolabelled molecules. Initially the straightforward nucleophilic substitution
reaction with benzyl bromide was carried out in order to form [11C] benzyl thiocyanate.
Following this reaction a series of [11C] phenacyl thiocyanate were synthesised all in excellent
RCY. Owing to the reactivity of the thiocyanate group it was necessary to further react or
protect it if it was to be any use as a radiolabelling method. A reaction was found whereby
phenacyl thiocyanates are able to undergo an intramolecular cyclisation in the presence
of an acid, forming a thiazole ring in good to excellent RCY in all cases. These thiazole
functionalities have been shown to be biologically prevalent as well as showing anticancer
activity.148,157
Further development and exploitation of the thiocyanate ion has also been carried out in the
synthesis lab. In the reaction with ammonium thiocyanate and anilines a range of aminoben-
zothiazole molecules have been synthesised. These structures have also been shown to have
biological relevance and the potential for their use as radiotracers.153 These aminobenzothia-
zole molecules have not yet been fully implemented in the radiochemistry lab as yet, largely
due to their more complex synthetic procedure.
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4 Future work
The development of [11C]ammonium thiocyanate is an exciting new prospect with great
potential as a [11C] radiolabelling reagent. However in order to implement it as a viable
labelling route a considerable amount of work needs to be carried out in the area.
The initial task would be to continue the work carried out in the synthetic lab with the
synthesis of aminobenzothiazoles and unsymmetrical thioureas and move it forwards into the
radiochemistry lab. This is likely to require better control of the reaction conditions, such
as temperature, stoichiometries and reaction times. With a more automated system this will
be more straight forward. Once the synthesis of these molecules has been optimised in the
radiochemistry lab a much wider scope for this chemistry will be available.
Since the thiocyanate ion is nucleophilic, the vast majority of 18F labelling is carried out
using a nucleophilic [18F] fluoride ion.158 Hence a vast amount of radiochemical methodology
suitable for us in 11C radiolabelling has been developed for these nucleophilic labelling reac-
tions. An interesting class of reactions is the use of iodonium salts as a method of adding a
nucleophile to an aromatic ring (Scheme 4.10). It is hypothesised that this method may be
suitable for the addition of the thiocyanate group to an aromatic ring, a reaction otherwise
very difficult to achieve.
Scheme 4.10 Reaction of an iodonium salt with the thiocyanate ion to give phenyl thio-
cyanate.
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Chapter 5
Trapping and reaction on a
microfluidic device
The use of microfluidic devices (MFD) and flow chemistry in the synthesis of radiotracers for
PET imaging is a field which is developing rapidly and becoming better established.159,160
This is largely due to the inherent properties of microfluidics which are particularly well
suited to radiopharmaceutical synthesis; these include facile automation, small space re-
quirements, easy shielding and improved reaction times due to efficient heat and mass
transfer. As previously discussed in the introduction (Section 4.1) there have been a num-
ber of examples demonstrating the use of MFDs in radiotracer development and synthesis.
These include the fully integrated formation of [18F]FDG.105 And other [18F] radiotracers
including [18F]Fallypride106,107 and [18F]Fluoroisonidazole.106,108 However the use of MFD
for the synthesis of PET radiotracers are not just confined to [18F] containing molecules,
these techniques have also been implemented in the synthesis of [11C] radiotracers including
[11C]Raclopride,111,112 [11C]olaparib, [11C]JNJ3102002817 and [11C]MK-0233.161 These [11C]
MFD radiolabelling methods largely rely on the palladium catalysed gas / liquid phase re-
action of 11CO with an amine precursor and a suitable aryl halide via a carbonylation re-
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action.45,109,110 A suitable palladium catalyst is necessary which can either be heterogeneous
supported and packed into the microreactor,44 or homogeneous.41 The 11CO is typically in-
troduced into the MFD along with the reaction solution using flow rates which enable good
mixing and high surface area contact between the two phases. A high surface area contact
is necessary due to the poor solubility of carbon monoxide gas in common organic solvents.
In all cases RCYs were on par or exceed comparable batch production methods.
A further development in the field of flow chemistry for radiotracer development has seen the
implementation of the loop method,24 whereby a precursor is trapped on a standard HPLC
or PTFE loop by evaporation of the solvent, this is followed by the flow of 11CH3I
162 or
11CH3OTf
163 in a He carrier gas which reacts with the precursor on the loop, giving very
good radiochemical yields, purities and short reaction times. While not strictly a microfluidic
system, the use of flow chemistry and narrow bore channels is comparable in many ways
to microfluidic techniques. This method reduces the quantities of precursor that is being
used which can often be costly and in limited supply, the high surface area of the tubing
allows excellent contact between the radiolabelling reagent and precursor. Labelling reactions
performed in this way proved either superior, in terms of RCYs, or equal to batch processing
methods.
A key objective of the research was to develop a microfluidic method for trapping and reacting
11CS2. Instead of trapping the cold precursor on the tubing/channel wall, the goal was to
first trap the 11C labelled reagent; in this case 11CS2 on the device before it is reacted with
the precursor. 11CS2 has good physical characteristics, melting (-111
oC) and boiling point
(46 oC), which should enable easy trapping, condensation, evaporation and distillation.
The process would involve generating 11CS2 and passing it through a cooled microfluidic
channel in a stream of He carried gas to trap it on the channel surface. The device would
then be warmed to ambient temperature. A droplet of cold precursor solution is then passed
along the channel, and as it makes contact with the channel wall the trapped 11CS2 reacts to
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form the desired product. This is then be flushed out of the MFD and collected for quality
control (QC).
Potential advantages of this method include precise control of the amount of precursor in
a droplet and to approach stoichiometric or near stoichiometric quantities of radiolabelling
reagent and precursor, this will allow purification of the final product to be easier and faster.
In a typical production 20 nmol of carbon disulfide is produced assuming a SA 100 GBq/µmol
and 5 GBq. The quantity of radioactive material generated is too small to allow a stoichio-
metric reaction. This is because it is not possible to measure the precursor in such small
quantities without having a very large dilution factor. Large excesses of the cold precursor
can often be advantageous, giving the reaction pseudo 1st order kinetics.19 This can greatly
increase the rate of the reaction allowing reactions which would usually take considerably
longer to reach completion within the necessary limited time periods, due to the constraint of
the short half-lives. However this large excess and pseudo 1st order kinetics can also have a
negative impact in terms of selectivity, side product formation and purity of the final product.
By using a MFD and trapping the radiolabelling reagent on the channel wall first, before
passing a precursor droplet (of known volume and concentration) along the channel. It is
anticipated that control of the precursor droplet will be accurate enough to add a close
to stoichiometric amount of precursor to the trapped radiolabelling reagent. Approaching
stoichiometric levels in a radiolabelling reaction could be advantageous in terms or reactivity
and purification.
The device chosen (Fig. 5.1) has a cross sectional channel area of 0.011 mm2, therefore a
droplet covering 10 mm of the channel length would have a volume of 0.11 mm3 or 110 nL.
In a 10% solution of cyclohexyl amine (MW: 99.17 g/mol, Density: 0.86 g/cm3) that equates
to 95 nanomoles in the device. Assuming 11CS2 is trapped with a SA of 100 GBq/µmol and
5 GBq, that would give 20 nmol. This equates to a 5:1 stoichiometry of amine precursor to
11CS2. This stoichiometry could easily be reduced to 1:1 with a smaller reaction droplet or
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more dilute reaction solution.
Fig. 5.1 Microfluidic device used in 11CS2 trapping experiments.
Aside from the stoichiometry of the reaction, working with these small volumes could also
greatly reduce the impurity profile of the product droplet. The method would allow in-
credibly strict control of volumes and concentrations due to the highly accurate nature of
microfluidic devices. Radiolabelling reactions carried out in this way could theoretically re-
duce the impurity profile of the radiotracer product sufficiently so that purification would
not be necessary or at least be minimal and the dose could be reformulated and administered
straight to the patient. This would require the radiotracer product to be within the GMP
guidelines.164 These guidelines can be seen in Table 5.1. With careful control of the reaction
Table 5.1 Common quality control tests for [18F]FDG and limits according to the European
Pharmacopeia and United States Pharmacopeia.164
Type of quality control EuPh USP
RCP >90% >90%
Chemical purity >90% >90%
Residual solvents <4.1 mg/Vmax <0.04%
pH 4.5-8.5 4.5-7.5
Sterility sterile sterile
Bacterial endotoxin <175 EU <175 EU
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in the MFD an RCP of >95% could be achieved as has been shown with previous reactions
with 11CS2. In traditional batch syntheses HPLC is required to achieve a chemical purity
of >95% by removing the large excesses of starting materials, precursors, solvents and side
products. By using a 1:1 ratio (or near to) of radiolabelling reagent and precursor, providing
the reaction is sufficiently efficient, a chemical purity of >95% may be achieved relatively
easily as at stoichiometric levels RCP is directly related to chemical purity. A further con-
sideration in batch type radiotracer synthesis is the amount of solvent used and the residual
amount in the sample. Usually after HPLC purification the radiotracer is reformulated by
passing it through a SepPak or similar filtration system, the radiotracer sticks to the filter
while the HPLC solvent is flushed through. The radiotracer is then washed off the SepPak
filter with ethanol and saline ready for injection into the subject. As discussed, if the purity
of the reaction in the MFD is high enough then HPLC purification would not be necessary
and therefore reformulation would not be necessary. Instead the radiotracer droplet could
be flushed from the MFD using ethanol and saline ready for injection. The reaction solvent
would be of sufficiently low volume to fall within the GMP guidelines; the volume of reaction
droplet is 110 nL, assuming a 1.5 mL dilution in ethanol and saline that would give 0.007%
by volume of the reaction solvent, well below the 0.04% allowed limits. The enclosed nature
of the MFD and minimal transferral and exposure of reagents and equipment would allow
the bacterial endotoxin level to be minimised and sterility to be ensured.
One consideration that should be made when dealing with such small quantities of precursor
is the variability in the amount of 11C produced in each experiment. These variations can
depend on the length of time between runs due to the amount of 12CO2 present in the lines
resulting in reduced SA, whether the cyclotron target is still hot from a recent bombardment
resulting in more 11CO2 being formed or down to the performance of the
11CH3I synthesis
unit which can vary from run to run. With these variations it may even be possible to add
an excess of the precursor to the 11CS2 trapped on the MFD.
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1 Trapping of 11CS2
The first challenge with the design of the system was to determine an efficient way of trapping
the 11CS2 on the channel walls. Initial experiments focused on using a simple length of PTFE
tubing to mimic the microfluidic channel (Fig. 5.2). This was because PTFE tubing is cheap
and readily available in a wide range of inner diameters (ID), from 0.18 mm to 1.0 mm, all
with an 1/16” outer diameter (OD).
Fig. 5.2 Coiled PTFE tubing to mimic glass MFD
11CS2 was generated as previously described in Chapter 2. Initially
11CS2 was passed through
a section of coiled tubing 30 cm in length with an ID of 0.25 mm at 10 mL/min submerged
in a dry ice acetone bath at -780C. A pin diode located next to the cooling bath indicated
a sharp spike in activity which passed through the tubing to the collection vial, indicating
that -78 oC is not a sufficiently low temperature to trap 11CS2 from the He stream.
The reaction was repeated at a lower temperature using a liquid nitrogen bath at -1960C. As
the 11CS2 stream passed through the cooled tubing, the adjacent pin diode showed a sharp
rise in activity which then plateaued off indicating successful trapping of the 11CS2 on the
inner tubing wall. The tubing was removed from the cooling bath and allowed to warm to
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ambient temperature while the flow of He continued. As the tubing warmed the activity in
the tubing was seen to drop as the 11CS2 thawed and passed across into the collection vial.
Initial success in trapping on the simple polymeric tubing warranted further investigation of
trapping and reaction experiments with more precision engineered glass fabricated MFDs.
These have the advantage of being more uniform in channel sizes with precise dimensions and
higher degree of tolerance. They also allow the channels to be narrower and consequently have
a smaller total volume. T-junctions can be incorporated into the design allowing minimal
deadspace between fittings and junctions consequently reducing disturbance to the flow profile
which can not be achieved so easily in polymeric tubing.
The glass MFD (Fig. 5.1) used was a prefabricated device purchased from Dolomite microflu-
idics made using HF etching and thermal bonding, it had a channel cross section of 100 µm x
110 µm (depth x width) and a surface roughness of 5 nm, 2 inlets connected by a T-junction
followed by a 278 mm reaction channel with a volume of 2.5 µL and a single outlet. The MFD
was connected to the 1/16” OD delivery and outflow lines by the Dolomite linear connector
and header system. This system works by holding the flat ends of the tubing pressed up
to the end of the microfluidic channels forming a seal rated up to 30 bar in pressure while
minimising the dead volume and maintaining an undisturbed flow profile.
Under identical conditions to those used in the trapping on polymeric tubing the glass device
unfortunately shattered due to the thermal shock of being cooled in liquid nitrogen bath.
This could be overcome by more gradual and slower cooling, the MFD was pre-cooled in a dry
ice acetone bath to -780C before being cooled further in liquid nitrogen bath to -1960C, this
stepwise cooling procedure reduced thermal shock and cracking of the MFD. Once cooled to
-1960C a flow of He was maintained at 10 mL/min to prevent any water vapour condensing
and causing blockages. However during 11CS2 production the gas flow suddenly stopped,
indicating a blockage in the system. Upon removing the MFD from the cooling bath and
allowing in to warm the blockage cleared and the flow in the MFD resumed. This indicated
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that the likely cause of the blockage was residual water from the sand in the column. When
heated, a small volume of water present in the sand is vaporised which passes along the
tubing and forms ice crystals in the cooled microfluidic channel, the expansion and growth of
the ice crystal eventually caused the blockage, upon warming the blockage melted and flow
resumed. This type of blockage was not observed in the polymeric tubing due to the larger
internal diameter of the channel compared to the glass MFD as can be seen in Table 5.2.
In an attempt to prevent these blockages occurring the sand was rigorously dried in the oven
along with the columns. Prior to the experiment the whole system was flushed with a flow
of He gas for 20 minutes in an attempt to evaporate and remove any residual water from the
system. These drying attempts however failed to avoid channel blockages.
It was apparent that it was not possible to fully exclude water from the system, as small
quantities may be present in the delivery lines, valve towers and other sources. It was
necessary to incorporate a trap which would prevent the water from reaching the MFD.
During previous experiments it was found that 11CS2 did not trap in the acetonitrile and dry
ice trap at -780C. Therefore a section of wide bore tubing (0.75 mm ID, 15 cm in length) was
placed between the furnace where 11CS2 is formed and the glass MFD placed in the liquid
nitrogen bath. This would prevent any water vapour from reaching the MFD by freezing it
on the polymer tubing, the large bore of the pre-trap tubing would allow the flow of He and
11CS2 to continue without blockages.
With the new system set up a further experiment was carried out. The MFD was sequentially
cooled as previously described, the pre trap was placed in the cooling bath at -780C and the
system flushed with He. 11CS2 was generated from
11CH3I in the furnace and carried through
the system in a stream of He carrier gas. Flow continued throughout with no blockages
forming. Indicating that the pre trap was successfully preventing and water from entering
the MFD. A pin diode adjacent to the pre-trap indicated no trapping of radioactivity. Pin
diodes next to the cooled MFD and collection vial showed near quantitative trapping of the
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11CS2 on the MFD, with only a small amount of activity passing through into the vial. When
the MFD was raised from the cooling bath and it had equilibrated to room temperature the
radioactivity remained on the MFD until the He flow was resumed, which moved the activity
into the collection vial, suggesting that the volatile 11CS2 remained on the channel walls as
a liquid in the absence of and flow through the MFD.
Table 5.2 Table documenting the success of various 11CS2 trapping experiments with dif-
ferent devices at different temperatures.
Reactor Diameter (µm) Length (mm) Temp Trapping Blockage
PTFE tube 250 300 -78 oC No No
PTFE tube 250 300 -196 oC Yes No
MFD 100 x 110 278 -78 oC No No
MFD 100 x 110 278 -196 oC Yes Yes
MFD + pre-trap 100 x 110 278 -196 oC Yes No
2 Formation of dithiocarbamate
Once the successful trapping of 11CS2 on the MFD channel walls had been achieved it was
necessary to introduce the precursor into the MFD in order for it to react with the 11CS2 to
form the radiolabelled molecule.
The MFD used in these experiments was identical to that used in previous trapping experi-
ments (Fig. 5.3). During previous trapping experiments the second inlet channel was blocked
off to prevent the He / 11CS2 stream from flowing up it and not trapping as wanted. How-
ever for the introduction of a precursor it is necessary to connect a section of tubing to the
second MFD inlet. Prior to connecting the precursor delivery line a 50% (4.3 M) 50 µL slug
of cyclohexylamine and acetonitrile solution was loaded into the tubing. This line was also
connected to a syringe pump filled with air to drive the slug of precursor solution through
the MFD in a controlled manner after trapping of 11CS2 is complete.
The system was controlled by a series of solenoid valves which could be changed in order to
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Fig. 5.3 Diagram of the MFD used in the trapping experiments
direct the flow of gasses through various parts of the system (Fig. 5.4). It is necessary that
certain parts of the system can be isolated if necessary to control the direction of flow through
the system, this is of particular importance when trapping the 11CS2 in the microfluidic chip
or delivering the precursor droplet. It is also important that radioactive waste can be directed
to a wast collection bag in the case of a problem such as a blockage in the system or leakage.
Trapping of the 11CS2 on the MFD was carried out using the exact method as previously
used with a flow rate of 10 mL/min during the trapping. Once the pin diode indicated that
trapping of the 11CS2 on the MFD had been successful, the MFD was lifted out of the liquid
nitrogen bath and allowed to warm. A USB microscope camera was focused on the device so
that the solvent/reagent droplet could be observed as it moved through the channel. Once
the MFD had warmed and the frost on the surface thawed; as viewed by the USB microscope,
the syringe pump was started at 100 µL/min. Soon after the pump was started the activity
on the MFD began to fall and the activity in the vial began to rise, indicating that the flow
from the syringe pump was moving the 11CS2 from the MFD to the collection vial. However
the slug of precursor solution was not observed in the USB microscope. HPLC of the collected
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Fig. 5.4 Schematic of the valve tower system used to control the flow through the system.
sample was inconclusive as the amount of radioactivity was too low. It is possible that the
flow rate of the syringe pump was too high, causing the precursor droplet to break up and
disperse along the channel length resulting in a poor collection in the vial. The technical
difficulties of these experiments proved to be challenging considering the balance of various
delicate procedures.
The experiment was repeated however a larger droplet of cyclohexylamine in acetonitrile
solution was loaded into the tubing (250 µL). A pneumatic lifting jack was also introduced
to raise the MFD out of the liquid nitrogen bath after trapping in order to reduce the amount
of handling and radioactive exposure to the operator. The system now consisted of the methyl
iodide box leading to the furnace where the 11CS2 is synthesised, followed by the cooling trap
to remove any water. This lead to the cooled MFD attached to a lifting jack, also leading
to the MFD was the precursor line connected to a syringe pump, the outflow of the MFD
then lead to a collection vial (Fig. 5.5). Once trapping was carried out in the same manner
as previous, the MFD was lifted from the liquid nitrogen bath and allowed to warm. When
the channels could be seen clearly on the USB microscope the syringe pump was started.
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Droplets of liquid were seen to enter the MFD and began to flow along the channel. After a
short period an obvious brown precipitate appeared to form at the interface of the droplets
and the channel walls which soon blocked the channel and prevented any further flow. Due
to the blockage it was not possible to extract any of the sample for HPLC analysis. This
indicated the there was a reaction taking place between the cyclohexylamine and the trapped
11CS2 however the product (likely to be the dithiocarbamate salt) formed was not soluble in
the acetonitrile solvent resulting in a blockage.
Fig. 5.5 Full schematic of the trapping experiment. a) MeI production box, b) 11CS2
production unit, c) furnace pin diode, d) water pre-trap cooling bath, e) air filled syringe
pump to drive reaction droplet, f) reaction droplet, g) cooled MFD, h) MFD pin diode, i)
USB microscope, j) collection vial, k) collection vial pin diode.
Scheme 5.1 Formation of the dithiocarbamate salt (monocyclohexyldithiocarbamate cy-
clohexylammonium salt) 35 from carbon disulfide and cyclohexylamine
The dithiocarbamate salt (monocyclohexyldithiocarbamate cyclohexylammonium salt) is
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quite insoluble in acetonitrile (Scheme 5.1), therefore it was necessary to replace acetoni-
trile with a more polar solvent. Ethanol was chosen on it low freezing point (-114 oC) and
its polarity.
Fig. 5.6 Image of the trapping experiment set up
The MFD was sequentially cooled to -1960C in liquid nitrogen, 11CS2 was produced in the
furnace and flowed through the system where it trapped in the MFD, once trapping was
complete the flow was stopped and the MFD lifted from the cooling bath by the pneumatic
lifting jack into focus of the USB microscope (Fig. 5.6). Observation via the microscope
showed that it took 7 minutes for the MFD to warm. At this point the syringe pump was
started at a flow rate of 50 µL/min. The tubing had been loaded with a 50% (4.3 M) solution
of cyclohexylamine in ethanol approximate 20 cm before the MFD. Droplets were seen to
flow along the microfluidic channel, becoming noticeably more brown as they travelled its
length. As the droplets exited the microfluidic channel and passed into the exit tubing they
became dispersed and failed to flow into the vial. Therefore in order to move the droplets
into the collection vial the MFD and exit tubing was flushed with 1 mL of ethanol. This
99
showed activity move from the MFD to the collection vial. A sample of the collection vial
was analysed by HPLC which showed a large peak corresponding to the dithiocarbamate
salt, with no other products or starting 11CS2 present (Fig. 5.7).
Fig. 5.7 Radio analytical HPLC of the dithiocarbamate salt (35) formed in the MFD
These results indicate that it is possible to trap 11CS2 on a cooled MFD without blockages
(Table 5.3), then warm the MFD to ambient temperature where the 11CS2 will stay on the
microfluidic channel surface. An amine solution can then be passed along the microfluidic
channel which will react with the 11CS2 to form a dithiocarbamate salt in excellent purity.
The whole process taking place in less than 10 min.
Table 5.3 Table documenting the success of dithiocarbamate forming reactions from
trapped 11CS2 on the MFD
Run Solvent Flow rate Volume Result
1 MeCN 100 100 µL Inconclusive
2 MeCN 50 250 µL Precipitate blocked
3 EtOH 50 1 µL (+ 1 mL) Dithiocarbamate salt formed
3 Conclusions
11CS2 can be quantitatively trapped on a simple section of coiled polymeric tubing cooled to
-196 oC. This trapping method was also shown to work for smaller diameter glass microfluidic
chips, however it was necessary to incorporate a pre-trap which allows 11CS2 to pass though
but prevents any moisture from reaching and consequently blocking the MFD. It was also
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necessary to cool the MFD sequentially to prevent thermal shock causing cracking. Once
trapping had been successful it was possible to remove the MFD from the liquid nitrogen
cooling bath while the 11CS2 remained on the channel wall while the MFD equilibrated to
room temperature. Once at room temperature the 11CS2 could be moved along the channel
and through to the collection vial with a steady stream of helium gas.
Following the successful trapping and control of 11CS2 on the MFD, cyclohexyl amine was
introduced into the device in a solution of ethanol. This was passed along the channel
once at room temperature reacting simultaneously with 11CS2 to form the corresponding
11C
radiolabelled dicyclohexyl-dithiocarbamate salt. The radiolabelled product could then be
flushed from the MFD, radio analytical HPLC of the ethanol solution indicated quantitative
formation of the dicyclohexyl-dithiocarbamate salt. This microfluidic trapping method has
been shown to be successful and a potentially viable method for labelling molecules with
11CS2.
These experiments are technically very challenging with multiple systems and pieces of equip-
ment in series which must be carefully controlled and monitored throughout the experiment.
The complex nature of the set up means that most problems arise due to engineering dif-
ficulties. Currently there is a significant amount of manual intervention to perform the
experiments which requires automation where possible. Reactor choice is very important
also as the channels must be of sufficient dimensions to prevent blockages while the material
chosen must be able to withstand the extreme temperatures which are used.
4 Future work
Unfortunately despite the stepwise cooling of the MFD, the repeated cooling and thawing
of them lead to them cracking (Fig. 5.8). Although it was possible to successfully trap and
react 11CS2 on the MFD there is scope to expand the number of reactions.
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Fig. 5.8 Broken MFD due to repeated cooling and warming
The key issue that needs to be addressed is the design on the MFD. Glass is too susceptible
to thermal shock, therefore a polymeric material would be more appropriate with a smaller
expansion coefficient. This ideally would allow direct cooling by liquid nitrogen rather than
stepwise cooling in a dry ice acetone bath first. An alternative cooling approach could also
be used, rather than submerging the MFD in a cooled bath a cryogenic jet could be focused
on on the MFD. This would allow more gradual cooling by controlling the flow rate of the
chip, consequently reducing thermal shock. A fine jet may also allow localised cooling of the
MFD for more complex experiments and faster warming.
Once a better MFD design has been established then further experiments may be carried
out. The first of these would be the further reaction of the dithiocarbamate salt into the
thiourea, as discussed further in Chapter 3, this would require heating of the MFD once the
dithiocarbamate salt has formed. Following the formation of thioureas it may be possible
to add further precursors to form more complex molecules such as isothioureas or similar.
Adding further precursors though would require more complex MFD designs with added inlet
channels for further precursor additions.
Aside from 11CS2 reactions it may be possible to use the method for trapping and reaction
of 11CH3I as well. Methyl iodide has a melting point of -66.5
oC and boiling point of 42.4 oC
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compared to that of carbon disulfide of -111.6 oC and 46.2 oC respectively. This similarity
in m.p. and b.p. means that they are likely to behave and trap in a similar manner. The
radiochemistry of 11CH3I is well established with many tracers labelled with it. This method
however, working on a stoichiometric or close to stoichiometric level will enable much easier
purification.
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Chapter 6
Microfluidic hydrogenation
1 Catalytic hydrogenation reactions using microflu-
idics
Catalytic hydrogenation reactions are a key part of industrial and research chemistry.165–167
They often require harsh conditions (elevated temperature and pressure) which cannot always
be carried out in traditional batch type apparatus. Naturally, these reactions have been
performed in microreactors due to the inherent advantages which they provide. There have
been various approaches towards these reactions in microreactors. Virtually all of these use
a heterogeneous catalyst in some form. Heterogeneous catalysts have key advantages in
terms of separation and reuse-ability, however there are also inherent drawbacks, including
more complex preparation of the microreactors which requires channels to be packed with
the catalyst material. Having such materials packed into microchannels can increase the
likelihood of blockages. For systems where the catalyst is coated around the inside of the
channel walls, this can lead to relatively poor contact between the reagent hydrogen and
catalyst, giving poor reaction rates. Homogeneous catalysts can overcome some of these
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problems however catalyst removal post reaction is often more challenging and the catalyst
cannot often be reused.
A number of microfluidic systems have been reported for performing hydrogenations in flow.
The palladium catalysed hydrogenation of an array of alkenes was explored using supercritical
carbon dioxide.168 In an early pioneering example of this glass microreactor channels were
coated with microencapsulated palladium. The supercritical CO2 which contained dissolved
hydrogen was passed through the channel at high pressure carrying with it the 10-undecen-1-
ol reagent. With a residence time of <1 s the 10-undecen-1-ol was quantitatively reduced.169
This method however still required the high pressure autoclave system in order to generate
the the supercritical carbon dioxide. There are a variety of other examples which use a
similar method of a channel wall coated with a heterogeneous catalyst on a solid support.169
Rather than coating the channel walls with the catalyst support, Jensen et al 170 reported a
packed bed system as an alternative approach. This method first packed glass beads into a
microreactor channel before a range of different Pt- and Pd- based catalyst were slurried and
loaded into the channel to adhere to the beads. The system was used to reduce a range of
alkenes in excellent yields.
An example of a homogeneous catalysed hydrogenation used a segmented organic and aqueous
phase method.171 The catalyst used was Ru(II)-TPPTS which was dissolved in the aqueous
phase. The substrates used were a selection of α,β-unsaturated aldehydes. A segmented
flow was first generated at a T-mixer, with flow rates of 250 µL/min for the organic phase
and 600 µL/min for the aqueous phase. At a second T-mixer the flow of hydrogen was
introduced, adding bubbles to the flow, giving a gas-liquid-liquid flow. The overall pressure
of the capillary ranged between 10 and 20 bar. These conditions gave good conversion rates
of the α,β- unsaturated aldehydes.
Although not strictly a microfluidic system, a novel method which has been used in a number
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of gas-liquid phase reaction is the tube-in-tube reactor172, where an inner permeable tube
contained the substrate solution and catalyst, while the outer tube was pressurised with
hydrogen, which was able to permeate through the inner tube and dissolves into solution.
Using residence times of around 90 seconds and a hydrogen pressure of 25 bar, quantitative
conversions were seen for a wide range of alkene containing substrates. Ley et al. went on
to use this tube-in-tube reactor set up to screen a range of Ir, Ru and Rh based catalysts
to determine their enantioselective ability to hydrogenate 3 olefin molecules173. The nature
of the reactor allowed the screening of 9 catalysts over a period of just a few hours and
hence determining which would be most suitable for further development. This method has
some key advantages over standard batch hydrogenations regarding both time and safety; as
demonstrated it is possible to screen a wide range of both catalysts and/or olefins in a short
time frame which is not feasible using traditional methods. The low volumes of hydrogen
used also reduce the risk, if leakages were to occur.
A commercially available bench-top system for hydrogenations, the H-cube (Fig. 6.1) uses a
continuous flow system, which has shown to be effective for a wide range of hydrogenations.
It generates the hydrogen for the reactions from the electrolysis of water, this means that
an external hydrogen source is not needed, greatly increasing safety. Catalyst as packed into
reusable cartridges which can be interchanged.174
2 Segmented flow formation
When working with a continuous gas liquid flow system there are a number of different flow
regimes depending on the relative flow rates of the gas and liquid. These include bubble
flow, segmented flow and annular flow. Bubble flow is characterised by a low gas flow with
bubbles of gas smaller than the channel diameter passing through the channel surrounded by
the liquid phase, segmented flow describes the regular and alternating formation of segments
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Fig. 6.1 H-cube bench-top hydrogenation system
of gas and liquid, while annular flow is caused by a rapid flow of gas through the centre
of a channel resulting in a thin film of liquid coating the internal surface of the channel
(Fig. 6.2).175 Common to all gas liquid phase reaction is the need of efficient mass transport
of the gas into the liquid phase.
Fig. 6.2 Various flow regimes of gas/liquid phase flow. a) Bubble flow, b) Segmented flow,
c) Annular flow.
Previous work carried out in the group used microfluidic reactors for palladium catalysed
carbonylation reactions. This work used a segmented flow regime in order to generate repro-
107
ducible flow patterns with good mass transport and gas liquid surface area contact.175 The
microfluidic device (MFD) used had a channel length of 5 m, internal channel dimensions of
100 x 220 µm and a Y-junction (Fig. 6.3). Gas flow rate was controlled using a mass flow
controller and liquid flow rates controlled using a syringe pump. Generation of segmented
flow within the chip was facile, however maintaining a stable segmented flow in the device for
extended periods of time was problematic. This instability in the flow regime was thought
to be for a number of reasons. Due to the glass surface of the MFD wetting of the channel
results in marginally slower movement of the liquid segments compared to the hydrogen gas,
resulting in gradual merging of the segments.
Fig. 6.3 Images of 5 m, glass MFD. a) Whole chip, b) Head piece showing Y-junction.
Stable segmented flow in polymeric tubing was found to be much easier to achieve, largely
due to the larger internal diameter (ID) of the channel, material wetting properties and the
continuous nature of the channel without and sharp bends.
A segmented flow regime has two advantages. It allows good contact between the phases
in the channel which increases diffusing of the gas phase into the liquid phase. Secondly it
allows greater control over the residence time of the reagents, enabling the reaction to reach
completion.
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3 Segmented flow hydrogenation
The catalytic hydrogenation of styrene using Wilkinson’s catalyst was selected as a model
reaction (Scheme 6.1). Prior to any microfluidic or flow reactions being carried out the
reaction was first tested in a traditional batch process, styrene was added to a solution of
toluene containing Wilkinson’s catalyst (0.5 mol %) and placed under a positive pressure of
hydrogen, the reaction mixture was stirred for 16 hours at 95 oC. 1H NMR spectrum indicated
quantitative conversion to the ethylbenzene (36) product; showing that our chosen model
reaction was feasible and quantitative conversion could be achieved flow reactions could be
started.
Scheme 6.1 Hydrogenation of styrene to ethylbenzene (36) catalysed by Wilkinson’s cat-
alyst
3.1 Stopped flow reactions
A simple stopped flow reactor was set up in order to carry out the hydrogenation of styrene.
This consisted of a syringe pump charged with toluene, the outflow of this led to an analytical
injector valve loaded with a solution of toluene containing styrene and Wilkinson’s catalyst.
The outflow of the injector valve was connected to a Y-connector, the second inlet of the
Y-connector led to a hydrogen cylinder controlled by a mass flow meter. The exit of the
Y-connector led to the reaction channel; this consisted of a 2 m section of 1
16
inch outer
diameter (OD) fluorinated ethylene propylene (FEP) tubing with a 0.1 mm ID capped by
a shut off valve (Fig. 6.4). Liquid and hydrogen flow rates were set at 40 µL/min and 0.4
sccm respectively which gave a uniform segmented flow with gas segments of approximately
9 mm and liquid segments of 5 mm. Once a stable flow had been reached the loaded injector
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valve was turned, releasing the reagent solution into the flow. In previous experiments using
dyes the retention time between injection and reaching the end of the reaction channel was
measured at 210 sec. At this predetermined time the shut off vale was closed and the syringe
pump stopped, however the gas flow was continued to pressurise the system up to 3 bar.
The coiled reaction channel was placed in an oil bath at 95 oC. After 2 hours the hydrogen
appeared to have been used up with no gas segments visible. 1H NMR spectroscopy of the
product however indicated that the reaction had not been successful, the 0.1 mm ID reaction
channel was replaced with larger bore (0.8 mm ID) in order to increase the contact area
between the gas and liquid phases (Fig. 6.5).
Fig. 6.4 Set up of initial segmented flow hydrogenation system. a) Hydrogen cylinder, b)
syringe pump, c) mass-flow meter, d) analytical injector valve, e) hydrogen line, f) solution
line, g) Y-connector, h)reaction channel, i) shut off valve.
It was apparent that at elevated pressure the hydrogen segments were diffusing through the
channel walls causing the breakdown of segments and of course lack of reaction. Therefore it
was necessary to replace the FEP reaction channel with a less permeable tubing. Polyether
ether ketone (PEEK) tubing with a 0.8 mm ID was used to replace the permeable FEP
tubing. However unlike FEP, PEEK is opaque rather than clear so the droplet formation
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could not be observed. To overcome this a short section of FEP tubing and shut off valve
was added between the Y- connector and PEEK reaction channel (Fig. 6.6). This acted as
a window to check that segment formation was uniform, with slug lengths of approximately
0.5 mm and bubble lengths of 3 mm forming of a rate of 3 Hz. After injection of the reagent
solution and the residence time had been reached the shut off valve at the end or the reaction
channel was closed and the liquid flow stopped, once the pressure had risen to 3 bar the
shut of valve at the start of the reaction channel was closed. The coiled reaction channel
was then placed in an oil bath with the temperature set to 90 oC for 16 hours, the 1H NMR
spectroscopy showed successful hydrogenation of styrene to ethylbenzene at 80% conversion.
Fig. 6.5 Coloured segments flowing through coiled tubing.
Further development of the system involved removing the injector, due to the fragile nature of
the flow regime the slight pressure change in the turning on the injector valve was sometimes
enough to disturb the flow and cause a breakdown of the segments. Instead of the injector the
reagent solution was loaded directly into the syringe pump. Secondly the FEP observation
window was removed from the system, this was to minimise the number of different sections
and unions of tubing which can disturb the segmented flow, there was confidence that the
chosen flow conditions would form regular segmented flow. The third alteration was to replace
the PEEK reaction channel with a 500 µL stainless steel HPLC loop (Fig. 6.7). FEP has
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Fig. 6.6 Section of FEP tubing before PEEK reaction channel to observe segment forma-
tion.
a hydrogen permeability of 34100 cm3/m2/24 h compared to 1431 cm3/m2/24 h for PEEK,
while stainless steel has zero permeability. With these alterations to the system made, using
flow rates of 500 µL/min for the hydrogen and 25 µL/min for the reagent solution, pressurising
the system to 4 bar at 85 oC, gave a conversion of styrene to ethyl benzene of 90% when left
to react for 16 hours as quantified by 1H NMR spectroscopy.
Fig. 6.7 500µL stainless steel HPLC loop used as the reaction channel.
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3.2 Continuous flow
As an alternative to a stopped flow system it was of interest to set up a continuous flow
system and compare the results (Fig. 6.8).
The stainless steel tubing was replaced with a 10 m long section of polytetrafluoroethylene
(PTFE) tubing with an ID of 0.8 mm, due to this system not being pressurised, permeability
of the tubing was not a concern. Segmented flow was established with a very low flow rate,
in order to reduce pressure build up and increase residence time through the tubing. Flow
rates of 100 µL/min for the hydrogen and 7 µL/min for the reagent solution gave a retention
time of around 4 hours at 85 oC. This delivered 1.68 mL of solution to give a conversion of
30% as quantified by 1H NMR spectroscopy. However it is anticipated that the conversion
will be greatly improved by increasing both the residence time and temperature.
Fig. 6.8 Continuous flow hydrogenation system.
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4 Annular flow hydrogenation in glass MFD
Previous segmented flow experiments had shown good conversion rates, however quantitative
conversion of styrene to ethylbenzene had not yet been observed in any of the systems used.
Therefore an alternative approach was sought. It was believed that the issue was one of mass
transport, gas liquid contact is good in a segmented flow system however diffusion is slow
and long time periods are necessary for good conversion. Therefore instead of segmented
flow an annular flow system would be used as this gives a greater contact between the liquid
and gas phases and due to its more turbulent nature, diffusion is no longer a limiting factor.
The reactor system was comprised of a 5 m glass MFD connected to a hydrogen bottle
controlled by a mass flow meter and a syringe pump loaded with the reagent solution (toluene,
styrene and Wilkinson’s catalyst). The MFD was heated to 120 oC, under hydrogen flow rates
of 2.0 sccm (2 bar inlet pressure) and liquid flow rates of 10 µL/min, a stable annular flow was
observed. Residence time of the reagent solution was just 100 seconds, however despite this
short time conversion from styrene to ethylbenzene was found to be quantitative as measured
by GC.176
Owing to the success of the conversion of styrene to ethylbenzene a range of 10 other alkene
containing groups were tested (Table 6.1). Substrates with terminal alkynes (entry 37 and
38) showed similar near quantitative to the alkane products. This is in accordance with
previous studies using Wilkinson’s catalyst, however such reactions are usually carried out
using much longer times and higher pressures.177 For examples containing an α, β-unsaturated
ketone (entries 39-44) good to excellent yields were also observed with the exception of entry
41 due to the methyl group adjacent to the double bond causing steric hindrance. Wilkinson’s
catalyst is also capable of hydrogenating alkynes, however in the case of diphenylacetylene
(entry 45) low conversions were seen. Poor conversions were also observed for the sterically
hindered phenylcyclohexene (entry 46).
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Table 6.1 Substrates and products of microfluidic annular flow hydrogenation catalysed
by homogeneous Wilkinson’s catalyst.
Entry Substrate Product Conversion (%)
36 >99
37 98
38 88
39 93
40 >99
41 39
42 95
43 69
44 90
45 19
46 5
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5 Rhodium deposit
During the repeated hydrogenation reactions a black deposit was seen to build up in the
channel, most noticeably at the Y-junction, gas liquid interface and continued for the next
4-5 channel switchbacks (Fig. 6.9). Continued hydrogenation experiments resulted in further
deposition and eventually blockage of the channel. These types of blockages are one of the key
problems with homogeneous catalytic reactions carried out in a microfluidic device. Solutions
to overcome these blockage include ultrasound and tuning solvents for good solubility.178–180
Fig. 6.9 Black deposit build up in MFD channel.
The black deposit was suspected to be metallic rhodium from the decomposition of the
Wilkinson’s catalyst. As metallic rhodium has well known catalytic properties it was decided
to investigate its catalytic activity using our model styrene hydrogenation reaction. Using
identical conditions with the exception of added Wilkinson’s catalyst in the reagent solu-
tion the reaction was carried out on a MFD with a coating of the black rhodium deposit.
Somewhat surprisingly quantitative conversion of the styrene to ethylbenzene was observed.
As a control experiment the conversion of styrene to ethylbenzene using annular flow carried
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out but the MFD was replaced by a section of PTFE tubing of similar dimensions (200 µm
ID and 5 m long) and identical conditions. Much lower yields (50%) were seen in the PTFE
tubing compared to the glass MFD. During the reaction the black deposit was seen to form
however it did not adhere to the PTFE walls, this is likely to be responsible for the lower
yields seen. This also indicates that many of the initial annular flow experiments carried out
in the MFD are not a sole product of homogeneous catalysis but a mixture of a homo and
heterogeneous catalytic process.
Following this result the remaining 10 substrates were tested under the same conditions
(Table 6.2). For the majority of these reaction the rhodium deposit proved to be more
catalytically active than the homogeneous Wilkinson’s catalyst with improved yields in most
cases, this was particularly noticeable for entry 41 which showed and improvement from 39%
to 100% when using the supported rhodium catalyst as opposed to the Wilkinson’s catalyst.
However an improvement in yield was not seen in all cases, the enone substrates entries
43 and 44 showed a decrease in conversion. In contrast, conversion of the alkyne substrate
diphenylacetylene entry 45 underwent quantitative conversion with the heterogeneous system
but as a mixture of products, 69% 1,2-diphenylethane and 31% stilbene. In the homogeneous
system only 1,2-diphenylethane is seen.
It was noticed that a common impurity peak was occurring in the GC traces regardless of the
substrate used. Further analysis showed that this side product was methylcyclohexane (47),
this was forming from the complete saturation of the aromatic toluene ring (Scheme 6.2).
By passing neat toluene through a rhodium coated MFD using the same conditions that had
previously been used a 7% conversion was observed. This conversion could be increased to
20% if a toluene solution (1 M in decane) was used due to the saturation of the catalyst
surface being reduced. This reaction is of particular interest as the conversion of toluene to
methylcyclohexane has potential applications in hydrogen storage technology.181
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Scheme 6.2 Hydrogenation of toluene to methylcyclohexane (47) catalysed by the rhodium
deposit.
Table 6.2 Substrates and products of microfluidic annular flow hydrogenation catalysed
by homogeneous Wilkinson’s catalyst.
Entry Substrate Product Conversion (%) Improvement (%)
36 >99 0
37 >99 1
38 >99 12
39 >99 7
40 >99 0
41 >99 61
42 98 3
43 10 (-59)
44 <5 -85
45 69 50
31 31
46 <1 (-4)
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6 Deposit analysis
The activity of the catalyst was clear however little was known about its chemical composition
or structure. An initial experiment was carried out to determine the robustness of the
catalytic surface. A continuous flow of styrene (1 M) in toluene and hydrogen was passed
through the MFD coated with rhodium for 24 hours. Aliquots were taken at 2 hour time
points and analysed by GC. The chromatographs showed no deterioration in the conversion
with quantitative formation of ethylbenzene seen in all samples. In this 24 hour time period
there was also no evidence of flaking or degradation of the catalytic surface from the channel
wall.
Analysis of the catalyst itself was difficult as it was strongly adhered to the channel wall.
Optical microscopy was used to look at the level of coating along the channel (Fig. 6.10), form
this we were able to estimate that the catalyst layer was between 2 and 10 µ in thickness.
Fig. 6.10 x4 magnification of the channels under an optical microscope, top channels show-
ing complete coverage while the lower channels show reduced coverage.
Although it was not possible to remove the rhodium deposit from the channel wall it was
possible to produce it using a PTFE reaction channel instead of the glass MFD. A sample
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was collected and analysed by scanning electron microscopy (SEM) (Fig. 6.11) and tunnelling
electron microscopy (TEM), these both confirmed the presence of rhodium and that the mor-
phology of the sample was amorphous rather than nanoparticulate. Powder X-ray diffraction
was also able to confirm that the sample was not crystalline.
Fig. 6.11 SEM image of the rhodium deposit, showing irregularity and high surface area.
In attempts to form the rhodium deposit on the channel wall it was found that an alkene
such as styrene was necessary for the process. Passing a solution of toluene and Wilkinson’s
catalyst through the MFD with hydrogen did not produce a deposit. This indicates that
the deposit formation relies on the Rh-alkyl intermediate to form before it is reduced to
the Rh0 deposit, this intermediate is known to form after the insertion of dihydrogen in the
catalytic cycle (Fig. 6.12). The formation of the catalyst is fast and can be seen to form at
the Y-junction of the MFD where the solution and hydrogen make contact.
7 Conclusions
The primary aim of this investigation wast to hydrogenate a number of alkene containing
substrates to their corresponding alkane analogues in a microfluidic system with hydrogen
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Fig. 6.12 Catalytic cycle of Wilkinson’s catalyst for the hydrogenation of styrene to ethyl
benzene.
gas. Using the hydrogenation of styrene to ethyl benzene in the presence of homogeneous
Wilkinson’s catalyst in toluene as a model reaction, it was possible to achieve a conversion of
90% over a period of 16 hours using a stopped slow segmented method. Using a continuous
segmented flow method with a residence time of 4 hours a conversion of 30% was achieved.
These methods showed promise however conversion were not quantitative and the reaction
time unacceptably long.
To improve the percentage conversion as well as the rate an annular flow system with a glass
MFD was used. Initial experiments using this system showed quantitative conversion from
styrene to ethyl benzene in just 100 seconds. Due to the success of this reaction and the
improvement in both time and conversion the range of other substrates were also tested using
the same system method. Results were varied but generally gave good to excellent yields,
poorer conversions were observed for more sterically hindered alkenes.
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During these reactions a black metallic deposit was observed to deposit on the MFD channel
wall. Reaction carried out using this deposited catalyst layer without the addition of ho-
mogeneous Wilkinson’s catalyst gave improved conversions in the majority of cases. It was
also apparent that the catalytic deposit had a certain amount of catalytic activity in the
conversion of toluene to methylcyclohexane with conversions of up to 20%.
Analysis of the catalytic deposit showed that it was a non crystalline rhodium based deposit.
Repeated hydrogenation experiments showed that the deposit was robust and showed no
deterioration in the levels of conversion after continued usage.
8 Future work
The main areas of development lie with a better understanding of the rhodium catalytic
surface which is being formed. Further analysis of the material would give a better insight
to its catalytic activity.
Currently the deposit covers just the first 4-5 channel of the MFD which has approximately
60 in total. This equates to a surface are of approximately 2 cm3, if the deposition could be
spread more evenly across the channel length a much larger surface are would be available
possibly resulting in higher yields and faster reaction times.
Furthermore the conversion of toluene to methylcyclohexane shows particular promise. The
conversion of aromatics into saturated hydrocarbons is of continued interest for large indus-
trial applications for the production of synthetic precursors182 as well as the reduction of
volatile organics from the combustion of diesel fuels.166,182 More recently the methylcyclo-
hexane has gained interest from the field of hydrogen storage and release.183 If this process
could be optimised and the yields improved then it may prove to be a useful method for the
rapid storage of hydrogen.
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Chapter 7
Experimental
General experimental considerations
All starting material were of reagent grade purchased from Sigma-Aldrich or VWR Interna-
tional and were used without any further purification. All preparations involving Wilkinson’s
catalyst were performed under an inert nitrogen atmosphere. GC analysis was performed
on a Hewlett-Packard 5890 Series II Gas Chromatograph. All NMR spectra were recorded
on a Bruker AV-400 spectrometer at 294 K. Chemical shifts are reported in ppm using the
residual proton impurities in the solvents. Mass spectrometry analysis were conducted on a
Micromass Autospec Premier machine by the Mass Spectrometry Service, Imperial College
London. The radio-HPLC system consisted of an Agilent 1100 series with quaternary pump
and diode array UV detector connected in series to a NaI radiodetector of in-house design.
radio-HPLC analysis (flow: 1.5 mL/min, column: Eclipse XDB-C18, 5 µm, 4.6 x 150 mm).
Radioactivity measurements were performed using a Isomed 2000 dose calibrator.
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1 Synthesis of 11CS2
1.1 Automated synthesis of 11CH3I from
11CO2
[11C]carbon dioxide was produced using a Siemens Eclipse HP cyclotron by 11 MeV proton
bombardment of a target containing nitrogen and 1% oxygen unless otherwise stated. In
a typical irradiation a 10 µA proton beam for 5 minutes was used. At EOB 11CO2 was
transferred with a helium sweep from the target at flow rate 200 mL/min into an automated-
commercially available Synthra gas phase methyl iodide production system (Fig. 2.1). 11CO2
was converted to 11CH4 via a high temperature (400
oC) gas phase reaction over a nickel
catalyst. 11CH4 was cryogenically trapped at -196
oC using a liquid nitrogen trap. On release,
11CH4 was converted to
11CH3I using the high temperature (700
oC) gas phase iodination
reaction. 11CH3I was transferred from the Synthra unit to a hotcell under a flow of helium
(10 sccm).
1.2 Synthesis of 12CS2
1.2.1 Synthesis of 12CS2 from methyl iodide
Sulphur (1 g) was mixed with chromatography sand (2 g) and loaded into a 30 cm, glass
Omnifit tube (10 mm ID), 2 small plugs of quartz wool either side held the mixture in
place. The tube was placed in a Carbolite Wire Wound Single Zone Tube Furnace heated
to 500 oC. This temperature is considerably higher than the auto ignition temperature of
sulfur (232oC) therefore for safety purposes it was imperative to exclude oxygen. A nitrogen
line attached to the tube inlet which passed through a bubbler, constructed from Swagelok
components containing methyl iodide (1 mL). The outlet needle of the reaction was inserted
into a d3-acetonitrile (1 mL) trap. A nitrogen flow 5 mL/min was used to pass the volatile
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methyl iodide vapours through the tube reactor (Fig. 2.4). Purple iodine vapour from the
decomposition of MeI was observed in the tube. Some sulfur was observed to have distilled
over. After approximately 10 minutes of heating the furnace was turned off and the N2 flow
ceased and the mixture analysed by NMR spectroscopy. 13C NMR (CD3CN, 101 MHz) δ:
194.0.
1.2.2 Synthesis of 12CS2 from methane
A quartz tube (10 mm OD, 7 mm ID, length 500 mm) packed with silica (1 g) and sulfur
(0.8 g), positioned adjacently and separated by quartz wool (Fig. 2.8), was heated to 700 oC
using a Carbolite furnace. Initially the silica alone was heated under a flow of nitrogen to
remove any traces of water. The sulfur was then positioned into the furnace and the contents
were subject to a flow of methane (99.99 %) controlled by a mass flow meter (1 sccm). The
resultant gases were bubbled through an NMR tube filled with deuterated acetonitrile, cooled
to 5 oC ice bath. After 15 minutes, the reaction was stopped and the solution analysed by
NMR spectroscopy. 13C NMR (CD3CN, 101 MHz) δ: 192.6 ppm.
1.3 Synthesis of 11CS2
1.3.1 Synthesis of 11CS2 from
11CH3I
Using the same tube set up and composition as for the synthetic lab as described above, the
inlet was connected to the methyl iodide production unit in the minicell, while the outlet led
to a needle into an acetonitrile (1 mL) trap. 5 minutes prior to release of the 11C methyl
iodide, the furnace was switched on and allowed to reach the desired temperature of 500
oC. The 11C methyl iodide was released from the minicell under a flow of helium at 10
mL/min. Pin diodes indicated an increase in radioactivity in the tube and subsequently in
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the acetonitrile trap. Analytical radio HPLC co-injected with 12CS2 indicated a peak at 5.49
minutes from both the UV and radio-detectors indicative of 11CS2 production, H2O:MeCN
50:50, 1.5 mL/min.
1.3.2 Synthesis of 11CS2 from
11CH4
A quartz tube packed with a mixture of silica (1 g) and sulfur (1 g), held in position by plugs
of quartz wool. The system was flushed with helium while being heated to 750 oC using a
Carbolite furnace. 11CO2 was generated in the cyclotron using a 10 µA bean current for 2
minutes. The 11CO2 was released into a Synthra synthesis unit where it was trapped at -196
oC before being released over an oven at 450 oC in the presence of hydrogen to give 11CH4.
At this point the 11CH4 was released into the hot cell at a flow rate of 10 mL/min in a
stream of helium carrier gas. Once in the hot cell the 11CH4 passed through the heated (750
oC) column containing the silica catalyst and gaseous sulfur. The exit stream was passed
through a solution of acetonitrile. Radio analytical HPLC of the trapping solution indicated
that 11CS2 had been formed in low yields, 50% according to radio HPLC however this doe not
account for the unmeasured untapped gasses as qualitative readings in the hotcell indicated
that the majority of the radioactivity was passing through the ice bath without trapping.
2 Target chemistry
This work was carried out in collaboration with Professor Mikael Jensen at the Centre for
Nuclear Technologies, DTU, Denmark. All targetry experiments were carried out on a GE
PETtrace 800 cyclotron using an aluminium gas target made in house. The port was sealed
with a havar foil. The outlet of the target was attached to a length of 1/16 PEEK tubing
connecting it to a Swagelok 2 way switching valve. One port of the valve was connected to a
nitrogen (100 %) pressurised at 5 bar. The other valve port led to a needle valve to control
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the flow from the target. This led to a collection vial containing trapping solvent followed
by an ascarite trap and collection bag (Fig. 2.12).
2.1 Uncooled target sulfur bombardment
Elemental sulfur (68 mg) was loaded into the target. The target chamber was subject to ten
nitrogen gas cycles at 5 bar in order to remove any oxygen present. The target was loaded
onto the cyclotron while it was pressurised to 5 bar of nitrogen. The target was irradiated
with a beam current of 10 µA for 10 minutes. After bombardment the temperature was
measured at 160-170 oC. The high temperature had caused the polyoxymethylene fitting
connecting the tubing to the target to melt resulting in the leakage of radiation from the
target.
2.2 Air cooled target sulfur bombardment
50 mg of sulfur was loaded into the target. The target was mounted as previously described
and a jet of compressed air was localised on the polyoxymethylene fitting to prevent overheat-
ing and melting. A beam of 5 µA irradiated the target for 5 minutes. The 2 way switching
valve was turned, releasing steady flow of the target contents through the collection vials.
The DMSO vial gave an initial activity of 315 MBq, 19 minutes after bombardment while
the ascarite trap showed 610 MBq. The head-space of the DMSO vial was flushed with
2 x 50 mL of He and the activity measured again, (214 MBq). The decay of the sample
was measured using a gamma camera which showed a signal of 511 keV suggesting pure β+
emission showing that 11C is the only radioactive species present. Multiple reading of the
radioactivity over time also confirmed this due to the decay pathway. Plotting of the decay
curves give a t1
2
of 19.8 min for the ascarite trap and 16.9 min for the DMSO trap.
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2.3 Air cooled target sulfur bombardment
A repeat of the experiment 2.2 to confirmed our results. No sulfur was added to the target as
there was a sufficient amount remaining from the previous experiment The volume of DMSO
was increased (10 mL) in order to aid trapping. The target was bombarded at 5 µA for
10 minutes. Similar activity measurements were taken of the ascarite vial (717 MBq) and
DMSO vial (274 MBq) and their decay monitored with time. Plotting of the decay curves
give a t1
2
of 24.8 min for the ascarite trap and 16.9 min for the DMSO trap.
2.4 Water cooled target sulfur bombardment
Elemental sulfur (50 mg) was loaded into an identical aluminium target fitted with added
counterflow water cooling system. The target chamber was flushed as before with the nitrogen
gas in order to remove any oxygen present. The target was loaded onto the cyclotron while
it was pressurised to 5 bar. The target was irradiated with a beam of 10 µA for 5 minutes.
The valve was released and the target contents bubbled through an acetonitrile trap (20 mL)
ascarite trap and collection bag. Radioactivity in each of the 3 traps 20 minutes after EOB
were as follows, acetonitrile (254 MBq, 15%), ascarite (997 MBq, 57%), bag (482 MBq, 28%).
The t1
2
of the acetonitrile (t1
2
= 19.8 min) and ascarite (t1
2
= 20.2 min) were also calculated
from decay.
2.5 Water cooled target sulfur bombardment
No further sulfur was loaded into the target. The target was purged with nitrogen at 5 bar.
The target was irradiated with a beam of 10 µA for 10 minutes. The valve was released and
the target contents bubbled through an acetonitrile trap (20 mL) ascarite trap and collection
bag. A sample of the acetonitrile was taken for radio analytical HPLC. This showed that
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11CS2 was no present as it did not co-elute with a co-injected
12CS2 reference. The acetonitrile
trap was degassed for 5 minutes 53 minutes after EOB, prior to degassing the radioactivity
was measured at 363.5 MBq. After 5 minutes of degassing the activity had dropped to 136.7
MBq, equating to a decay corrected drop of 170.0 MBq, 55%.
2.6 Control target experiments to determine product
2.6.1 Sulfur free target bombardment
All sulfur residue was removed from the target. The target was loaded and purged with
nitrogen at 5 bar. The target was irradiated with a beam of 5 µA for 2 minutes. The target
contents were released through the sequence of traps. Initial radioactivity readings were,
acetonitrile (98 MBq, 35%), ascarite (131 MBq, 47%), bag (49 MBq, 18%). The acetonitrile
vial was degassed for 5 minutes, prior to degassing the radioactivity was measured at 55.0
MBq. After 5 minutes of degassing the activity had dropped to 1.1 MBq. Equating to a
decay corrected drop of 45.3 MBq, 98%, indicating that the radioactive material trapping in
the acetonitrile in experiment 2.5 was a product of the sulfur in the target.
2.6.2 Carbon disulfide target bombardment
Carbon disulfide (10 µL) was loaded into a clean target. The target was purged with nitrogen
and bombarded at 3 µA for 5 minutes. Inspection of the target chamber showed that the
carbon disulfide had decomposed into an amorphous material that was not characterised.
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2.6.3 Effectiveness of trapping 11CO2
A new target was purged with nitrogen doped with oxygen (4%). The target was bombarded
at 5µA for 2 minutes. Release of the target through the traps resulted in acetonitrile (10.2
MBq, 33%), ascarite (21.1 MBq, 67%), bag (0.1 MBq, <1%). The acetonitrile vial was
degassed for 2 minutes, prior to degassing the radioactivity was measured at 5.1 MBq. After
2 minutes of degassing the activity had dropped to 1.1 MBq. Equating to a decay corrected
drop of 3.5 MBq, 76%.
3 Thiourea radiochemistry
3.1 General 11C labelling of thioureas
There were two synthetic methods for the formation of symmetrical thioureas, for the major-
ity the reaction could be performed at 95 oC in acetonitrile where it was trapped. However for
the amines with less acidic protons, aniline and o-phenylenediamine required a higher tem-
perature reaction, therefore DMSO was used at 150 oC. All thiourea reference compounds
were purchased from commercial sources.
3.1.1 Acetonitrile thiourea synthesis
1 2 3
5 7 8
An amine substrate (10 µL) was added to acetonitrile (0.5 mL). 11CS2 was bubbled through
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an acetonitrile solution (2 mL). Once the 11CS2 had been delivered a sample (0.1 mL) was
removed and added to the amine substrate solution. After 10 minutes of stirring at 95 oC
a sample was taken for radio HPLC analysis (H2O:MeCN 50:50, 1.5 mL/min.), this showed
quantitative conversion of >99 % RCY to the thiourea product in all cases.
3.1.2 DMSO thiourea synthesis (aniline, o-phenylenediamine)
4 6
An amine substrate (10 µL) was added to DMSO (0.5 mL). 11CS2 was bubbled through
a DMSO solution (1.5 mL). Once the 11CS2 had been delivered a sample (0.2 mL) was
removed and added to the amine substrate solution. After 10 minutes of stirring at 150 oC
a sample was taken for radio HPLC analysis (H2O:MeCN 50:50, 1.5 mL/min.), this showed
quantitative conversion of >99 % RCY to the thiourea product in all cases.
3.2 IT1A synthesis
The synthesis of IT1A and IT1t was adapted from the method published by Thoma et al.133
3.2.1 Synthesis of 1,3-dicyclohexyl-2-thiourea (5)
To a solution of cyclohexylamine (4.6 mL) in acetonitrile (30 mL) was added carbon disulfide
(1.2 mL) dropwise over 25 minutes forming a white precipitate. Once this addition was
complete the reaction mixture was heated to reflux for 4 hours. As the reaction progresses
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a pale yellow colour develops. Once complete the mixture was filtered to give fine white
crystals. Yield 3.61 g 75%. 1H NMR (D2O, 400 MHz) δ: 3.95 (s, 2H NH), 1.92 - 1.77 (m,
4H), 1.64 (m, J = 10.9, 3.6, 3.1 Hz, 4H), 1.53 (dp, J = 12.2, 4.1, 3.5 Hz, 2H), 1.34 - 1.04
(m, 10H).
3.2.2 Synthesis of chloro precursor (3-chloromethyl-5,6-dihydro-imidazo[2,1-
b]thiazole) (11)133
1,3-dichloro-propan-2-one (0.63 g) was added to a solution of 2-imidizolidinethione (0.51 g)
in acetonitrile (10 mL) and heated to reflux for 16 hours. The reaction mixture was filtered
giving a white solid. 1H NMR (D2O, 400 MHz) δ: 7.04 (s, 1H), 4.75 (s, 2H), 4.28 (m, 2H),
3.87 (m, 2H),
3.2.3 Synthesis of IT1A133
To a suspension of 3-chloromethyl-5,6-dihydro-imidazo[2,1-b]thiazole (0.25 g) in acetonitrile
(10 mL) was added 1,3-dicyclohexyl-2-thiourea (0.18 g). The suspension was heated to reflux
for 20 hours. The resulting white solid was filtered and then recrystallised from equal parts
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of methanol and ether. Yield 0.30 g, 79% 1H NMR (D2O, 400 MHz) δ: 6.65 (s, 2H), 4.43
(m, 4H), 4.25 (s, 2H), 3.66 (m, 2H), 1.01-1.89 (m, 20H). ESI-MS: m/z 379 (100 %).
3.2.4 Synthesis of bromo precursor (3-bromomethyl-5,6-dihydro-imidazo[2,1-
b]thiazole)(12)
3-chloromethyl-5,6-dihydro-imidazo[2,1-b]thiazole (0.4 g) was added to LiBr (2.5 g) in ace-
tonitrile (20 mL) and heated to reflux for 24 hours. The mixture was filtered to re-
move the filtrate, the solid then washed with ether to remove any salts to give a white
solid. 1H NMR spectroscopy indicates 90% conversion from the 3-chloromethyl-5,6-dihydro-
imidazo[2,1-b]thiazole to the 3-bromomethyl-5,6-dihydro-imidazo[2,1-b]thiazole. 1H NMR
(D2O, 400 MHz) δ: 6.75 (s, 1 H), 4.40 (s, 2 H), 4.39 (m, 4 H).
3.3 11C IT1A synthesis
3.3.1 [11C] Benzyl N,N’-dicyclohexylcarbamimidothioate production (10)
Cyclotron Bombardment of 20 µA for 5 minutes. 11CS2 produced as previously described
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was bubbled through an acetonitrile solution (1 mL) containing cyclohexylamine (10 µL).
Once trapping was complete the vial was heated to 95oC for 10 minutes. Radio HPLC
showed successful formation of the thiourea with an elution time of 6.7 minutes (1.5 mL/min,
H2O:MeCN). Benzyl bromide (10 µL) was added to the reaction mixture and heated to
95oC for a further 10 minutes. Radio HPLC (1.5 mL/min, H2O:MeCN) indicated successful
formation of the benzyl N,N’-dicyclohexylcarbamimidothioate product with an elution time
of 4.1 min (Fig. 3.2), the cold reference sample was obtained from previous experiments
carried out by research colleagues.
3.3.2 Attempt at IT1A formation from iodo precursor
Cyclotron Bombardment of 20 µA for 5 minutes. 11CS2 was delivered into a vial contain-
ing acetonitrile (2 mL) and cyclohexylamine (10 µL). Once the activity in the vial had
peaked it was heated to 95 oC for 12 minutes. Radio HPLC indicated successful formation
of the thiourea with an elution time of 7.25 min. A suspension of 3-iodomethyl-5,6-dihydro-
imidazo[2,1-b]thiazole in acetonitrile was then added to the vial and heated for a further 12
minutes at 95 oC. HPLC showed no formation of the IT1A target molecule, but a significant
amount of unknown products which formed.
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3.4 Tanaproget synthesis
3.4.1 1,4-dihdro-2H-3,1-benzoxazine-2-thiol synthesis (9)
2-Aminobenzyl alcohol (10 mg) was added to DMSO (1.5 mL) Cyclotron bombardment of
10 µA for 5 minutes. 11CS2 was bubbled through the solution, turning yellow upon delivery.
Once the 11CS2 had been delivered and trapped in the sample vial, the sample vial was placed
in a preheated heating block at 150 oC. The solution was stirred at 150 oC for 10 minutes,
after heating the solution was dark green in colour, however upon cooling it changed to an
orange colour. Radio HPLC (1.5 mL/min, H2O:MeCN) indicated quantitative formation of
the desired 1,4-dihdro-2H-3,1-benzoxazine-2-thiol product with a retention time of 3.2 min as
compared to the reference sample obtained from previous experiments carried out by research
colleagues.
3.4.2 Tanaproget synthesis
The precursor and tanaproget reference material were give to us by Graham Smith ans Louis
Allot from the Institute of Cancer Research and University of Hull.
Acyclic tanaproget (3.2 mg) was added to DMSO (0.5 mL) Cyclotron bombardment of 20 µA
for 2 minutes. 11CS2 produced as previously described, was bubbled through the solution.
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Once the 11CS2 had been delivered and trapped in the sample vial, the sample vial was placed
in a preheated heating block at 150 oC. The solution was stirred at 150 oC for 5 minutes.
Radio HPLC indicated 54% (4.4 min) product formation and 46% unreacted 11CS2 (6.0 min).
AMF pH 8.0:MeCN 48:52, 1.5 mL/min.
3.4.3 Improved Tanaproget synthesis
Acyclic tanaproget (4 mg) was added to DMSO (0.5 mL) Cyclotron bombardment of 20 µA
for 2 minutes. 11CS2 was bubbled through the solution. Once the
11CS2 had been delivered
and trapped in the sample vial, the sample vial was placed in a preheated heating block at
150 oC. After 2 minutes of heating an aliquot was taken and analysed by HPLC, indicating
13% product formation. A second aliquot was taken at 12 minutes indicating 91% product
formation. Finally a 3rd aliquot was taken at 24 minutes showing 99% product formation.
AMF pH 8.0:MeCN 48:52, 1.5 mL/min.
4 Thiocyanate chemistry
4.1 Synthetic chemistry
4.1.1 2-Amino-4-phenylthiazole formation184
Thiourea (40 mg, 0.55 mmol) was added to a solution of DMSO-d6 (0.6 mL) with stirring.
2-Bromoacetophenone (105 mg, 0.55 mmol) was added to the solution and stirred at ambi-
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ent temperature for 3 minutes. 1H NMR spectroscopy indicated 2-amino-4-phenylthiazole
product formation. 1H NMR (DMSO-d6, 400 MHz) δ: 9.95 (bs, 1H), 7.82 (bs, 2H, NH2),
7.62-6.81 (m, 6H).
4.1.2 Ammonium thiocyanate formation
Methanolic ammonia solution (2 M, 2 mL) was added to acetonitrile (50 mL), CS2 (0.6 mL)
was added and the solution refluxed for 30 minutes. The solvent was then removed under
reduced pressure revealing a white solid. NMR spectroscopy and mass spectrometry indicate
ammonium thiocyanate product formation. 1H NMR (Acetonitrile-d3, 400 MHz) δ: 6.23 (s).
13C NMR (Acetonitrile-d3, 101 MHz) δ: 117.3. EI-MS: m/z 18 (NH4
+) 58 (SCN−).
4.1.3 Phenacyl thiocyanate synthesis185 (13)
2-Bromoacetophenone (0.6 g, 3 mmol) and ammonium thiocyanate (0.23 g, 3 mmol) were
added to acetonitrile (12 mL) and the reaction mixture stirred for 1 hour at room tempera-
ture. The resulting solid was filtered off and the filtrate collected. The solvent was removed
under reduced pressure affording a pink orange solid (0.43 g, 81%). 1H NMR (DMSO-d6, 400
MHz) δ: 8.09 - 7.95 (m, 2H), 7.81 - 7.68 (m, 1H), 7.59 (t, J = 7.7 Hz, 2H), 5.13 (s, 2H). 13C
NMR (DMSO-d6, 101 MHz) δ: 192.8, 135.6, 134.8, 129.4, 129.0, 113.3, 42.3. ES-MS: m/z
175.9. FTIR(cm−1) 2148 (S-CN stretch)
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4.1.4 Benzyl thiocyanate formation185 (14)
Benzylbromide (1.2 mL, 10 mmol) and ammonium thiocyanate (0.77 g, 10 mmol) were added
to acetonitrile (25 mL) and the reaction mixture stirred for 1 hour under reflux. The filtrate
was collected leaving ammonium bromide salt as a white solid. The solvent was removed
under reduced pressure resulting in an orange pink oil (1.28 g, 86%). 1H NMR (Chloroform-
d, 400 MHz) δ: 7.48 - 7.33 (m, 5H), 4.18 (s, 2H). 13C NMR (Chloroform-d, 101 MHz) δ:
134.4, 129.2, 129.0, 128.9, 112.0, 38.4. FTIR(cm−1) 2153 (S-CN stretch)
4.1.5 General substituted phenacyl thiocyanate synthesis148
Bromoacetophenone (5 mmol) and ammonium thiocyanate (0.38 g, 5 mmol) were added to
acetonitrile (15 mL) and the reaction mixture refluxed for 1 hour. The solid was filtered
off from the filtrate and the solvent removed under reduced pressure affording solid. NMR
spectroscopy indicated formation of the substituted phenacyl thiocyanate product.
4.1.6 1-(3-nitrophenyl)-2-thiocyanatoethanone (15)
Yield: 0.83 g, 75%. 1H NMR (Acetonitrile-d3, 400 MHz) δ: 8.75 (t, J = 2.0 Hz, 1H), 8.51
(ddd, J = 8.2, 2.2, 1.0 Hz, 1H), 8.36 (ddd, J = 8.2, 2.2, 1.0 1H), 7.83 (t, J = 8.0 Hz, 1H),
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4.88 (s, 2H). 13C NMR (Acetonitrile-d3, 101 MHz) δ: 190.6, 135.7, 134.3, 130.6, 128.4, 123.1,
117.3, 111.7, 42.0.
4.1.7 4-chlorobenzoylmethyl thiocyanate (16)
Yield: 0.78 g, 74%. 1H NMR (DMSO-d6, 400 MHz) δ: 8.10 - 7.97 (m, 2H), 7.73 - 7.60 (m,
2H), 5.09 (s, 2H). 13C NMR (DMSO-d6, 101 MHz) δ: 191.9, 139.7, 133.5, 130.9, 129.5, 113.2,
42.0.
4.1.8 3,4-dichloro-phenacyl thiocyanate (17)
Yield: 0.83 g, 68%. 1H NMR (Chloroform-d, 400 MHz) δ: 8.05 (d, J = 2.0 Hz, 1H), 7.79
(dd, J = 8.4, 2.1 Hz, 1H), 7.65 (d, J = 8.4 Hz, 1H), 4.69 (s, 2H). 13C NMR (Chloroform-d,
101 MHz) δ: 188.8, 139.7, 134.1, 133.5, 131.4, 130.4, 127.4, 111.2, 42.3.
4.1.9 2-cyano-phenacyl thiocyanate (18)
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Yield: 0.45 g, 45%. 1H NMR (Acetonitrile-d3, 400 MHz) δ: 8.17 - 8.06 (m, 1H), 7.97 - 7.89
(m, 1H), 4.84 (s, 1H). 13C NMR (Acetonitrile-d3, 101 MHz) δ: 191.3, 137.5, 132.9, 128.9,
117.3, 111.7, 42.2.
4.1.10 1-(4-methoxyphenyl)-2-thiocyanatoethanone (19)
Yield: 0.73 g, 71%. 1H NMR (Chloroform-d, 400 MHz) δ: 8.00 - 7.89 (m, 2H), 7.07 - 6.94 (m,
2H), 4.74 (s, 2H), 3.92 (s, 3H). 13C NMR (Chloroform-d, 101 MHz) δ: 189.2, 164.8, 130.9,
127.0, 114.4, 112.1, 55.7, 42.9.
4.1.11 2-oxo-1,2-diphenylethyl thiocyanate (20)
Yield: 1.03 g, 82%. 1H NMR (Chloroform-d, 400 MHz) δ: 7.91 - 7.85 (m, 2H), 7.58 - 7.51
(m, 1H), 7.46 - 7.34 ( 7H), 6.19 (s, 1H). 13C NMR (Chloroform-d, 101 MHz) δ: 192.34, 134.6,
134.6, 133.4, 130.0, 129.9, 129.5, 129.1 (d, J = 6.1 Hz), 128.6, 112.4, 62.7.
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4.1.12 General thiazole synthesis186
The previously synthesised phenacyl thiocyanate (0.5 g) was added to a flask containing
acetic acid (20 mL). The solution was heated to reflux until the solid dissolved and a 50 %
solution of sulfuric acid (4 mL) was added. Reflux was continued for a further 20 minutes.
The reaction mixture was allowed to cool before being poured into cold water forming a
precipitate. This solid was collected by filtration and washed with hexane.
4.1.13 4-phenyl-4-thiazolin-2-one (21)
Yield: 0.47g, 94%. 1H NMR (DMSO-d6, 400 MHz) δ: 11.79 (s, 1H), 7.66 (d, J = 7.5 Hz,
2H), 7.43 (t, J = 7.5 Hz, 2H), 7.37 (t, J = 7.3 Hz, 1H), 6.82 (d, J = 1.8 Hz, 1H). 13C NMR
(DMSO-d6, 101 MHz) δ: 173.4, 134.3, 130.1, 129.3, 129.0, 125.4, 98.6.
4.1.14 4-(3-nitrophenyl)thiazol-2(3H)-one (22)
Yield: 0.38g, 76%. 1H NMR (DMSO-d6, 400 MHz) δ: 12.08 (s, 1H), 8.54 (t, J = 2.0 Hz,
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1H), 8.22 - 8.18 (m, 1H), 8.12 (ddd, J = 7.9, 1.9, 1.0 Hz, 1H), 7.73 (t, J = 8.0 Hz, 1H), 7.17
(d, J = 1.5 Hz, 1H). 13C NMR (DMSO-d6, 101 MHz) δ: 173.1, 172.5, 148.8, 132.3, 131.6,
130.9, 123.5, 119.9, 101.9.
4.1.15 (4-chlorophenyl)-2(3H)-thiazolone (23)
Yield: 0.35g, 70%. 1H NMR (DMSO-d6, 400 MHz) δ: 11.84 (s, 1H), 7.73 - 7.64 (m, 2H), 7.55
- 7.46 (m, 2H), 6.89 (d, J = 1.8 Hz, 1H). 13C NMR (DMSO-d6, 101 MHz) δ: 172.9, 133.1,
132.8, 128.90 , 128.5, 126.7, 99.2.
4.1.16 (3,4-dichlorophenyl)-2(3H)-thiazolone (24)
Yield: 0.46g, 92%. 1H NMR (DMSO-d6, 400 MHz) δ: 11.86 (s, 2H), 7.96 (d, J = 2.1 Hz,
2H), 7.73 - 7.61 (m, 4H), 7.04 (d, J = 1.9 Hz, 2H). 13C NMR (DMSO-d6, 101 MHz) δ: 172.6,
131.8, 131.5, 131.0, 130.9, 130.1, 126.7, 125.0, 100.8.
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4.1.17 4-(2-oxidanylidene-3H-1,3-thiazol-4-yl)benzenecarbonitrile (25)
Yield: 0.40g, 80%. 1H NMR (DMSO-d6, 400 MHz) δ: 11.99 (s, 1H), 7.94 - 7.90 (m, 2H), 7.88
- 7.83 (m, 2H), 7.17 (d, J = 1.9 Hz, 1H). 13C NMR (DMSO-d6, 101 MHz) δ: 173.1, 134.0,
133.3, 128.5, 125.9, 119.1, 111.1, 102.9.
4.1.18 4-(4-methoxyphenyl)-2-oxo-thiazole (26)
Yield: 0.42g, 84%. 1H NMR (DMSO-d6, 400 MHz) δ: 11.69 (s, 1H), 7.63 - 7.56 (m, 2H),
7.02 - 6.94 (m, 2H), 6.63 (d, J = 2.1 Hz, 2H), 3.78 (s, 3H). 13C NMR (DMSO-d6, 101 MHz)
δ: 173.5, 159.9, 134.2, 126.8, 122.9, 114.7, 96.3, 55.7.
4.1.19 General substituted aminobenzothiazole synthesis155
Ammonium thiocyanate (1.52 g, 50 mmol) and substituted aniline precursor (20 mmol) were
added to acetic acid (50 mL). The mixture was stirred in a cooling water bath for 10 minutes.
A dropping funnel was charged with bromine (1.54 mL, 30 mmol) in acetic acid (15 mL) and
added to the stirring solution over 30 minutes. Stirring was continued in a cooling bath
for 2 hours. Cold water was added to the solution before it was basified using ammonium
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hydroxide solution to pH 11.0. The product was then extracted with ethyl acetate (3 x 30
mL). The organic layer was then washed with water (30 mL), dried over magnesium sulfate
and removed under reduced pressure to give a crude solid. The solid was then recrystallised
from benzene.
4.1.20 2-Amino-6-methoxybenzothiazole (28)
Yield: 1/08 g, 40%. 1H NMR (DMSO-d6, 400 MHz) δ: 7.29 (d, J = 2.6 Hz, 1H), 7.26 - 7.17
(m, 3H), 6.81 (dd, J = 8.7, 2.7 Hz, 1H), 3.74 (s, 3H). 13C NMR (DMSO-d6, 101 MHz) δ:
165.2, 154.7, 147.3, 132.4, 118.5, 113.3, 106.0, 56.0. ES+MS: m/z 181.0
4.1.21 2-Amino-6-fluorobenzothiazole (29)
Yield: 2.71 g, 81%. 1H NMR (DMSO-d6, 400 MHz) δ: 7.58 (dd, J = 8.8, 2.7 Hz, 1H), 7.46
(s, 2H), 7.30 (dd, J = 8.7, 4.8 Hz, 1H), 7.04 (td, J = 9.1, 2.8 Hz, 1H). 13C NMR (DMSO-d6,
101 MHz) δ: 166.8, 158.8, 156.4, 149.9, 132.4 (d, J = 11.2 Hz), 118.6 (d, J = 9.1 Hz), 113.2
(d, J = 23.5 Hz), 108.2 (d, J = 27.4 Hz).
4.1.22 2-Amino-6-chlorobenzothiazole (30)
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Yield: 1.35 g, 37%, 1H NMR (DMSO-d6, 400 MHz) δ: 7.77 (d, J = 2.2 Hz, 1H), 7.60 (s, 3H),
7.30 (d, J = 8.5 Hz, 1H), 7.22 (dd, J = 8.6, 2.2 Hz, 1H). 13C NMR (DMSO-d6, 101 MHz) δ:
167.6, 152.2, 133.1, 126.0, 124.9, 121.0, 119.0.
4.1.23 2-Amino-6-methylbenzothiazole (31)
Yield: 3.26 g, 92%, 1H NMR (DMSO-d6, 400 MHz) δ: 7.42 (dd, J = 1.6, 0.8 Hz, 1H), 7.35
- 7.30 (m, 3H), 7.21 (d, J = 8.1 Hz, 1H), 7.00 (ddd, J = 8.1, 1.8, 0.7 Hz, 1H), 2.30 (s, 3H).
13C NMR (DMSO-d6, 101 MHz) δ: 165.6, 150.6, 129.8, 128.3, 126.4, 120.4, 117.4, 20.2.
4.1.24 General thiourea synthesis from ammonium thiocyanate187
A substituted aniline precursor (10 mmol) and ammonium thiocyanate (10 mmol) were re-
fluxed in 1 M hydrochloric acid (25 mL) overnight. Upon cooling water (25 mL) was added
and left in the fridge for crystals to form.
4.1.25 Phenylthiourea (32)
Yield: 0.22g, 14%. 1H NMR (DMSO-d6, 400 MHz) δ: 9.70 (s, 1H), 7.54 (br s, 2H, NH), 7.41
(dd, J = 8.4, 1.4 Hz, 2H), 7.36 - 7.29 (m, 2H), 7.16 - 7.07 (m, 1H). 13C NMR (DMSO-d6,
101 MHz) δ: 181.5, 139.6, 129.1, 124.8, 123.5.
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4.1.26 4-Fluorophenylthiourea (33)
Yield: 0.11g, 6%. 1H NMR (DMSO-d6, 400 MHz) δ: 9.66 (s, 1H), 7.51 (br s, 2H, NH), 7.39
(dd, J = 8.8, 5.0 Hz, 2H), 7.20 - 7.07 (m, 2H). 13C NMR (DMSO-d6, 101 MHz) δ: 135.9,
126.0 (d, J = 8.3 Hz), 115.8, 115.6, 40.6, 40.4.
4.1.27 4-Methoxyphenylthiourea (34)
Yield: 0.02g, 1%. 1H NMR (DMSO-d6, 400 MHz) δ: 9.47 (s, 1H), 7.29 (br s, 2H, NH), 7.20
(d, J = 8.3 Hz, 2H), 6.90 - 6.85 (m, 2H), 3.72 (s, 3H). 13C NMR (DMSO-d6, 101 MHz) δ:
157.0, 126.0, 114.4, 55.7.
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4.2 Halide substitution radiochemistry
4.2.1 General 11C substituted phenacyl thiocyanate synthesis
13 15 16
17 18 19
Cyclotron bombardment of 20 µA for 3 minutes. 11CS2 was produced as previously described
(1.3.1) and bubbled through acetonitrile (1 mL). Methanolic ammonia solution (50 µL, 2 M)
was added to the vial and heated to 95 oC for 10 minutes. The vial was removed from the
heater and brominated precursor (5 mg) in a solution of acetonitrile (0.1 mL) added. The
vial was stirred for a further 10 minutes at room temperature before radio HPLC analysis
(AMF pH 8.0 : MeCN, 50:50, 1.5 mL/min) with a spiked co-injection confirmed the presence
of the thiocyanate product. Retention times and RCYs respectively: 13 (4.2 min, >95%),
15 (3.1 min, >95%), 16 (4.7 min, >95%), 17 (7.5 min, >95%), 18 (2.7 min, >95%), 19 (3.4
min, >95%).
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4.2.2 General 11C thiazole synthesis
21 22 23
24 25 26
Cyclotron bombardment of 20 µA for 3 minutes. 11C ammonium thiocyanate was formed as
previously described (4.1.2). Bromoacetophenone precursor (5 mg) in a solution of acetoni-
trile (0.1 mL) was added to the 11C ammonium thiocyanate solution. The vial was stirred for
a further 5 minutes with heating to give 11C phenacyl thiocyanate. To the solution contain-
ing the 11C phenacyl thiocyanate was added 50% H2SO4 (0.5 mL) and acetic acid (0.5 mL).
Heating was continued for a further 5 minutes before radio HPLC analysis (AMF pH 8.0 :
MeCN, 60:40, 1.5 mL/min) with spiked co-injection confirmed the presence of the thiazole
product. Retention times and RCYs respectively: 21 (5.2 min, >95%), 22 (2.9 min, 70%),
23 (4.6 min, 73%), 24 (7.9 min, 89%), 25 (2.3 min, 88%), 26 (2.9 min, >95%)
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5 Trapping and reactions on a microfluidic device
5.0.1 General considerations
For all experiments 11CS2 was formed using the method described in experiment 1.3.1 and
flowed through the system in a stream of helium carrier gas at 10 mL/min unless otherwise
stated. The cyclotron conditions used were a bombardment of the target at 10 µA for 5
minutes if not described. All tubing used was 1/16” OD PTFE. All radio analytical HPLC
was carried using flow rate of 1.5 mL/min in acetonitrile and water in a 50:50 ratio unless
otherwise stated on an Agilent Eclipse XDB-C18, 5 µm, 4.6 x 150 mm column.
5.1 11CS2 trapping
5.1.1 Attempted trapping in cooled tubing (-78 oC)
Upon exit from the furnace the tubing (0.18 mm ID, 50 cm in length) was coiled and placed
in an acetone / dry ice bath (-78oC). No apparent trapping of 11CS2 was observed in the
tubing as indicated by the pin diode readings. After a few minutes of flow the bubbling
in the vial stopped, while flow into the system had not been shut off, this indicated that a
blockage in the tubing had formed preventing the flow of gas from reaching the vial. Removal
of the tubing from the cooling bath allowed the tubing to warm to ambient temperature, this
cleared the blockage and flow resumed. This indicated that the blockage was likely due to a
small amount of water freezing in the tubing.
5.1.2 Trapping in cooled tubing (-196 oC), reaction with amine
11CS2 produced as previously described however the sand was pre-dried before loading into
the column to remove any residual water. Coiled tubing trap was placed in a N2 (l) bath at
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-196 oC. Pin diodes located adjacent to the cooled trap and collection vial indicated successful
trapping of the 11CS2 with no blockages. Upon warming of the trap the activity was observed
to pass from the trap to the vial containing acetonitrile (1 mL) and cyclohexylamine (10 µL).
Radio HPLC at 1.5 mL/min in acetonitrile and water in a 50:50 ratio showed full conversion
to dithiocarbamate with no residual 11CS2 or
11CH3I. Heating of the vial to 95
oC for 12
minutes showed total conversion to the 1,3-dicyclohexyl-2-thiourea by HPLC.
5.1.3 Trapping in cooled MFD (-196 oC)
A MFD prefabricated from Dolomite Microfluidics with a reactor channel 110 µm wide and
100 µm deep, and the main reactor channel was 300 mm in length. The total volume of
the device was 2.5 µL. Prior to immersion in the N2 (l) bath the MFD was pre-cooled in a
acetonitrile / dry ice bath to reduce thermal shock and prevent cracking. Once the MFD
had been cooled to -196 oC the system was flushed with He, flow was maintained through
the MFD once cooled to prevent blockages. Cyclotron Bombardment of 10 µA for 5 minutes.
11CS2 produced as previously described. Soon after the furnace had reached temperature
and 11CH3I was delivered from the mini cell flow in the vial ceased, indicating a blockage in
the MFD. Soon after the removal of the MFD from the cooling bath the blockage cleared
and flow resumed.
5.1.4 Trapping in cooled MFD (-196 oC) with a pre trap
The system was altered to include a section of coiled FEP tubing (0.5 mm ID, 5 cm long)
placed in a dry ice/ acetone bath at -78 oC between the furnace and the MFD. The MFD
was cooled first to -78 oC and then to -196 oC (Fig. 5.5). The system was then flushed with
helium for 5 minutes to monitor any blockages. Pin diode readings indicated that trapping
on the MFD was successful with only a small amount of radiation passing into the vial. Upon
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removal of the MFD from the cooling bath it warmed to room temperature, Once at room
temperature the flow of helium was resumed and the activity was seen to pass from the MFD
into the vial.
5.2 Dithiocarbamate formation (35)
5.2.1 On-chip trapping of 11CS2 and reaction with cyclohexylamine
Chip cooled to -78 oC then -196 oC with the pre-trap cooled to -78 oC in a dry ice/acetone
bath. A slug of cyclohexylamine solution 0.1 mL (50:50 acetonitrile:cyclohexylamine) was
loaded into tubing connected to the MFD. Cyclotron Bombardment of 20 µA for 5 minutes.
11CS2 was successfully trapped on the MFD as described in experiment 5.1.4. The MFD was
then removed from the cooling bath and allowed to equilibrate to room temperature, this
took 8 minutes and was monitored by the USB digital microscope. The slug of amine was
flowed through the MFD at 100 µL/min.The digital USB microscope showed that when the
slug enters the MFD a brown precipitate formed immediately blocking the channel, some
activity did pass into vial but a very small amount.
5.2.2 Chip trapping of 11CS2 and reaction with amine in ethanol
A solution of ethanol and cyclohexylamine 50:50 (1µL) loaded into tubing (20 cm) before
the MFD. Cyclotron Bombardment of 30 µA for 2 minutes. 11CS2 produced as previously
described. Pin diodes indicated successful trapping on MFD. The MFD was lifted out of
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the cooling bath and allowed to warm up for 8 minutes. The segment of ethanol and cy-
clohexylamine solution was passed through the device at 50 µL/min. The droplet turned
brown in colour on contact with the channel walls. The droplet was flushed out of the MFD
and exit tubing with ethanol (0.5 mL). Radio HPLC indicated complete conversion to the
dithiocarbamate with no 11CS2 remaining.
6 Microfluidic hydrogenation
6.1 Segmented flow hydrogenation reactions
6.1.1 Stopped flow hydrogenation reactions, PEEK tubing
A hydrogen gas cylinder controlled by a Sierra Instruments micro-trak mass flow meter and
a 5 mL SGE gas tight syringe charged with toluene on a Harvard apparatus Pump 11 Elite
syringe pump were connected to a Rheodyne dual mode, analytical injector (Part no. 7725)
via 30 cm PEEK, 1/16” OD, 0.8 mm ID tubing, to a Upchurch Scientific PEEK Y-connector
(Part no. P-512). This was connected to a 4 cm length of FEP, 1/16”, OD 0.8 mm ID tubing.
Connected to a Upchurch Scientific PEEK shut-off valve (Part no. P-7322) connected to 180
cm PEEK, 1/16” OD, 0.8 mm ID tubing was capped with a Upchurch Scientific PEEK
shut-off valve (Part no. P-7322) connecting another short section (15 cm) of FEP tubing, as
an outflow channel (Fig. 6.4). Flow rates of 300 µL/min and 15 µL/min, for the hydrogen
and toluene respectively resulting in a retention time of 210 seconds. The PEEK tubing was
coiled and placed in an oil bath at 90 oC. The Rheodyne valve was opened releasing the
reagent solution into the segmented flow and the timer started. At 210 seconds the shut-off
valve at the end of the reaction channel was closed, and the syringe pump stopped. The
hydrogen flow was continued until the pressure gauge on the mass flow meter read 3 bar, the
shut off valve at the start of the PEEK tubing was then closed, sealing the reaction loop.
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The reaction was left heating for 16 hours. 1H NMR spectroscopy analysis showed that the
reaction has been successful with conversions of between 60-65% to ethylbenzene. 1H NMR
(400 MHz, Toluene-d8) δ 7.20-7.05 (m, 5H), 2.49 (q, J = 7.6 Hz, 2H), 1.14 (t, J = 7.6 Hz,
3H).
6.1.2 Stopped flow hydrogenation reactions, stainless steel tubing.
A hydrogen cylinder connected to a Sierra Instruments micro-trak mass flow meter was
used to deliver hydrogen at a constant flow rate. A 5 mL SGE luerlock syringe (Part
no. 008760) was charged with the a solution of styrene (1 M) in deuterated toluene with
chlorotris(triphenylphosphine) rhodium(I) (Wilkinson’s catalyst) (0.5 mol%), was fitted to
a Harvard apparatus Pump 11 Elite syringe pump. These two devices were connected to
two short sections of PTFE 1/16” OD 0.25 mm ID tubing (30 cm), which met at a Up-
church Scientific PEEK Y-conector (Part no. P-512). To the outflow of this Y- connector
was attached a 500 µL Rheodyne stainless steel loop (Part no. 7755-026) with an internal
diameter (ID) of 0.76 mm. At the end of the stainless steel loop was connected an Upchurch
Scientific PEEK shut-off valve (Part no. P-7322); before connecting to a clear FEP outflow
tube, with an ID 0.8 mm and length 30 cm. The flow rates were set to 300 µL/min for the
flow of hydrogen gas and 25 µL/min for the flow of the syringe pump. An even and regular
segmented flow was formed which passed through the stainless steel loop placed in an oil
bath at 95 oC. Once a desired segmented flow had been established after 15 seconds flow is
continued until it emerges from the stainless steel loop. The shut-off valve was closed and the
solution flow from the syringe pump stopped. The hydrogen flow was left on at a constant
flow rate allowing the pressure to build up to 4 bar, compressing the segments inside the
stainless steel loop. This was left heating for around 3 hours before the pressure was released
and the solution was collected. Proton NMR and GC analysis showed that the reaction has
been successful with conversions of 91% to ethylbenzene. 1H NMR (400 MHz, Toluene-d8) δ
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7.20-7.05 (m, 5H), 2.49 (q, J = 7.6 Hz, 2H), 1.14 (t, J = 7.6 Hz, 3H).
6.1.3 Continuous flow hydrogenation reactions.
A hydrogen cylinder connected to a Sierra Instruments micro-trak mass flow meter was used
to deliver hydrogen at a constant flow rate. A 5 mL SEG syringe charged with a solution of
styrene (1 M) in deuterated toluene with chlorotris(triphenylphosphine) rhodium(I) (Wilkin-
son’s catalyst) (0.5 mol%), was fitted to a Harvard apparatus Pump 11 Elite syringe pump.
These two devices were connected to two short sections of PTFE tubing, which met at a
Upchurch Scientific PEEK Y-conector (Part no. P-512). To the outflow of this Y- connector
was attached a 10 m length of 1/16” OD, 0.8 mm ID, PTFE tubing (Fig. 6.8). The flow
rates were set at 100 µL/min with respects to the hydrogen and 7 µL/min with respects to
the reagent solution. The segments flowed in to the PTFE tubing which was placed in an oil
bath at 85 oC. The residence time of the segments through the tubing was approximately 4
hours from formation to exit at the end. The pressure at the hydrogen regulator was set to 2
bar so the mass flow meter would automatically shut off if the internal pressure of the tubing
reached this level. Proton NMR analysis showed that the reaction has been successful with
conversions of 30% to ethylbenzene. 1H NMR (400 MHz, Toluene-d8) δ 7.20-7.05 (m, 5H),
2.49 (q, J = 7.6 Hz, 2H), 1.14 (t, J = 7.6 Hz, 3H).
6.2 Annular flow hydrogenation reactions
6.2.1 Homogeneous hydrogenations
A microfluidic device, fabricated by Dolomite, Ltd. The reactor channels were 220 µm wide
and 100 µm deep, and the main reactor channel was 5 m in length. The total volume of the
device was 86 µL. External PTFE (1/16” OD, 0.25 mm ID) tubing was connected to the
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microfluidic reactor by using a standard Dolomite microflux connecting assembly. A Harvard
apparatus pump 11 elite syringe pump was used to infuse the substrate and catalyst solution.
The second inlet was connected to the H2 gas line. Hydrogen flow was controlled by a Sierra
Instruments Micro-Trak mass flow meter. In a typical reaction procedure, a toluene solution
of the substrate (1 M) and Wilkinson’s catalyst (0.5 mol%) was infused into the MFD at a
flow rate of 10 mL/min. Hydrogen gas flow was maintained at 2.0 sccm, resulting in annular-
type flow through the device. Back pressure in the system for this particular MFD was 2
bar under these flow conditions. The device was heated to 120 oC by using an aluminium
heating block placed on hotplate and regulated by using an electronic contact thermometer.
An aliquot (900 µL) was collected for each sample, which was passed through a small pad of
Celite prior to GC analysis.
6.2.2 Heterogeneous rhodium deposition
The channel surface was coated in a layer of catalytically active metallic Rh by simply passing
a premixed toluene solution of styrene (1 M) and Wilkinson’s catalyst (0.5 mol%) through
the device at a flow rate of 10 mL/min, hydrogen flow of 2.0 sccm, and heating to 120 oC.
Approximately 1 mL of solution was passed through the device to generate an even coverage
of the first 4-5 channels. Attempts to increase the surface coverage by infusing more catalyst/
substrate solution resulted in a deeper layer of the Rh deposit near the gas-liquid inlets; this
layer restricted flow, which resulted in an undesirable increase in back pressure.
6.2.3 Heterogeneous rhodium control
A 1/16” PEEK T-piece was connected to the liquid and gas inlet lines, and a 5 m reaction
coil of PTFE tubing (1/16” OD, 0.2 mm ID) was placed into an oil bath at 120 oC. Identical
liquid and gas flow rates to that described above were employed. In a typical procedure, a
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premixed toluene solution of styrene (1 M) and Wilkinson’s catalyst (0.5 mol%) was infused
into the reactor. A black precipitate of metallic Rh was observed to form over the course of
the reaction. This passed through the reactor without adhering to the tubing walls and was
collected for analysis by TEM and powder X-ray diffraction analysis.
6.2.4 Heterogeneous hydrogenations
Using the channel coated with the rhodium layer an identical system to that of the homo-
geneous reaction system described above was used. Liquid and gas flow rates were identical
in all cases. In a typical procedure, a toluene solution of the substrate (1 m) without any
added catalyst was infused into the device at a flow rate of 10 mL/min and under gas flow
of 2.0 sccm. An aliquot (900 µL) was collected for each sample, which was analysed directly
by GC. Reactions of toluene were performed either neat or as a 1 m solution in decane.
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Appendix
1 HPLC data
The radioactive HPLC for each compound is shown on top, with the reference HPLC trace
shown below either as a pure reference or a spiked co-injection.
* indicates co-injected (spiked) reference sample rather than a pure reference sample.
1.1 Carbon disulfide
174
1.2 Thioureas
1.2.1 1,3-dimethyl-2-thiourea
1.2.2 1,3-dibenzyl-2-thiourea
175
1.2.3 N,N’-bis-(1-phenyl-ethyl)-thiourea
176
1.2.4 1,3-diphenyl-2-thiourea
1.2.5 1,3-bis(cyclohexyl)-thiourea
177
1.2.6 benzimidazole-2-thiol
1.2.7 imidazole-2-thione
178
1.2.8 octahydro-benzoimidazole-2-thione
1.2.9 3,4-dihydro-2(1H)-quinazolinethion
179
*1.3 Thiocyanates and derivatives
1.3.1 Benzyl thiocyanate
*
180
1.3.2 Phenacyl thiocyanate
*
1.3.3 1-(3-nitrophenyl)-2-thiocyanatoethanone
181
1.3.4 2-cyano-phenacyl thiocyanate
182
1.3.5 4-chlorobenzoylmethyl thiocyanate
1.3.6 3,4-dichloro-phenacyl thiocyanate
183
1.3.7 1-(4-methoxyphenyl)-2-thiocyanatoethanone
184
1.3.8 2-oxo-1,2-diphenylethyl thiocyanate
1.4 Thiazoles
1.4.1 4-Phenyl-4-thiazolin-2-one
185
1.4.2 4-(3-nitrophenyl)thiazol-2(3H)-one
186
1.4.3 4-(2-oxidanylidene-3H-1,3-thiazol-4-yl)benzenecarbonitrile
1.4.4 (4-chlorophenyl)-2(3H)-thiazolone
187
1.4.5 (3,4-dichlorophenyl)-2(3H)-thiazolone
188
1.4.6 4-(4-methoxyphenyl)-2-oxo-thiazole
189
